id	sid	tid	token	lemma	pos
work_tpiqgspaqvfeng2fovbximt4lm	1	1	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	3	Cytochrome	Cytochrome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	4	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	5	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	1	6	Genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	7	With	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	1	9	Antiplatelet	Antiplatelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	10	Effect	Effect	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	1	12	Clinical	Clinical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	13	Efficacy	Efficacy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	14	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	15	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	16	Therapy	Therapy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	17	ORIGINAL	ORIGINAL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	18	CONTRIBUTION	CONTRIBUTION	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	19	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	21	Cytochrome	Cytochrome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	22	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	23	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	1	24	Genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	25	With	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	26	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	1	27	Antiplatelet	Antiplatelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	28	Effect	Effect	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	29	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	1	30	Clinical	Clinical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	31	Efficacy	Efficacy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	32	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	33	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	34	Therapy	Therapy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	35	Alan	Alan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	36	R.	R.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	37	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	38	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	39	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	40	Jeffrey	Jeffrey	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	41	R.	R.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	42	O’Connell	O’Connell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	43	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	44	DPhil	DPhil	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	45	Kevin	Kevin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	46	P.	P.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	47	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	48	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	49	BS	BS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	50	Amish	Amish	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	51	Gandhi	Gandhi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	52	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	53	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	54	Kathleen	Kathleen	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	55	Ryan	Ryan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	56	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	57	MPH	MPH	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	58	Richard	Richard	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	59	B.	B.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	60	Horenstein	Horenstein	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	61	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	62	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	63	Coleen	Coleen	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	64	M.	M.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	65	Damcott	Damcott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	66	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	67	PhD	phd	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	68	Ruth	Ruth	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	69	Pakyz	Pakyz	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	70	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	71	BS	BS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	72	Udaya	Udaya	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	73	S.	S.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	74	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	75	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	76	PhD	phd	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	77	Quince	Quince	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	78	Gibson	Gibson	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	79	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	80	MBA	MBA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	81	Toni	Toni	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	82	I.	I.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	83	Pollin	Pollin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	84	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	85	PhD	phd	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	86	Wendy	Wendy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	87	Post	Post	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	88	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	89	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	90	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	91	MS	MS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	92	Afshin	Afshin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	93	Parsa	Parsa	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	94	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	95	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	96	Braxton	Braxton	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	97	D.	D.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	98	Mitchell	Mitchell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	99	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	100	PhD	phd	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	101	Nauder	Nauder	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	102	Faraday	Faraday	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	103	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	104	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	105	William	William	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	106	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	107	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	108	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	109	Paul	Paul	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	110	A.	a.	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	111	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	112	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	113	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	114	D	D	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	115	UAL	UAL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	116	ANTIPLATELET	antiplatelet	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	117	THERAPY	THERAPY	NNS
work_tpiqgspaqvfeng2fovbximt4lm	1	118	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	119	including	include	VBG
work_tpiqgspaqvfeng2fovbximt4lm	1	120	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	121	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	1	122	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	123	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	124	inhibits	inhibit	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	1	125	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	126	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	127	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	128	preventing	prevent	VBG
work_tpiqgspaqvfeng2fovbximt4lm	1	129	ische-	ische-	FW
work_tpiqgspaqvfeng2fovbximt4lm	1	130	mic	mic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	131	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	1	132	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	1	133	improving	improve	VBG
work_tpiqgspaqvfeng2fovbximt4lm	1	134	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	1	135	fol-	fol-	RB
work_tpiqgspaqvfeng2fovbximt4lm	1	136	lowing	low	VBG
work_tpiqgspaqvfeng2fovbximt4lm	1	137	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	1	138	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	1	139	syndromes	syndrome	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	1	140	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	1	141	percutaneous	percutaneous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	1	142	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	1	143	intervention	intervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	144	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	1	145	PCI).1,2	pci).1,2	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	146	To	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	1	147	exert	exert	VB
work_tpiqgspaqvfeng2fovbximt4lm	1	148	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	1	149	antiplatelet	antiplatelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	150	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	151	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	152	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	153	requires	require	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	1	154	conversion	conversion	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	155	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	156	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	1	157	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	1	158	thiol	thiol	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	159	metabolite	metabolite	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	160	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	1	161	SR	SR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	162	26334	26334	CD
work_tpiqgspaqvfeng2fovbximt4lm	1	163	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	1	164	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	165	hepatic	hepatic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	1	166	cytochrome	cytochrome	FW
work_tpiqgspaqvfeng2fovbximt4lm	1	167	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	168	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	1	169	CYP	CYP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	170	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	1	171	iso-	iso-	VBP
work_tpiqgspaqvfeng2fovbximt4lm	1	172	enzymes	enzyme	NNS
work_tpiqgspaqvfeng2fovbximt4lm	1	173	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	1	174	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	1	175	inhibit	inhibit	VBP
work_tpiqgspaqvfeng2fovbximt4lm	1	176	adenosine	adenosine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	177	di-	di-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	178	phosphate	phosphate	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	179	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	1	180	ADP)–stimulated	adp)–stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	1	181	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	182	For	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	1	183	editorial	editorial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	1	184	comment	comment	NN
work_tpiqgspaqvfeng2fovbximt4lm	1	185	see	see	VB
work_tpiqgspaqvfeng2fovbximt4lm	1	186	p	p	NNP
work_tpiqgspaqvfeng2fovbximt4lm	1	187	896	896	CD
work_tpiqgspaqvfeng2fovbximt4lm	1	188	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	2	1	Author	author	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	2	Affiliations	Affiliations	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	2	4	Division	Division	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	6	Endocrinology	Endocrinology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	8	Dia-	Dia-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	9	betes	bete	NNS
work_tpiqgspaqvfeng2fovbximt4lm	2	10	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	11	Nutrition	Nutrition	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	13	Department	Department	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	14	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	15	Medicine	Medicine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	16	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	17	Drs	Drs	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	18	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	20	O’Connell	O’Connell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	22	Gandhi	Gandhi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	24	Horenstein	Horenstein	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	26	Damcott	Damcott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	27	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	28	Pollin	Pollin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	29	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	30	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	31	Mitchell	Mitchell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	32	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	33	Mss	Mss	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	34	Ryan	Ryan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	35	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	36	Pakyz	Pakyz	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	38	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	39	Mr	Mr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	40	Gib-	Gib-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	41	son	son	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	42	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	43	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	44	Division	Division	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	45	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	46	Nephrology	Nephrology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	47	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	48	Department	Department	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	49	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	50	Medi-	Medi-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	51	cine	cine	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	52	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	53	Dr	Dr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	54	Parsa	Parsa	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	55	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	56	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	57	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	58	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	59	Maryland	Maryland	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	60	School	School	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	61	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	62	Medi-	Medi-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	63	cine	cine	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	64	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	65	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	66	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	2	67	Geriatric	Geriatric	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	68	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	69	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	70	Education	Education	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	71	Clinical	Clinical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	72	Center	Center	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	73	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	74	Veterans	Veterans	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	75	Administration	Administration	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	76	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	77	Cen-	Cen-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	78	ter	ter	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	79	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	80	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	81	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	82	Dr	Dr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	83	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	84	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	85	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	2	86	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	87	Center	Center	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	88	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	89	Throm-	Throm-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	90	bosis	bosis	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	91	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	92	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	93	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	94	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	95	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	96	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	97	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	98	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	99	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	100	Mr	Mr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	101	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	102	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	103	Drs	Drs	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	104	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	105	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	106	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	107	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	108	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	109	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	110	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	111	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	2	112	Di-	di-	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	113	vision	vision	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	114	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	115	Cardiology	Cardiology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	116	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	117	Department	Department	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	118	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	119	Medicine	Medicine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	120	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	121	Drs	Drs	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	122	Post	Post	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	123	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	124	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	125	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	126	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	2	127	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	128	Department	Department	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	129	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	130	Anesthesiology	Anesthesiology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	131	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	2	132	Critical	Critical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	133	Care	Care	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	134	Medicine	Medicine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	135	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	136	Dr	Dr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	137	Faraday	Faraday	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	138	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	2	139	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	140	Johns	Johns	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	141	Hopkins	Hopkins	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	142	Uni-	Uni-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	143	versity	versity	NN
work_tpiqgspaqvfeng2fovbximt4lm	2	144	School	School	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	145	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	2	146	Medicine	Medicine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	147	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	2	148	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	2	149	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	3	1	Corresponding	Corresponding	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	2	Author	author	NN
work_tpiqgspaqvfeng2fovbximt4lm	3	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	3	4	Alan	Alan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	5	R.	R.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	6	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	8	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	10	Divi-	Divi-	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	3	11	sion	sion	NN
work_tpiqgspaqvfeng2fovbximt4lm	3	12	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	3	13	Endocrinology	Endocrinology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	15	Diabetes	diabetes	NN
work_tpiqgspaqvfeng2fovbximt4lm	3	16	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	3	17	Nutrition	nutrition	NN
work_tpiqgspaqvfeng2fovbximt4lm	3	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	19	Uni-	Uni-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	20	versity	versity	NN
work_tpiqgspaqvfeng2fovbximt4lm	3	21	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	3	22	Maryland	Maryland	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	23	School	School	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	3	25	Medicine	Medicine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	27	660	660	CD
work_tpiqgspaqvfeng2fovbximt4lm	3	28	W	w	NN
work_tpiqgspaqvfeng2fovbximt4lm	3	29	Red-	Red-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	30	wood	wood	NN
work_tpiqgspaqvfeng2fovbximt4lm	3	31	St	St	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	32	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	33	Room	Room	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	34	494	494	CD
work_tpiqgspaqvfeng2fovbximt4lm	3	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	36	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	3	38	MD	MD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	39	21201	21201	CD
work_tpiqgspaqvfeng2fovbximt4lm	3	40	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	3	41	ashuldin	ashuldin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	3	42	@medicine.umaryland.edu	@medicine.umaryland.edu	.
work_tpiqgspaqvfeng2fovbximt4lm	3	43	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	3	44	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	4	1	Context	Context	NNP
work_tpiqgspaqvfeng2fovbximt4lm	4	2	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	4	3	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	4	4	improves	improve	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	4	5	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	4	6	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	4	7	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	4	8	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	4	9	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	4	10	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	4	11	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	4	12	syndromes	syndrome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	4	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	4	14	following	follow	VBG
work_tpiqgspaqvfeng2fovbximt4lm	4	15	percutaneous	percutaneous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	4	16	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	4	17	intervention	intervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	4	18	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	4	19	inhibiting	inhibit	VBG
work_tpiqgspaqvfeng2fovbximt4lm	4	20	adenosine	adenosine	NN
work_tpiqgspaqvfeng2fovbximt4lm	4	21	diphosphate	diphosphate	NN
work_tpiqgspaqvfeng2fovbximt4lm	4	22	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	4	23	ADP)–dependent	adp)–dependent	NN
work_tpiqgspaqvfeng2fovbximt4lm	4	24	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	4	25	activation	activation	NN
work_tpiqgspaqvfeng2fovbximt4lm	4	26	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	5	1	However	however	RB
work_tpiqgspaqvfeng2fovbximt4lm	5	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	5	3	nonrespon-	nonrespon-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	5	4	siveness	siveness	NNP
work_tpiqgspaqvfeng2fovbximt4lm	5	5	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	5	6	widely	widely	RB
work_tpiqgspaqvfeng2fovbximt4lm	5	7	recognized	recognize	VBN
work_tpiqgspaqvfeng2fovbximt4lm	5	8	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	5	9	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	5	10	related	relate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	5	11	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	5	12	recurrent	recurrent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	5	13	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	5	14	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	5	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	6	1	Objective	objective	JJ
work_tpiqgspaqvfeng2fovbximt4lm	6	2	To	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	6	3	identify	identify	VB
work_tpiqgspaqvfeng2fovbximt4lm	6	4	gene	gene	NN
work_tpiqgspaqvfeng2fovbximt4lm	6	5	variants	variant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	6	6	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	6	7	influence	influence	VBP
work_tpiqgspaqvfeng2fovbximt4lm	6	8	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	6	9	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	6	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	7	1	Design	design	NN
work_tpiqgspaqvfeng2fovbximt4lm	7	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	7	3	Setting	setting	NN
work_tpiqgspaqvfeng2fovbximt4lm	7	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	7	5	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	7	6	Participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	7	7	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	7	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	7	9	Pharmacogenomics	Pharmacogenomics	NNP
work_tpiqgspaqvfeng2fovbximt4lm	7	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	7	11	Antiplatelet	Antiplatelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	7	12	In-	in-	IN
work_tpiqgspaqvfeng2fovbximt4lm	7	13	tervention	tervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	7	14	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	7	15	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	7	16	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	7	17	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	7	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	7	19	2006	2006	CD
work_tpiqgspaqvfeng2fovbximt4lm	7	20	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	7	21	2008	2008	CD
work_tpiqgspaqvfeng2fovbximt4lm	7	22	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	7	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	7	24	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	7	25	administered	administer	VBD
work_tpiqgspaqvfeng2fovbximt4lm	7	26	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	7	27	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	7	28	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	7	29	days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	7	30	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	7	31	429	429	CD
work_tpiqgspaqvfeng2fovbximt4lm	7	32	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	7	33	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	7	34	persons	person	NNS
work_tpiqgspaqvfeng2fovbximt4lm	7	35	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	7	36	measured	measure	VBN
work_tpiqgspaqvfeng2fovbximt4lm	7	37	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	7	38	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	7	39	ex	ex	NNP
work_tpiqgspaqvfeng2fovbximt4lm	7	40	vivo	vivo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	7	41	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	7	42	aggregometry	aggregometry	NN
work_tpiqgspaqvfeng2fovbximt4lm	7	43	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	8	1	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	8	2	genome	genome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	8	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	8	4	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	8	5	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	8	6	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	8	7	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	8	8	performed	perform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	8	9	followed	follow	VBN
work_tpiqgspaqvfeng2fovbximt4lm	8	10	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	8	11	genotyping	genotype	VBG
work_tpiqgspaqvfeng2fovbximt4lm	8	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	8	13	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	8	14	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	8	15	of-	of-	CD
work_tpiqgspaqvfeng2fovbximt4lm	8	16	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	8	17	cytochrome	cytochrome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	8	18	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	8	19	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	8	20	CYP	CYP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	8	21	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	8	22	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	8	23	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	8	24	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	8	25	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	8	26	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	8	27	rs4244285	rs4244285	NNP
work_tpiqgspaqvfeng2fovbximt4lm	8	28	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	8	29	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	9	1	Findings	finding	NNS
work_tpiqgspaqvfeng2fovbximt4lm	9	2	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	9	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	9	4	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	9	5	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	9	6	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	9	7	extended	extend	VBN
work_tpiqgspaqvfeng2fovbximt4lm	9	8	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	9	9	examining	examine	VBG
work_tpiqgspaqvfeng2fovbximt4lm	9	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	9	11	relation	relation	NN
work_tpiqgspaqvfeng2fovbximt4lm	9	12	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	9	13	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	9	14	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	9	15	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	9	16	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	9	17	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	9	18	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	9	19	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	9	20	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	9	21	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	9	22	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	9	23	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	9	24	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	9	25	independent	independent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	9	26	sample	sample	NN
work_tpiqgspaqvfeng2fovbximt4lm	9	27	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	9	28	227	227	CD
work_tpiqgspaqvfeng2fovbximt4lm	9	29	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	9	30	un-	un-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	9	31	dergoing	dergoe	VBG
work_tpiqgspaqvfeng2fovbximt4lm	9	32	percutaneous	percutaneous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	9	33	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	9	34	intervention	intervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	9	35	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	10	1	Main	main	JJ
work_tpiqgspaqvfeng2fovbximt4lm	10	2	Outcome	Outcome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	10	3	Measure	measure	NN
work_tpiqgspaqvfeng2fovbximt4lm	10	4	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	10	5	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	10	6	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	10	7	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	10	8	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	10	9	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	10	10	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	10	11	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	10	12	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	10	13	pidogrel	pidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	10	14	treatment	treatment	NN
work_tpiqgspaqvfeng2fovbximt4lm	10	15	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	10	16	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	10	17	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	10	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	11	1	Results	Results	NNP
work_tpiqgspaqvfeng2fovbximt4lm	11	2	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	11	3	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	11	4	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	11	5	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	11	6	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	11	7	highly	highly	RB
work_tpiqgspaqvfeng2fovbximt4lm	11	8	heritable	heritable	JJ
work_tpiqgspaqvfeng2fovbximt4lm	11	9	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	11	10	h2=	h2=	NFP
work_tpiqgspaqvfeng2fovbximt4lm	11	11	0.73	0.73	CD
work_tpiqgspaqvfeng2fovbximt4lm	11	12	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	11	13	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	11	14	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	11	15	.001	.001	CD
work_tpiqgspaqvfeng2fovbximt4lm	11	16	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	11	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	12	1	Thirteen	thirteen	CD
work_tpiqgspaqvfeng2fovbximt4lm	12	2	single	single	JJ
work_tpiqgspaqvfeng2fovbximt4lm	12	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	12	4	nucleotide	nucleotide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	12	5	polymorphisms	polymorphism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	12	6	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	12	7	chromosome	chromosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	8	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	12	9	within	within	IN
work_tpiqgspaqvfeng2fovbximt4lm	12	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	12	11	CYP2C18–CYP2C19–CYP2C9–CYP2C8	cyp2c18–cyp2c19–cyp2c9–cyp2c8	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	12	cluster	cluster	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	13	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	12	14	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	12	15	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	12	16	diminished	diminished	JJ
work_tpiqgspaqvfeng2fovbximt4lm	12	17	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	18	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	12	20	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	12	21	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	12	22	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	12	23	degree	degree	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	12	25	statistical	statistical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	12	26	significance	significance	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	27	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	12	28	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	29	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	12	30	1.5	1.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	12	31	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	12	32	10−13	10−13	CD
work_tpiqgspaqvfeng2fovbximt4lm	12	33	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	12	34	rs12777823	rs12777823	NNP
work_tpiqgspaqvfeng2fovbximt4lm	12	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	12	36	additive	additive	NNP
work_tpiqgspaqvfeng2fovbximt4lm	12	37	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	12	38	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	12	39	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	13	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	13	2	rs12777823	rs12777823	NNP
work_tpiqgspaqvfeng2fovbximt4lm	13	3	polymorphism	polymorphism	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	4	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	13	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	13	6	strong	strong	JJ
work_tpiqgspaqvfeng2fovbximt4lm	13	7	linkage	linkage	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	8	disequilibrium	disequilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	9	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	13	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	13	11	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	13	12	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	13	13	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	13	14	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	13	16	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	13	17	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	13	18	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	13	19	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	13	20	diminished	diminished	JJ
work_tpiqgspaqvfeng2fovbximt4lm	13	21	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	22	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	13	24	accounting	account	VBG
work_tpiqgspaqvfeng2fovbximt4lm	13	25	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	13	26	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	13	27	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	28	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	13	29	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	13	30	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	31	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	13	32	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	33	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	34	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	13	35	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	13	36	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	13	37	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	13	38	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	13	39	4.3	4.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	13	40	�	�	NNS
work_tpiqgspaqvfeng2fovbximt4lm	13	41	10−11	10−11	CD
work_tpiqgspaqvfeng2fovbximt4lm	13	42	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	13	43	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	14	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	14	2	relation	relation	NN
work_tpiqgspaqvfeng2fovbximt4lm	14	3	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	14	4	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	14	5	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	14	6	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	14	7	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	14	8	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	14	9	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	14	10	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	14	11	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	14	12	replicated	replicate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	14	13	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	14	14	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	14	15	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	14	16	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	14	17	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	14	18	undergoing	undergo	VBG
work_tpiqgspaqvfeng2fovbximt4lm	14	19	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	14	20	intervention	intervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	14	21	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	14	22	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	14	23	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	14	24	.02	.02	NFP
work_tpiqgspaqvfeng2fovbximt4lm	14	25	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	14	26	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	15	1	Furthermore	furthermore	RB
work_tpiqgspaqvfeng2fovbximt4lm	15	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	15	3	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	15	4	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	15	5	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	15	6	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	15	7	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	15	8	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	9	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	10	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	15	11	more	more	RBR
work_tpiqgspaqvfeng2fovbximt4lm	15	12	likely	likely	JJ
work_tpiqgspaqvfeng2fovbximt4lm	15	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	15	14	20.9	20.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	15	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	16	vs	vs	IN
work_tpiqgspaqvfeng2fovbximt4lm	15	17	10.0	10.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	18	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	19	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	15	20	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	15	21	have	have	VB
work_tpiqgspaqvfeng2fovbximt4lm	15	22	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	15	23	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	15	24	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	15	25	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	26	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	15	27	death	death	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	28	during	during	IN
work_tpiqgspaqvfeng2fovbximt4lm	15	29	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	30	year	year	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	31	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	15	32	follow	follow	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	33	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	15	34	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	35	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	15	36	hazard	hazard	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	37	ratio	ratio	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	38	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	15	39	2.42	2.42	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	40	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	15	41	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	42	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	43	confidence	confidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	44	interval	interval	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	45	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	15	46	1.18	1.18	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	47	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	15	48	4.99	4.99	CD
work_tpiqgspaqvfeng2fovbximt4lm	15	49	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	15	50	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	15	51	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	15	52	.02	.02	NFP
work_tpiqgspaqvfeng2fovbximt4lm	15	53	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	15	54	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	16	1	Conclusion	conclusion	NN
work_tpiqgspaqvfeng2fovbximt4lm	16	2	CYP2C19	CYP2C19	NFP
work_tpiqgspaqvfeng2fovbximt4lm	16	3	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	16	4	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	16	5	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	16	6	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	16	7	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	16	8	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	16	9	diminished	diminished	JJ
work_tpiqgspaqvfeng2fovbximt4lm	16	10	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	16	11	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	16	12	sponse	sponse	NN
work_tpiqgspaqvfeng2fovbximt4lm	16	13	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	16	14	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	16	15	treatment	treatment	NN
work_tpiqgspaqvfeng2fovbximt4lm	16	16	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	16	17	poorer	poor	JJR
work_tpiqgspaqvfeng2fovbximt4lm	16	18	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	16	19	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	16	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	17	1	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	17	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	18	1	2009;302(8):849	2009;302(8):849	NNP
work_tpiqgspaqvfeng2fovbximt4lm	18	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	18	3	858	858	CD
work_tpiqgspaqvfeng2fovbximt4lm	18	4	www.jama.com	www.jama.com	NN
work_tpiqgspaqvfeng2fovbximt4lm	18	5	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	18	6	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	18	7	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	18	8	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	18	9	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	18	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	19	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	19	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	19	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	19	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	20	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	20	2	Reprinted	reprinted	JJ
work_tpiqgspaqvfeng2fovbximt4lm	20	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	20	4	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	20	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	20	6	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	20	7	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	20	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	20	9	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	20	10	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	20	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	20	12	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	20	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	21	1	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	21	2	849	849	CD
work_tpiqgspaqvfeng2fovbximt4lm	21	3	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	21	4	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	21	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	21	6	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	21	7	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	21	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	21	9	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	21	10	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	21	11	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	21	12	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	21	13	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	21	14	04/05/2021	04/05/2021	NN
work_tpiqgspaqvfeng2fovbximt4lm	21	15	activation	activation	NN
work_tpiqgspaqvfeng2fovbximt4lm	21	16	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	21	17	irreversibly	irreversibly	RB
work_tpiqgspaqvfeng2fovbximt4lm	21	18	binding	bind	VBG
work_tpiqgspaqvfeng2fovbximt4lm	21	19	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	21	20	platelet	platelet	VB
work_tpiqgspaqvfeng2fovbximt4lm	21	21	P2Y12	P2Y12	NNP
work_tpiqgspaqvfeng2fovbximt4lm	21	22	receptors	receptor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	21	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	22	1	3	3	LS
work_tpiqgspaqvfeng2fovbximt4lm	22	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	22	3	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	22	4	Variability	variability	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	6	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	7	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	8	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	22	9	well	well	RB
work_tpiqgspaqvfeng2fovbximt4lm	22	10	established.6	established.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	22	11	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	22	12	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	22	13	Patients	Patients	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	22	14	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	22	15	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	16	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	17	who	who	WP
work_tpiqgspaqvfeng2fovbximt4lm	22	18	demonstrate	demonstrate	VBP
work_tpiqgspaqvfeng2fovbximt4lm	22	19	higher	high	JJR
work_tpiqgspaqvfeng2fovbximt4lm	22	20	ex	ex	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	21	vivo	vivo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	22	platelet	platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	23	reactivity	reactivity	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	24	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	22	25	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	26	increased	increase	VBN
work_tpiqgspaqvfeng2fovbximt4lm	22	27	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	28	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	29	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	22	30	events.9	events.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	22	31	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	22	32	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	22	33	Variation	Variation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	34	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	35	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	36	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	37	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	38	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	39	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	40	clopi-	clopi-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	41	dogrel	dogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	42	has	have	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	22	43	been	be	VBN
work_tpiqgspaqvfeng2fovbximt4lm	22	44	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	22	45	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	46	lipo-	lipo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	47	philic	philic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	48	statins	statin	NNS
work_tpiqgspaqvfeng2fovbximt4lm	22	49	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	22	50	calcium	calcium	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	51	channel	channel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	52	block-	block-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	53	ers	ers	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	54	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	22	55	proton	proton	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	56	pump	pump	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	57	inhibitors	inhibitor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	22	58	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	22	59	St	St	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	60	John	John	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	61	’s	’s	POS
work_tpiqgspaqvfeng2fovbximt4lm	22	62	wort	wort	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	63	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	22	64	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	22	65	smoking.13	smoking.13	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	66	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	22	67	16	16	NNP
work_tpiqgspaqvfeng2fovbximt4lm	22	68	However	however	RB
work_tpiqgspaqvfeng2fovbximt4lm	22	69	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	22	70	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	22	71	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	22	72	account	account	VBP
work_tpiqgspaqvfeng2fovbximt4lm	22	73	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	74	only	only	RB
work_tpiqgspaqvfeng2fovbximt4lm	22	75	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	22	76	small	small	JJ
work_tpiqgspaqvfeng2fovbximt4lm	22	77	frac-	frac-	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	78	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	79	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	80	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	22	81	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	82	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	22	83	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	22	84	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	23	1	Re-	re-	UH
work_tpiqgspaqvfeng2fovbximt4lm	23	2	cently	cently	RB
work_tpiqgspaqvfeng2fovbximt4lm	23	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	23	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	23	5	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	6	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	23	7	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	8	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	23	9	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	10	CYP2C19	cyp2c19	VBP
work_tpiqgspaqvfeng2fovbximt4lm	23	11	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	23	12	GenBank	GenBank	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	13	1557	1557	CD
work_tpiqgspaqvfeng2fovbximt4lm	23	14	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	23	15	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	23	16	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	23	17	allele	allele	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	18	has	have	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	23	19	been	be	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	20	shown	show	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	21	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	23	22	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	23	23	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	24	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	25	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	23	26	de-	de-	RB
work_tpiqgspaqvfeng2fovbximt4lm	23	27	creased	crease	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	28	activation	activation	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	29	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	30	clopidogrel17,18	clopidogrel17,18	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	31	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	23	32	antiplatelet	antiplatelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	33	effect19	effect19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	34	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	23	35	23	23	CD
work_tpiqgspaqvfeng2fovbximt4lm	23	36	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	23	37	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	38	in-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	23	39	creased	crease	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	40	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	23	41	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	23	42	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	43	pa-	pa-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	23	44	tients	tient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	23	45	receiving	receive	VBG
work_tpiqgspaqvfeng2fovbximt4lm	23	46	clopidogrel.18,24	clopidogrel.18,24	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	47	-	-	:
work_tpiqgspaqvfeng2fovbximt4lm	23	48	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	23	49	To	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	23	50	identify	identify	VB
work_tpiqgspaqvfeng2fovbximt4lm	23	51	genes	gene	NNS
work_tpiqgspaqvfeng2fovbximt4lm	23	52	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	53	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	54	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	55	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	56	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	57	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	58	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	23	59	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	23	60	performed	perform	VBD
work_tpiqgspaqvfeng2fovbximt4lm	23	61	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	23	62	genome	genome	RB
work_tpiqgspaqvfeng2fovbximt4lm	23	63	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	23	64	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	23	65	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	66	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	67	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	68	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	69	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	23	70	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	71	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	72	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	73	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	74	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	75	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	76	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	77	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	78	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	23	79	Old	Old	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	80	Order	Order	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	81	Amish	Amish	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	82	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	23	83	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	23	84	relatively	relatively	RB
work_tpiqgspaqvfeng2fovbximt4lm	23	85	homogeneous	homogeneous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	23	86	founder	founder	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	87	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	88	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	23	89	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	23	90	confounding	confounding	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	91	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	23	92	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	23	93	including	include	VBG
work_tpiqgspaqvfeng2fovbximt4lm	23	94	medication	medication	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	95	usage	usage	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	96	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	23	97	lifestyle	lifestyle	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	98	variabil-	variabil-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	23	99	ity	ity	NN
work_tpiqgspaqvfeng2fovbximt4lm	23	100	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	23	101	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	23	102	minimized	minimize	VBN
work_tpiqgspaqvfeng2fovbximt4lm	23	103	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	24	1	Replication	replication	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	2	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	24	3	extension	extension	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	24	5	genetic	genetic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	24	6	findings	finding	NNS
work_tpiqgspaqvfeng2fovbximt4lm	24	7	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	24	8	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	9	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	24	10	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	24	11	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	24	12	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	13	analyses	analysis	NNS
work_tpiqgspaqvfeng2fovbximt4lm	24	14	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	24	15	performed	perform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	24	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	24	17	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	24	18	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	19	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	24	20	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	24	21	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	22	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	24	23	car-	car-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	24	24	diovascular	diovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	24	25	disease	disease	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	26	recruited	recruit	VBN
work_tpiqgspaqvfeng2fovbximt4lm	24	27	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	24	28	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	24	29	cardiac	cardiac	JJ
work_tpiqgspaqvfeng2fovbximt4lm	24	30	catheterization	catheterization	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	31	laboratory	laboratory	NN
work_tpiqgspaqvfeng2fovbximt4lm	24	32	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	24	33	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	24	34	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	24	35	Maryland	Maryland	NNP
work_tpiqgspaqvfeng2fovbximt4lm	24	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	25	1	METHODS	METHODS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	25	2	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	25	3	Populations	Populations	NNP
work_tpiqgspaqvfeng2fovbximt4lm	25	4	Amish	Amish	NNP
work_tpiqgspaqvfeng2fovbximt4lm	25	5	Pharmacogenomics	Pharmacogenomics	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	25	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	25	7	Anti-	Anti-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	25	8	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	25	9	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	25	10	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	25	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	26	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	26	2	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	26	3	Pharmacogenomics	Pharmacogenomics	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	26	5	Anti-	Anti-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	6	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	26	7	Intervention	intervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	26	8	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	26	9	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	10	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	26	11	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	12	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	26	13	NCT0079936	NCT0079936	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	14	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	26	15	recruited	recruit	VBD
work_tpiqgspaqvfeng2fovbximt4lm	26	16	429	429	CD
work_tpiqgspaqvfeng2fovbximt4lm	26	17	gener-	gener-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	26	18	ally	ally	NN
work_tpiqgspaqvfeng2fovbximt4lm	26	19	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	26	20	white	white	JJ
work_tpiqgspaqvfeng2fovbximt4lm	26	21	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	26	22	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	26	23	years	year	NNS
work_tpiqgspaqvfeng2fovbximt4lm	26	24	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	26	25	older	old	JJR
work_tpiqgspaqvfeng2fovbximt4lm	26	26	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	26	27	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	28	2006	2006	CD
work_tpiqgspaqvfeng2fovbximt4lm	26	29	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	26	30	October	October	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	31	2008	2008	CD
work_tpiqgspaqvfeng2fovbximt4lm	26	32	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	26	33	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	26	34	additional	additional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	26	35	details	detail	NNS
work_tpiqgspaqvfeng2fovbximt4lm	26	36	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	26	37	see	see	VB
work_tpiqgspaqvfeng2fovbximt4lm	26	38	eMethods	emethod	NNS
work_tpiqgspaqvfeng2fovbximt4lm	26	39	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	26	40	http://www.jama	http://www.jama	NNP
work_tpiqgspaqvfeng2fovbximt4lm	26	41	.org	.org	.
work_tpiqgspaqvfeng2fovbximt4lm	26	42	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	26	43	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	27	1	These	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	27	2	individuals	individual	NNS
work_tpiqgspaqvfeng2fovbximt4lm	27	3	comprised	comprise	VBD
work_tpiqgspaqvfeng2fovbximt4lm	27	4	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	27	5	number	number	NN
work_tpiqgspaqvfeng2fovbximt4lm	27	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	27	7	relative	relative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	27	8	pairs	pair	NNS
work_tpiqgspaqvfeng2fovbximt4lm	27	9	informative	informative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	27	10	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	27	11	estimating	estimate	VBG
work_tpiqgspaqvfeng2fovbximt4lm	27	12	heritabilities	heritabilitie	NNS
work_tpiqgspaqvfeng2fovbximt4lm	27	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	27	14	including	include	VBG
work_tpiqgspaqvfeng2fovbximt4lm	27	15	105	105	CD
work_tpiqgspaqvfeng2fovbximt4lm	27	16	parent	parent	NN
work_tpiqgspaqvfeng2fovbximt4lm	27	17	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	27	18	offspring	offspre	VBG
work_tpiqgspaqvfeng2fovbximt4lm	27	19	pairs	pair	NNS
work_tpiqgspaqvfeng2fovbximt4lm	27	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	27	21	175	175	CD
work_tpiqgspaqvfeng2fovbximt4lm	27	22	sibling	sible	VBG
work_tpiqgspaqvfeng2fovbximt4lm	27	23	pairs	pair	NNS
work_tpiqgspaqvfeng2fovbximt4lm	27	24	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	27	25	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	27	26	grandparent	grandparent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	27	27	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	27	28	grandchild	grandchild	NN
work_tpiqgspaqvfeng2fovbximt4lm	27	29	pair	pair	NN
work_tpiqgspaqvfeng2fovbximt4lm	27	30	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	27	31	48	48	CD
work_tpiqgspaqvfeng2fovbximt4lm	27	32	avun-	avun-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	27	33	cular	cular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	27	34	pairs	pair	NNS
work_tpiqgspaqvfeng2fovbximt4lm	27	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	27	36	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	27	37	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	27	38	first	first	JJ
work_tpiqgspaqvfeng2fovbximt4lm	27	39	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	27	40	cousin	cousin	NN
work_tpiqgspaqvfeng2fovbximt4lm	27	41	pairs	pair	NNS
work_tpiqgspaqvfeng2fovbximt4lm	27	42	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	28	1	Medical	medical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	28	2	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	28	3	family	family	NN
work_tpiqgspaqvfeng2fovbximt4lm	28	4	histories	history	NNS
work_tpiqgspaqvfeng2fovbximt4lm	28	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	28	6	anthro-	anthro-	NN
work_tpiqgspaqvfeng2fovbximt4lm	28	7	pometry	pometry	NN
work_tpiqgspaqvfeng2fovbximt4lm	28	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	28	9	physical	physical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	28	10	examinations	examination	NNS
work_tpiqgspaqvfeng2fovbximt4lm	28	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	28	12	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	28	13	blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	28	14	samples	sample	NNS
work_tpiqgspaqvfeng2fovbximt4lm	28	15	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	28	16	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	28	17	overnight	overnight	JJ
work_tpiqgspaqvfeng2fovbximt4lm	28	18	fast	fast	NN
work_tpiqgspaqvfeng2fovbximt4lm	28	19	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	28	20	obtained	obtain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	28	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	29	1	Complete	complete	JJ
work_tpiqgspaqvfeng2fovbximt4lm	29	2	blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	3	count	count	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	4	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	29	5	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	6	number	number	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	7	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	29	8	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	29	9	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	29	10	se-	se-	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	11	rum	rum	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	12	lipids	lipid	NNS
work_tpiqgspaqvfeng2fovbximt4lm	29	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	29	14	total	total	JJ
work_tpiqgspaqvfeng2fovbximt4lm	29	15	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	29	17	high-	high-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	29	18	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	19	lipoprotein	lipoprotein	NNP
work_tpiqgspaqvfeng2fovbximt4lm	29	20	cholesterol	cholesterol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	29	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	29	22	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	29	23	tri-	tri-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	29	24	glycerides	glyceride	NNS
work_tpiqgspaqvfeng2fovbximt4lm	29	25	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	29	26	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	29	27	assayed	assay	VBN
work_tpiqgspaqvfeng2fovbximt4lm	29	28	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	29	29	Quest	Quest	NNP
work_tpiqgspaqvfeng2fovbximt4lm	29	30	Diagnostics	Diagnostics	NNP
work_tpiqgspaqvfeng2fovbximt4lm	29	31	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	29	32	Horsham	Horsham	NNP
work_tpiqgspaqvfeng2fovbximt4lm	29	33	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	29	34	Pennsylvania	Pennsylvania	NNP
work_tpiqgspaqvfeng2fovbximt4lm	29	35	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	29	36	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	29	37	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	29	38	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	29	39	low	low	JJ
work_tpiqgspaqvfeng2fovbximt4lm	29	40	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	29	41	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	42	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	43	cho-	cho-	RB
work_tpiqgspaqvfeng2fovbximt4lm	29	44	lesterol	lesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	45	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	29	46	calculated	calculate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	29	47	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	29	48	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	29	49	Friede-	Friede-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	29	50	wald	wald	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	51	equation	equation	NN
work_tpiqgspaqvfeng2fovbximt4lm	29	52	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	30	1	After	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	30	2	baseline	baseline	JJ
work_tpiqgspaqvfeng2fovbximt4lm	30	3	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	4	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	5	measurements	measurement	NNS
work_tpiqgspaqvfeng2fovbximt4lm	30	6	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	30	7	obtained	obtain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	30	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	30	9	partici-	partici-	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	10	pants	pant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	30	11	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	30	12	given	give	VBN
work_tpiqgspaqvfeng2fovbximt4lm	30	13	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	30	14	300-mg	300-mg	CD
work_tpiqgspaqvfeng2fovbximt4lm	30	15	oral	oral	JJ
work_tpiqgspaqvfeng2fovbximt4lm	30	16	load-	load-	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	17	ing	ing	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	18	dose	dose	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	19	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	30	20	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	21	followed	follow	VBN
work_tpiqgspaqvfeng2fovbximt4lm	30	22	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	30	23	75	75	CD
work_tpiqgspaqvfeng2fovbximt4lm	30	24	mg	mg	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	25	per	per	IN
work_tpiqgspaqvfeng2fovbximt4lm	30	26	day	day	NN
work_tpiqgspaqvfeng2fovbximt4lm	30	27	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	30	28	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	30	29	days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	30	30	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	31	1	Follow	follow	VB
work_tpiqgspaqvfeng2fovbximt4lm	31	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	31	3	up	up	RP
work_tpiqgspaqvfeng2fovbximt4lm	31	4	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	31	5	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	31	6	studies	study	NNS
work_tpiqgspaqvfeng2fovbximt4lm	31	7	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	31	8	repeated	repeat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	31	9	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	31	10	hour	hour	NN
work_tpiqgspaqvfeng2fovbximt4lm	31	11	following	follow	VBG
work_tpiqgspaqvfeng2fovbximt4lm	31	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	31	13	last	last	JJ
work_tpiqgspaqvfeng2fovbximt4lm	31	14	dose	dose	NN
work_tpiqgspaqvfeng2fovbximt4lm	31	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	31	16	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	31	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	32	1	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	32	2	second	second	JJ
work_tpiqgspaqvfeng2fovbximt4lm	32	3	follow	follow	VB
work_tpiqgspaqvfeng2fovbximt4lm	32	4	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	32	5	up	up	RP
work_tpiqgspaqvfeng2fovbximt4lm	32	6	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	32	7	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	32	8	measurement	measurement	NN
work_tpiqgspaqvfeng2fovbximt4lm	32	9	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	32	10	made	make	VBN
work_tpiqgspaqvfeng2fovbximt4lm	32	11	later	later	RBR
work_tpiqgspaqvfeng2fovbximt4lm	32	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	32	13	same	same	JJ
work_tpiqgspaqvfeng2fovbximt4lm	32	14	day	day	NN
work_tpiqgspaqvfeng2fovbximt4lm	32	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	32	16	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	32	17	hour	hour	NN
work_tpiqgspaqvfeng2fovbximt4lm	32	18	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	32	19	oral	oral	JJ
work_tpiqgspaqvfeng2fovbximt4lm	32	20	ingestion	ingestion	NN
work_tpiqgspaqvfeng2fovbximt4lm	32	21	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	32	22	324	324	CD
work_tpiqgspaqvfeng2fovbximt4lm	32	23	mg	mg	CD
work_tpiqgspaqvfeng2fovbximt4lm	32	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	32	25	chewable	chewable	JJ
work_tpiqgspaqvfeng2fovbximt4lm	32	26	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	32	27	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	33	1	Platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	2	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	3	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	33	4	assessed	assess	VBN
work_tpiqgspaqvfeng2fovbximt4lm	33	5	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	33	6	optical	optical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	33	7	aggregometry	aggregometry	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	8	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	33	9	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	33	10	PAP8E	pap8e	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	11	Aggregometer	Aggregometer	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	12	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	13	Bio	Bio	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	14	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	33	15	Data	Data	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	16	Corporation	Corporation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	17	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	33	18	Horsham	Horsham	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	33	20	Pennsylvania	Pennsylvania	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	21	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	22	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	33	23	platelet-	platelet-	IN
work_tpiqgspaqvfeng2fovbximt4lm	33	24	rich	rich	JJ
work_tpiqgspaqvfeng2fovbximt4lm	33	25	plasma	plasma	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	33	27	stimulated	stimulate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	33	28	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	33	29	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	30	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	31	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	33	32	µmol	µmol	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	33	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	33	34	L	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	35	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	36	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	33	37	arachidonic	arachidonic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	33	38	acid	acid	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	39	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	40	1.6	1.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	33	41	mmol	mmol	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	42	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	33	43	L	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	33	44	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	45	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	46	eMethods	eMethods	NNP
work_tpiqgspaqvfeng2fovbximt4lm	33	47	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	33	48	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	34	1	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	34	2	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	34	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	34	4	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	34	5	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	34	6	Patients	Patients	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	34	7	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	35	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	35	2	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	3	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	35	5	Balti-	Balti-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	6	more	more	JJR
work_tpiqgspaqvfeng2fovbximt4lm	35	7	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	8	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	35	9	NCT00370045	NCT00370045	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	10	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	35	11	enrolled	enrol	VBD
work_tpiqgspaqvfeng2fovbximt4lm	35	12	227	227	CD
work_tpiqgspaqvfeng2fovbximt4lm	35	13	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	35	14	older	old	JJR
work_tpiqgspaqvfeng2fovbximt4lm	35	15	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	35	16	18	18	CD
work_tpiqgspaqvfeng2fovbximt4lm	35	17	years	year	NNS
work_tpiqgspaqvfeng2fovbximt4lm	35	18	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	35	19	undergoing	undergo	VBG
work_tpiqgspaqvfeng2fovbximt4lm	35	20	nonemergent	nonemergent	NN
work_tpiqgspaqvfeng2fovbximt4lm	35	21	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	22	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	35	23	January	January	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	24	2004	2004	CD
work_tpiqgspaqvfeng2fovbximt4lm	35	25	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	35	26	May	May	NNP
work_tpiqgspaqvfeng2fovbximt4lm	35	27	2007	2007	CD
work_tpiqgspaqvfeng2fovbximt4lm	35	28	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	35	29	eMeth-	emeth-	NN
work_tpiqgspaqvfeng2fovbximt4lm	35	30	ods	od	NNS
work_tpiqgspaqvfeng2fovbximt4lm	35	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	35	32	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	36	1	Of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	36	2	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	36	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	36	4	140	140	CD
work_tpiqgspaqvfeng2fovbximt4lm	36	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	36	6	61.7	61.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	36	7	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	36	8	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	36	9	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	36	10	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	36	11	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	36	12	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	36	13	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	36	14	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	36	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	36	16	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	36	17	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	36	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	36	19	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	36	20	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	36	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	37	1	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	37	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	37	4	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	37	5	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	37	6	re	re	NNP
work_tpiqgspaqvfeng2fovbximt4lm	37	7	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	8	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	37	9	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	10	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	11	c	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	12	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	37	13	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	37	14	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	37	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	37	16	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	37	17	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	37	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	37	19	1.8	1.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	37	20	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	21	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	37	22	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	37	23	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	37	24	race	race	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	25	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	37	26	ethnicity	ethnicity	NN
work_tpiqgspaqvfeng2fovbximt4lm	37	27	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	38	1	Information	information	NN
work_tpiqgspaqvfeng2fovbximt4lm	38	2	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	38	3	race/	race/	JJ
work_tpiqgspaqvfeng2fovbximt4lm	38	4	ethnicity	ethnicity	NN
work_tpiqgspaqvfeng2fovbximt4lm	38	5	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	38	6	obtained	obtain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	38	7	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	38	8	self	self	NN
work_tpiqgspaqvfeng2fovbximt4lm	38	9	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	38	10	report	report	NN
work_tpiqgspaqvfeng2fovbximt4lm	38	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	39	1	On	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	39	2	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	39	3	day	day	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	39	5	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	39	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	39	7	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	39	8	received	receive	VBD
work_tpiqgspaqvfeng2fovbximt4lm	39	9	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	39	10	600-mg	600-mg	CD
work_tpiqgspaqvfeng2fovbximt4lm	39	11	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	39	12	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	13	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	39	14	112	112	CD
work_tpiqgspaqvfeng2fovbximt4lm	39	15	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	39	16	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	39	17	300-mg	300-mg	CD
work_tpiqgspaqvfeng2fovbximt4lm	39	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	39	19	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	20	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	39	21	25	25	CD
work_tpiqgspaqvfeng2fovbximt4lm	39	22	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	39	23	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	24	loading	loading	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	25	dose	dose	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	26	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	39	27	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	39	28	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	39	29	already	already	RB
work_tpiqgspaqvfeng2fovbximt4lm	39	30	receiving	receive	VBG
work_tpiqgspaqvfeng2fovbximt4lm	39	31	maintenance	maintenance	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	32	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	33	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	39	34	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	39	35	75-mg	75-mg	CD
work_tpiqgspaqvfeng2fovbximt4lm	39	36	daily	daily	RB
work_tpiqgspaqvfeng2fovbximt4lm	39	37	dose	dose	VB
work_tpiqgspaqvfeng2fovbximt4lm	39	38	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	39	39	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	39	40	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	41	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	39	42	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	39	43	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	39	44	received	receive	VBD
work_tpiqgspaqvfeng2fovbximt4lm	39	45	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	39	46	loading	loading	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	47	dose	dose	NN
work_tpiqgspaqvfeng2fovbximt4lm	39	48	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	40	1	There	there	EX
work_tpiqgspaqvfeng2fovbximt4lm	40	2	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	40	3	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	40	4	differences	difference	NNS
work_tpiqgspaqvfeng2fovbximt4lm	40	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	40	6	baseline	baseline	JJ
work_tpiqgspaqvfeng2fovbximt4lm	40	7	characteristics	characteristic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	40	8	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	40	9	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	40	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	40	11	long	long	JJ
work_tpiqgspaqvfeng2fovbximt4lm	40	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	40	13	term	term	NN
work_tpiqgspaqvfeng2fovbximt4lm	40	14	out-	out-	NN
work_tpiqgspaqvfeng2fovbximt4lm	40	15	comes	come	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	40	16	investigated	investigate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	40	17	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	40	18	stratified	stratified	JJ
work_tpiqgspaqvfeng2fovbximt4lm	40	19	analy-	analy-	NNS
work_tpiqgspaqvfeng2fovbximt4lm	40	20	ses	se	NNS
work_tpiqgspaqvfeng2fovbximt4lm	40	21	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	40	22	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	40	23	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	40	24	dosing	dosing	NN
work_tpiqgspaqvfeng2fovbximt4lm	40	25	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	40	26	thus	thus	RB
work_tpiqgspaqvfeng2fovbximt4lm	40	27	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	40	28	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	40	29	groups	group	NNS
work_tpiqgspaqvfeng2fovbximt4lm	40	30	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	40	31	combined	combine	VBN
work_tpiqgspaqvfeng2fovbximt4lm	40	32	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	40	33	fur-	fur-	NN
work_tpiqgspaqvfeng2fovbximt4lm	40	34	ther	ther	NN
work_tpiqgspaqvfeng2fovbximt4lm	40	35	analyses	analysis	NNS
work_tpiqgspaqvfeng2fovbximt4lm	40	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	41	1	Patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	41	2	received	receive	VBD
work_tpiqgspaqvfeng2fovbximt4lm	41	3	bivalirudin	bivalirudin	RB
work_tpiqgspaqvfeng2fovbximt4lm	41	4	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	41	5	hep-	hep-	NN
work_tpiqgspaqvfeng2fovbximt4lm	41	6	arin	arin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	41	7	therapy	therapy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	41	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	41	9	either	either	CC
work_tpiqgspaqvfeng2fovbximt4lm	41	10	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	41	11	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	41	12	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	41	13	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	41	14	107	107	CD
work_tpiqgspaqvfeng2fovbximt4lm	41	15	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	41	16	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	41	17	without	without	IN
work_tpiqgspaqvfeng2fovbximt4lm	41	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	41	19	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	41	20	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	41	21	120	120	CD
work_tpiqgspaqvfeng2fovbximt4lm	41	22	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	41	23	eptifibatide.27,28	eptifibatide.27,28	NNP
work_tpiqgspaqvfeng2fovbximt4lm	41	24	An-	an-	CC
work_tpiqgspaqvfeng2fovbximt4lm	41	25	ticoagulant	ticoagulant	NN
work_tpiqgspaqvfeng2fovbximt4lm	41	26	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	41	27	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	41	28	discontinued	discontinue	VBN
work_tpiqgspaqvfeng2fovbximt4lm	41	29	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	41	30	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	41	31	completion	completion	NN
work_tpiqgspaqvfeng2fovbximt4lm	41	32	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	41	33	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	41	34	procedure	procedure	NN
work_tpiqgspaqvfeng2fovbximt4lm	41	35	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	41	36	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	41	37	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	41	38	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	42	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	42	2	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	42	3	received	receive	VBD
work_tpiqgspaqvfeng2fovbximt4lm	42	4	81	81	CD
work_tpiqgspaqvfeng2fovbximt4lm	42	5	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	42	6	325	325	CD
work_tpiqgspaqvfeng2fovbximt4lm	42	7	mg	mg	NN
work_tpiqgspaqvfeng2fovbximt4lm	42	8	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	42	9	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	42	10	daily	daily	RB
work_tpiqgspaqvfeng2fovbximt4lm	42	11	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	42	12	at	at	RB
work_tpiqgspaqvfeng2fovbximt4lm	42	13	least	least	JJS
work_tpiqgspaqvfeng2fovbximt4lm	42	14	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	42	15	week	week	NN
work_tpiqgspaqvfeng2fovbximt4lm	42	16	prior	prior	RB
work_tpiqgspaqvfeng2fovbximt4lm	42	17	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	42	18	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	42	19	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	42	20	325	325	CD
work_tpiqgspaqvfeng2fovbximt4lm	42	21	mg	mg	NN
work_tpiqgspaqvfeng2fovbximt4lm	42	22	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	42	23	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	42	24	day	day	NN
work_tpiqgspaqvfeng2fovbximt4lm	42	25	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	42	26	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	42	27	procedure	procedure	NN
work_tpiqgspaqvfeng2fovbximt4lm	42	28	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	43	1	To	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	43	2	minimize	minimize	VB
work_tpiqgspaqvfeng2fovbximt4lm	43	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	43	4	effects	effect	NNS
work_tpiqgspaqvfeng2fovbximt4lm	43	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	43	6	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	43	7	anticoagulant	anticoagulant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	43	8	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	9	during	during	IN
work_tpiqgspaqvfeng2fovbximt4lm	43	10	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	43	12	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	13	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	14	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	43	15	mea-	mea-	RB
work_tpiqgspaqvfeng2fovbximt4lm	43	16	sured	sure	VBN
work_tpiqgspaqvfeng2fovbximt4lm	43	17	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	43	18	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	43	19	day	day	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	43	21	hospital	hospital	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	22	discharge	discharge	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	23	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	43	24	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	43	25	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	43	26	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	43	27	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	43	28	eptifi-	eptifi-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	43	29	batide	batide	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	30	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	43	31	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	43	32	days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	43	33	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	43	34	more	more	JJR
work_tpiqgspaqvfeng2fovbximt4lm	43	35	postdis-	postdis-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	43	36	c	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	37	h	h	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	38	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	43	39	rg	rg	FW
work_tpiqgspaqvfeng2fovbximt4lm	43	40	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	41	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	42	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	43	43	p	p	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	44	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	43	45	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	46	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	47	e	e	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	48	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	43	49	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	50	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	51	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	52	re	re	VBP
work_tpiqgspaqvfeng2fovbximt4lm	43	53	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	43	54	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	55	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	56	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	57	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	43	58	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	59	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	60	h	h	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	61	eptifibatide	eptifibatide	NN
work_tpiqgspaqvfeng2fovbximt4lm	43	62	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	44	1	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	44	2	total	total	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	44	4	results	result	NNS
work_tpiqgspaqvfeng2fovbximt4lm	44	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	44	6	baseline	baseline	JJ
work_tpiqgspaqvfeng2fovbximt4lm	44	7	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	8	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	9	studies	study	NNS
work_tpiqgspaqvfeng2fovbximt4lm	44	10	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	44	11	available	available	JJ
work_tpiqgspaqvfeng2fovbximt4lm	44	12	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	44	13	143	143	CD
work_tpiqgspaqvfeng2fovbximt4lm	44	14	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	44	15	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	44	16	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	44	17	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	18	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	44	19	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	44	20	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	21	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	44	22	enrollment	enrollment	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	44	24	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	44	25	results	result	NNS
work_tpiqgspaqvfeng2fovbximt4lm	44	26	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	44	27	postclopidogrel	postclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	28	platelet	platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	29	aggregation	aggregation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	30	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	31	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	32	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	33	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	34	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	35	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	36	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	37	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	38	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	39	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	40	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	41	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	44	42	v	v	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	43	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	44	44	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	45	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	46	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	44	47	b	b	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	48	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	49	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	50	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	51	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	44	52	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	44	53	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	44	54	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	44	55	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	44	56	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	44	57	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	45	1	Platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	2	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	3	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	45	4	assessed	assess	VBN
work_tpiqgspaqvfeng2fovbximt4lm	45	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	6	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	7	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	45	8	rich	rich	JJ
work_tpiqgspaqvfeng2fovbximt4lm	45	9	plasma	plasma	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	10	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	11	stimulation	stimulation	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	12	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	13	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	45	14	µmol	µmol	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	15	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	45	16	L	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	17	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	18	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	19	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	45	20	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	45	21	mmol	mmol	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	22	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	45	23	L	L	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	25	arachidonic	arachidonic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	45	26	acid	acid	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	27	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	45	28	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	45	29	C	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	30	h	h	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	31	ro	ro	CC
work_tpiqgspaqvfeng2fovbximt4lm	45	32	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	33	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	34	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	35	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	36	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	37	L	L	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	38	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	39	m	m	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	40	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	41	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	45	42	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	43	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	44	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	45	re	re	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	46	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	47	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	48	m	m	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	49	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	50	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	51	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	52	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	53	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	45	54	Model	Model	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	55	490	490	CD
work_tpiqgspaqvfeng2fovbximt4lm	45	56	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	45	57	4D	4d	CD
work_tpiqgspaqvfeng2fovbximt4lm	45	58	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	45	59	Chronolog	Chronolog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	60	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	45	61	Haver-	Haver-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	62	town	town	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	63	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	45	64	Pennsylvania	Pennsylvania	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	65	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	45	66	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	45	67	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	68	described	describe	VBN
work_tpiqgspaqvfeng2fovbximt4lm	45	69	previously	previously	RB
work_tpiqgspaqvfeng2fovbximt4lm	45	70	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	45	71	eMethods).7	eMethods).7	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	72	Aspirin	Aspirin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	73	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	45	74	325	325	CD
work_tpiqgspaqvfeng2fovbximt4lm	45	75	mg	mg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	76	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	45	77	d	d	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	78	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	45	79	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	45	80	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	81	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	45	82	75	75	CD
work_tpiqgspaqvfeng2fovbximt4lm	45	83	mg	mg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	84	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	45	85	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	86	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	45	87	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	45	88	prescribed	prescribe	VBN
work_tpiqgspaqvfeng2fovbximt4lm	45	89	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	90	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	45	91	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	45	92	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	93	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	45	94	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	95	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	96	hospital	hospital	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	97	dis-	dis-	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	98	charge	charge	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	99	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	45	100	according	accord	VBG
work_tpiqgspaqvfeng2fovbximt4lm	45	101	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	102	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	103	Col-	Col-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	104	lege	lege	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	105	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	106	Cardiology	Cardiology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	107	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	45	108	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	109	Heart	Heart	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	110	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	45	111	guidelines.1	guidelines.1	ADD
work_tpiqgspaqvfeng2fovbximt4lm	45	112	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	45	113	assessed	assess	VBD
work_tpiqgspaqvfeng2fovbximt4lm	45	114	medication	medication	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	115	adherence	adherence	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	116	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	117	self	self	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	118	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	45	119	report	report	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	120	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	45	121	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	122	review	review	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	123	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	124	source	source	NN
work_tpiqgspaqvfeng2fovbximt4lm	45	125	documents	document	NNS
work_tpiqgspaqvfeng2fovbximt4lm	45	126	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	127	hospitalizations	hospitalization	NNS
work_tpiqgspaqvfeng2fovbximt4lm	45	128	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	45	129	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	45	130	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	45	131	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	46	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	46	2	227	227	CD
work_tpiqgspaqvfeng2fovbximt4lm	46	3	enrolled	enrolled	JJ
work_tpiqgspaqvfeng2fovbximt4lm	46	4	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	46	5	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	46	6	con-	con-	NN
work_tpiqgspaqvfeng2fovbximt4lm	46	7	tacted	tacte	VBN
work_tpiqgspaqvfeng2fovbximt4lm	46	8	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	46	9	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	46	10	end	end	NN
work_tpiqgspaqvfeng2fovbximt4lm	46	11	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	46	12	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	46	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	46	14	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	46	15	months	month	NNS
work_tpiqgspaqvfeng2fovbximt4lm	46	16	post	post	JJ
work_tpiqgspaqvfeng2fovbximt4lm	46	17	-	-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	46	18	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	46	19	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	46	20	determine	determine	VB
work_tpiqgspaqvfeng2fovbximt4lm	46	21	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	46	22	occurrence	occurrence	NN
work_tpiqgspaqvfeng2fovbximt4lm	46	23	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	46	24	postdischarge	postdischarge	NNP
work_tpiqgspaqvfeng2fovbximt4lm	46	25	cardiovascular	cardiovascular	NNP
work_tpiqgspaqvfeng2fovbximt4lm	46	26	ische-	ische-	XX
work_tpiqgspaqvfeng2fovbximt4lm	46	27	mic	mic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	46	28	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	46	29	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	46	30	eMethods	eMethods	NNP
work_tpiqgspaqvfeng2fovbximt4lm	46	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	46	32	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	47	1	Of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	47	2	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	47	3	pa-	pa-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	47	4	tients	tient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	47	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	47	6	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	47	7	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	47	8	still	still	RB
work_tpiqgspaqvfeng2fovbximt4lm	47	9	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	47	10	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	47	11	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	47	12	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	47	13	year	year	NN
work_tpiqgspaqvfeng2fovbximt4lm	47	14	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	47	15	132	132	CD
work_tpiqgspaqvfeng2fovbximt4lm	47	16	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	47	17	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	47	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	48	1	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	48	2	physi-	physi-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	48	3	cian	cian	NN
work_tpiqgspaqvfeng2fovbximt4lm	48	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	48	5	blinded	blind	VBN
work_tpiqgspaqvfeng2fovbximt4lm	48	6	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	48	7	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	48	8	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	48	9	results	result	NNS
work_tpiqgspaqvfeng2fovbximt4lm	48	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	48	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	48	12	patient	patient	NN
work_tpiqgspaqvfeng2fovbximt4lm	48	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	48	14	adjudicated	adjudicate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	48	15	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	48	16	end	end	NN
work_tpiqgspaqvfeng2fovbximt4lm	48	17	points	point	NNS
work_tpiqgspaqvfeng2fovbximt4lm	48	18	through	through	IN
work_tpiqgspaqvfeng2fovbximt4lm	48	19	review	review	NN
work_tpiqgspaqvfeng2fovbximt4lm	48	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	48	21	source	source	NN
work_tpiqgspaqvfeng2fovbximt4lm	48	22	documents	document	NNS
work_tpiqgspaqvfeng2fovbximt4lm	48	23	obtained	obtain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	48	24	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	48	25	medical	medical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	48	26	records	record	NNS
work_tpiqgspaqvfeng2fovbximt4lm	48	27	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	49	1	Post-	Post-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	2	discharge	discharge	NN
work_tpiqgspaqvfeng2fovbximt4lm	49	3	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	4	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	49	5	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	49	6	de-	de-	RB
work_tpiqgspaqvfeng2fovbximt4lm	49	7	fined	fine	VBN
work_tpiqgspaqvfeng2fovbximt4lm	49	8	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	49	9	myocardial	myocardial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	10	infarction	infarction	NN
work_tpiqgspaqvfeng2fovbximt4lm	49	11	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	49	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	49	13	oc-	oc-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	14	currence	currence	NN
work_tpiqgspaqvfeng2fovbximt4lm	49	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	49	16	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	17	symptoms	symptom	NNS
work_tpiqgspaqvfeng2fovbximt4lm	49	18	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	49	19	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	49	20	troponin	troponin	NN
work_tpiqgspaqvfeng2fovbximt4lm	49	21	I	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	49	22	value	value	VBP
work_tpiqgspaqvfeng2fovbximt4lm	49	23	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	49	24	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	49	25	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	49	26	up-	up-	XX
work_tpiqgspaqvfeng2fovbximt4lm	49	27	per	per	IN
work_tpiqgspaqvfeng2fovbximt4lm	49	28	limits	limit	NNS
work_tpiqgspaqvfeng2fovbximt4lm	49	29	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	49	30	normal	normal	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	49	32	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	49	33	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	34	stroke	stroke	NN
work_tpiqgspaqvfeng2fovbximt4lm	49	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	49	36	stent	stent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	37	thrombosis	thrombosis	NN
work_tpiqgspaqvfeng2fovbximt4lm	49	38	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	49	39	definite	definite	JJ
work_tpiqgspaqvfeng2fovbximt4lm	49	40	stent	stent	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	41	throm-	throm-	NN
work_tpiqgspaqvfeng2fovbximt4lm	49	42	CYTOCHROME	CYTOCHROME	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	43	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	44	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	49	45	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	49	46	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	49	47	CLOPIDOGREL	CLOPIDOGREL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	48	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	49	850	850	CD
work_tpiqgspaqvfeng2fovbximt4lm	49	50	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	51	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	49	52	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	49	53	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	49	54	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	49	55	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	49	56	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	49	57	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	49	58	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	49	59	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	50	1	8	8	LS
work_tpiqgspaqvfeng2fovbximt4lm	50	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	50	3	Reprinted	Reprinted	NNP
work_tpiqgspaqvfeng2fovbximt4lm	50	4	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	50	5	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	50	6	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	50	7	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	50	8	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	50	9	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	50	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	51	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	51	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	51	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	51	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	52	1	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	52	2	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	52	4	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	52	5	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	6	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	52	7	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	8	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	9	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	10	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	11	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	12	04/05/2021	04/05/2021	CD
work_tpiqgspaqvfeng2fovbximt4lm	52	13	bosis	bosis	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	14	according	accord	VBG
work_tpiqgspaqvfeng2fovbximt4lm	52	15	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	16	Academic	Academic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	17	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	18	Consortium	Consortium	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	19	criteria29	criteria29	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	20	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	52	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	52	22	unplanned	unplanned	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	23	tar-	tar-	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	24	get	get	VBP
work_tpiqgspaqvfeng2fovbximt4lm	52	25	vessel	vessel	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	26	revascularization	revascularization	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	27	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	52	28	revascu-	revascu-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	29	larization	larization	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	30	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	31	vessel	vessel	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	32	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	52	33	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	34	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	35	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	36	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	37	enrollment	enrollment	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	38	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	52	39	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	52	40	unplanned	unplanned	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	41	nontar-	nontar-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	42	get	get	VB
work_tpiqgspaqvfeng2fovbximt4lm	52	43	vessel	vessel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	44	revascularization	revascularization	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	45	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	52	46	revascu-	revascu-	FW
work_tpiqgspaqvfeng2fovbximt4lm	52	47	larization	larization	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	48	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	49	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	52	50	vessel	vessel	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	51	different	different	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	52	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	53	that	that	DT
work_tpiqgspaqvfeng2fovbximt4lm	52	54	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	52	55	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	56	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	57	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	58	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	59	enrollment	enrollment	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	60	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	52	61	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	52	62	hospitalization	hospitalization	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	63	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	64	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	65	ischemia	ischemia	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	66	without	without	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	67	revascularization	revascularization	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	68	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	52	69	hospitaliza-	hospitaliza-	FW
work_tpiqgspaqvfeng2fovbximt4lm	52	70	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	71	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	72	chest	chest	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	73	pain	pain	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	74	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	75	evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	76	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	77	is-	is-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	78	chemia	chemia	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	79	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	80	electrocardiogram	electrocardiogram	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	81	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	52	82	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	52	83	evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	84	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	85	myocardial	myocardial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	86	infarction	infarction	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	87	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	88	measured	measure	VBN
work_tpiqgspaqvfeng2fovbximt4lm	52	89	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	90	troponin	troponin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	52	91	I	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	52	92	value	value	VBP
work_tpiqgspaqvfeng2fovbximt4lm	52	93	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	52	94	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	52	95	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	52	96	death	death	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	97	secondary	secondary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	98	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	52	99	any	any	DT
work_tpiqgspaqvfeng2fovbximt4lm	52	100	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	52	101	cause	cause	NN
work_tpiqgspaqvfeng2fovbximt4lm	52	102	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	53	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	53	2	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	53	3	protocols	protocol	NNS
work_tpiqgspaqvfeng2fovbximt4lm	53	4	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	53	5	approved	approve	VBN
work_tpiqgspaqvfeng2fovbximt4lm	53	6	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	53	7	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	53	8	respective	respective	JJ
work_tpiqgspaqvfeng2fovbximt4lm	53	9	institutional	institutional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	53	10	review	review	NN
work_tpiqgspaqvfeng2fovbximt4lm	53	11	boards	board	NNS
work_tpiqgspaqvfeng2fovbximt4lm	53	12	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	53	13	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	53	14	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	53	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	53	16	Maryland	Maryland	NNP
work_tpiqgspaqvfeng2fovbximt4lm	53	17	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	53	18	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	53	19	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	53	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	53	21	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	53	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	54	1	Writ-	writ-	IN
work_tpiqgspaqvfeng2fovbximt4lm	54	2	ten	ten	CD
work_tpiqgspaqvfeng2fovbximt4lm	54	3	informed	informed	JJ
work_tpiqgspaqvfeng2fovbximt4lm	54	4	consent	consent	NN
work_tpiqgspaqvfeng2fovbximt4lm	54	5	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	54	6	obtained	obtain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	54	7	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	54	8	each	each	DT
work_tpiqgspaqvfeng2fovbximt4lm	54	9	participant	participant	NN
work_tpiqgspaqvfeng2fovbximt4lm	54	10	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	54	11	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	54	12	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	54	13	compensated	compensate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	54	14	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	54	15	their	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	54	16	participation	participation	NN
work_tpiqgspaqvfeng2fovbximt4lm	54	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	55	1	Genotype	Genotype	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	2	Analysis	Analysis	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	3	Genotyping	Genotyping	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	4	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	55	5	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	55	6	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	7	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	8	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	55	9	per-	per-	RB
work_tpiqgspaqvfeng2fovbximt4lm	55	10	formed	form	VBN
work_tpiqgspaqvfeng2fovbximt4lm	55	11	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	55	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	55	13	Affymetrix	Affymetrix	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	14	GeneChip	GeneChip	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	15	Human	Human	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	16	Mapping	Mapping	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	17	500	500	CD
work_tpiqgspaqvfeng2fovbximt4lm	55	18	K	k	NN
work_tpiqgspaqvfeng2fovbximt4lm	55	19	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	55	20	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	55	21	M	m	NN
work_tpiqgspaqvfeng2fovbximt4lm	55	22	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	55	23	ver-	ver-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	24	sion	sion	NN
work_tpiqgspaqvfeng2fovbximt4lm	55	25	6.0	6.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	55	26	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	55	27	arrays	array	NNS
work_tpiqgspaqvfeng2fovbximt4lm	55	28	according	accord	VBG
work_tpiqgspaqvfeng2fovbximt4lm	55	29	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	55	30	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	55	31	manu-	manu-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	32	facturer	facturer	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	33	’s	’s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	34	instructions	instruction	NNS
work_tpiqgspaqvfeng2fovbximt4lm	55	35	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	55	36	Affymetrix	Affymetrix	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	37	Inc	Inc	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	38	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	55	39	Santa	Santa	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	40	Clara	Clara	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	41	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	55	42	California	California	NNP
work_tpiqgspaqvfeng2fovbximt4lm	55	43	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	55	44	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	56	1	Genotype	Genotype	NNP
work_tpiqgspaqvfeng2fovbximt4lm	56	2	calls	call	NNS
work_tpiqgspaqvfeng2fovbximt4lm	56	3	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	56	4	performed	perform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	56	5	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	56	6	BRLMM	BRLMM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	56	7	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	56	8	500	500	CD
work_tpiqgspaqvfeng2fovbximt4lm	56	9	K	k	NN
work_tpiqgspaqvfeng2fovbximt4lm	56	10	array	array	NN
work_tpiqgspaqvfeng2fovbximt4lm	56	11	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	56	12	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	56	13	Birdseed	Birdseed	NNP
work_tpiqgspaqvfeng2fovbximt4lm	56	14	version	version	NN
work_tpiqgspaqvfeng2fovbximt4lm	56	15	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	56	16	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	56	17	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	56	18	M	m	NN
work_tpiqgspaqvfeng2fovbximt4lm	56	19	ar-	ar-	NN
work_tpiqgspaqvfeng2fovbximt4lm	56	20	ray	ray	NN
work_tpiqgspaqvfeng2fovbximt4lm	56	21	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	56	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	57	1	Single	single	JJ
work_tpiqgspaqvfeng2fovbximt4lm	57	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	57	3	nucleotide	nucleotide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	57	4	polymor-	polymor-	NN
work_tpiqgspaqvfeng2fovbximt4lm	57	5	phisms	phism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	57	6	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	57	7	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	57	8	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	57	9	present	present	JJ
work_tpiqgspaqvfeng2fovbximt4lm	57	10	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	57	11	both	both	DT
work_tpiqgspaqvfeng2fovbximt4lm	57	12	arrays	array	NNS
work_tpiqgspaqvfeng2fovbximt4lm	57	13	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	57	14	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	57	15	minor	minor	JJ
work_tpiqgspaqvfeng2fovbximt4lm	57	16	allele	allele	NN
work_tpiqgspaqvfeng2fovbximt4lm	57	17	frequency	frequency	NN
work_tpiqgspaqvfeng2fovbximt4lm	57	18	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	57	19	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	57	20	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	57	21	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	57	22	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	57	23	included	include	VBN
work_tpiqgspaqvfeng2fovbximt4lm	57	24	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	57	25	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	57	26	analy-	analy-	NNS
work_tpiqgspaqvfeng2fovbximt4lm	57	27	ses	ses	NNP
work_tpiqgspaqvfeng2fovbximt4lm	57	28	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	58	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	58	2	mean	mean	JJ
work_tpiqgspaqvfeng2fovbximt4lm	58	3	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	58	4	call	call	NN
work_tpiqgspaqvfeng2fovbximt4lm	58	5	rate	rate	NN
work_tpiqgspaqvfeng2fovbximt4lm	58	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	58	7	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	58	8	400	400	CD
work_tpiqgspaqvfeng2fovbximt4lm	58	9	230	230	CD
work_tpiqgspaqvfeng2fovbximt4lm	58	10	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	58	11	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	58	12	98.7	98.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	58	13	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	58	14	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	59	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	59	2	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	59	3	within	within	IN
work_tpiqgspaqvfeng2fovbximt4lm	59	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	59	5	region	region	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	59	7	interest	interest	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	8	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	59	9	chromosome	chromosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	10	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	59	11	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	59	12	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	59	13	Hardy-	Hardy-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	59	14	Weinberg	Weinberg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	59	15	equilibrium	equilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	16	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	59	17	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	18	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	59	19	.05	.05	NFP
work_tpiqgspaqvfeng2fovbximt4lm	59	20	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	59	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	59	22	ex-	ex-	XX
work_tpiqgspaqvfeng2fovbximt4lm	59	23	cept	cept	FW
work_tpiqgspaqvfeng2fovbximt4lm	59	24	rs12572351	rs12572351	NNP
work_tpiqgspaqvfeng2fovbximt4lm	59	25	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	59	26	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	27	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	59	28	1.89	1.89	CD
work_tpiqgspaqvfeng2fovbximt4lm	59	29	�	�	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	30	10−5	10−5	CD
work_tpiqgspaqvfeng2fovbximt4lm	59	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	59	32	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	59	33	rs2860838	rs2860838	FW
work_tpiqgspaqvfeng2fovbximt4lm	59	34	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	59	35	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	59	36	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	59	37	1.03	1.03	CD
work_tpiqgspaqvfeng2fovbximt4lm	59	38	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	59	39	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	59	40	−	−	NNP
work_tpiqgspaqvfeng2fovbximt4lm	59	41	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	59	42	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	59	43	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	60	1	Fol-	Fol-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	2	low	low	JJ
work_tpiqgspaqvfeng2fovbximt4lm	60	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	60	4	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	5	genotyping	genotyping	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	60	7	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	60	8	known	know	VBN
work_tpiqgspaqvfeng2fovbximt4lm	60	9	com-	com-	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	10	mon	mon	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	11	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	60	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	60	14	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	60	15	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	16	CYP2C19	cyp2c19	VB
work_tpiqgspaqvfeng2fovbximt4lm	60	17	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	60	18	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	60	19	vari-	vari-	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	20	ant	ant	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	21	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	22	rs4244285	rs4244285	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	23	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	24	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	60	25	as	as	RB
work_tpiqgspaqvfeng2fovbximt4lm	60	26	well	well	RB
work_tpiqgspaqvfeng2fovbximt4lm	60	27	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	60	28	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	60	29	functional	functional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	60	30	variants	variant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	60	31	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	60	32	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	33	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	34	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	60	35	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	60	36	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	37	rs4986893	rs4986893	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	38	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	39	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	60	40	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	60	41	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	60	42	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	43	rs56337013	rs56337013	NN
work_tpiqgspaqvfeng2fovbximt4lm	60	44	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	45	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	60	46	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	60	47	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	60	48	17	17	CD
work_tpiqgspaqvfeng2fovbximt4lm	60	49	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	50	rs12248560	rs12248560	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	51	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	52	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	53	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	60	54	performed	perform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	60	55	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	60	56	TaqMan	TaqMan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	57	SNP	SNP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	58	genotyping	genotype	VBG
work_tpiqgspaqvfeng2fovbximt4lm	60	59	assays	assays	RB
work_tpiqgspaqvfeng2fovbximt4lm	60	60	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	61	Ap-	Ap-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	62	plied	ply	VBD
work_tpiqgspaqvfeng2fovbximt4lm	60	63	Biosystems	Biosystems	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	64	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	60	65	Foster	Foster	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	66	City	City	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	67	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	60	68	Califor-	Califor-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	69	nia	nia	NNP
work_tpiqgspaqvfeng2fovbximt4lm	60	70	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	60	71	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	61	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	61	2	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	61	3	concordance	concordance	NN
work_tpiqgspaqvfeng2fovbximt4lm	61	4	rate	rate	NN
work_tpiqgspaqvfeng2fovbximt4lm	61	5	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	61	6	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	61	7	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	61	8	98	98	CD
work_tpiqgspaqvfeng2fovbximt4lm	61	9	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	61	10	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	61	11	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	61	12	subset	subset	NN
work_tpiqgspaqvfeng2fovbximt4lm	61	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	61	14	du-	du-	NN
work_tpiqgspaqvfeng2fovbximt4lm	61	15	plicate	plicate	NN
work_tpiqgspaqvfeng2fovbximt4lm	61	16	samples	sample	NNS
work_tpiqgspaqvfeng2fovbximt4lm	61	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	62	1	Statistical	statistical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	62	2	Analysis	Analysis	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	3	Summary	Summary	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	4	statistics	statistic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	62	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	62	6	eg	eg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	62	8	means	mean	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	62	9	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	62	10	SDs	sd	NNS
work_tpiqgspaqvfeng2fovbximt4lm	62	11	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	62	12	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	62	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	62	14	frequencies	frequency	NNS
work_tpiqgspaqvfeng2fovbximt4lm	62	15	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	62	16	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	62	17	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	62	18	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	19	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	62	20	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	21	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	22	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	62	23	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	24	popula-	popula-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	62	25	tions	tion	NNS
work_tpiqgspaqvfeng2fovbximt4lm	62	26	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	62	27	generated	generate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	62	28	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	62	29	SAS	SAS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	30	ver-	ver-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	62	31	sion	sion	NN
work_tpiqgspaqvfeng2fovbximt4lm	62	32	9.1	9.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	62	33	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	62	34	SAS	SAS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	35	Institute	Institute	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	36	Inc	Inc	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	62	38	Cary	Cary	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	39	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	62	40	North	North	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	41	Carolina	Carolina	NNP
work_tpiqgspaqvfeng2fovbximt4lm	62	42	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	62	43	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	63	1	For	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	63	2	both	both	DT
work_tpiqgspaqvfeng2fovbximt4lm	63	3	studies	study	NNS
work_tpiqgspaqvfeng2fovbximt4lm	63	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	63	5	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	63	6	ag-	ag-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	63	7	gregation	gregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	63	8	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	63	9	expressed	express	VBN
work_tpiqgspaqvfeng2fovbximt4lm	63	10	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	63	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	63	12	maxi-	maxi-	XX
work_tpiqgspaqvfeng2fovbximt4lm	63	13	mum	mum	NNP
work_tpiqgspaqvfeng2fovbximt4lm	63	14	percentage	percentage	NN
work_tpiqgspaqvfeng2fovbximt4lm	63	15	change	change	NN
work_tpiqgspaqvfeng2fovbximt4lm	63	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	63	17	light	light	JJ
work_tpiqgspaqvfeng2fovbximt4lm	63	18	trans-	trans-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	63	19	mittance	mittance	NNP
work_tpiqgspaqvfeng2fovbximt4lm	63	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	63	21	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	63	22	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	63	23	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	63	24	poor	poor	JJ
work_tpiqgspaqvfeng2fovbximt4lm	63	25	plasma	plasma	NN
work_tpiqgspaqvfeng2fovbximt4lm	63	26	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	63	27	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	63	28	referent	referent	NN
work_tpiqgspaqvfeng2fovbximt4lm	63	29	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	64	1	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	64	2	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	3	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	4	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	64	5	assessed	assess	VBD
work_tpiqgspaqvfeng2fovbximt4lm	64	6	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	64	7	correlates	correlate	NNS
work_tpiqgspaqvfeng2fovbximt4lm	64	8	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	64	9	eg	eg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	64	11	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	64	13	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	64	15	body	body	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	16	mass	mass	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	17	index	index	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	18	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	64	19	BMI	BMI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	20	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	64	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	64	22	lipid	lipid	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	23	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	64	24	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	64	25	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	64	26	blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	27	pressure	pressure	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	28	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	64	29	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	30	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	31	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	64	32	sponse	sponse	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	33	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	64	34	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	64	35	regression	regression	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	36	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	64	37	based	base	VBN
work_tpiqgspaqvfeng2fovbximt4lm	64	38	ap-	ap-	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	39	proach	proach	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	40	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	41	implemented	implement	VBN
work_tpiqgspaqvfeng2fovbximt4lm	64	42	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	43	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	64	44	SOLAR	SOLAR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	45	version	version	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	46	4.07	4.07	CD
work_tpiqgspaqvfeng2fovbximt4lm	64	47	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	64	48	Southwest	Southwest	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	49	Foundation	Foundation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	50	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	51	Biomedical	Biomedical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	52	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	53	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	64	54	San	San	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	55	Antonio	Antonio	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	56	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	64	57	Texas),30	Texas),30	NNP
work_tpiqgspaqvfeng2fovbximt4lm	64	58	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	59	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	64	60	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	64	61	accounted	account	VBD
work_tpiqgspaqvfeng2fovbximt4lm	64	62	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	63	re-	re-	DT
work_tpiqgspaqvfeng2fovbximt4lm	64	64	latedness	latedness	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	65	among	among	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	66	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	67	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	64	68	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	69	including	include	VBG
work_tpiqgspaqvfeng2fovbximt4lm	64	70	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	64	71	polygenic	polygenic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	64	72	component	component	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	73	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	64	74	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	64	75	random	random	JJ
work_tpiqgspaqvfeng2fovbximt4lm	64	76	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	64	77	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	65	1	Triglyceride	Triglyceride	NNP
work_tpiqgspaqvfeng2fovbximt4lm	65	2	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	65	3	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	65	4	logarithm	logarithm	NN
work_tpiqgspaqvfeng2fovbximt4lm	65	5	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	65	6	transformed	transform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	65	7	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	65	8	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	65	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	65	10	back	back	NN
work_tpiqgspaqvfeng2fovbximt4lm	65	11	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	65	12	transformed	transform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	65	13	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	65	14	presentation	presentation	NN
work_tpiqgspaqvfeng2fovbximt4lm	65	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	66	1	Dis-	Dis-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	66	2	tribution	tribution	NN
work_tpiqgspaqvfeng2fovbximt4lm	66	3	analyses	analysis	NNS
work_tpiqgspaqvfeng2fovbximt4lm	66	4	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	66	5	generated	generate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	66	6	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	66	7	SAS	SAS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	66	8	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	67	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	67	2	statistical	statistical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	67	3	tests	test	NNS
work_tpiqgspaqvfeng2fovbximt4lm	67	4	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	67	5	2-sided	2-sided	CD
work_tpiqgspaqvfeng2fovbximt4lm	67	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	68	1	Association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	2	analyses	analyse	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	68	3	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	68	4	SNPs	SNPs	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	68	5	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	68	6	ADP	adp	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	7	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	68	8	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	68	9	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	10	aggrega-	aggrega-	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	11	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	12	following	follow	VBG
work_tpiqgspaqvfeng2fovbximt4lm	68	13	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	68	14	administra-	administra-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	68	15	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	16	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	68	17	performed	perform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	68	18	under	under	IN
work_tpiqgspaqvfeng2fovbximt4lm	68	19	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	68	20	variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	21	component	component	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	22	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	23	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	68	24	assesses	assess	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	68	25	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	68	26	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	27	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	68	28	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	29	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	68	30	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	68	31	additive	additive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	68	32	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	33	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	68	34	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	68	35	quantitative	quantitative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	68	36	trait	trait	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	68	38	while	while	IN
work_tpiqgspaqvfeng2fovbximt4lm	68	39	simultaneously	simultaneously	RB
work_tpiqgspaqvfeng2fovbximt4lm	68	40	estimating	estimate	VBG
work_tpiqgspaqvfeng2fovbximt4lm	68	41	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	68	42	effects	effect	NNS
work_tpiqgspaqvfeng2fovbximt4lm	68	43	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	68	44	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	45	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	68	46	age2	age2	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	47	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	68	48	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	49	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	68	50	preclopidogrel	preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	68	51	platelet	platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	68	52	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	53	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	68	54	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	68	55	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	68	56	aforementioned	aforementioned	JJ
work_tpiqgspaqvfeng2fovbximt4lm	68	57	polygenic	polygenic	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	58	component	component	NN
work_tpiqgspaqvfeng2fovbximt4lm	68	59	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	69	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	2	polygenic	polygenic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	69	3	component	component	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	4	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	69	5	mod-	mod-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	69	6	eled	ele	VBN
work_tpiqgspaqvfeng2fovbximt4lm	69	7	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	69	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	9	relationship	relationship	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	10	matrix	matrix	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	11	de-	de-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	69	12	rived	rive	VBD
work_tpiqgspaqvfeng2fovbximt4lm	69	13	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	14	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	15	complete	complete	JJ
work_tpiqgspaqvfeng2fovbximt4lm	69	16	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	69	17	pedi-	pedi-	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	18	gree	gree	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	19	structure	structure	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	20	available	available	JJ
work_tpiqgspaqvfeng2fovbximt4lm	69	21	through	through	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	22	published	publish	VBN
work_tpiqgspaqvfeng2fovbximt4lm	69	23	genealogical	genealogical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	69	24	records	record	NNS
work_tpiqgspaqvfeng2fovbximt4lm	69	25	main-	main-	RB
work_tpiqgspaqvfeng2fovbximt4lm	69	26	tained	taine	VBN
work_tpiqgspaqvfeng2fovbximt4lm	69	27	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	28	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	29	church.31	church.31	NNP
work_tpiqgspaqvfeng2fovbximt4lm	69	30	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	31	heritabil-	heritabil-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	69	32	ity	ity	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	33	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	34	baseline	baseline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	69	35	platelet	platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	69	36	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	37	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	69	38	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	39	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	40	corresponds	correspond	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	69	41	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	42	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	43	proportion	proportion	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	44	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	45	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	46	trait	trait	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	47	variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	48	ac-	ac-	RB
work_tpiqgspaqvfeng2fovbximt4lm	69	49	counted	count	VBD
work_tpiqgspaqvfeng2fovbximt4lm	69	50	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	51	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	69	52	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	69	53	polygenic	polygenic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	69	54	compo-	compo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	69	55	nent	nent	NN
work_tpiqgspaqvfeng2fovbximt4lm	69	56	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	70	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	70	2	genomic	genomic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	70	3	control	control	NN
work_tpiqgspaqvfeng2fovbximt4lm	70	4	�	�	.
work_tpiqgspaqvfeng2fovbximt4lm	70	5	coeffi-	coeffi-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	70	6	cient	cient	NN
work_tpiqgspaqvfeng2fovbximt4lm	70	7	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	70	8	1.03	1.03	CD
work_tpiqgspaqvfeng2fovbximt4lm	70	9	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	70	10	thus	thus	RB
work_tpiqgspaqvfeng2fovbximt4lm	70	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	70	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	70	13	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	70	14	values	value	NNS
work_tpiqgspaqvfeng2fovbximt4lm	70	15	reported	report	VBN
work_tpiqgspaqvfeng2fovbximt4lm	70	16	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	70	17	unadjusted	unadjusted	JJ
work_tpiqgspaqvfeng2fovbximt4lm	70	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	71	1	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	71	2	power	power	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	3	calculation	calculation	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	4	indicated	indicate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	71	5	80	80	CD
work_tpiqgspaqvfeng2fovbximt4lm	71	6	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	7	power	power	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	8	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	71	9	detect	detect	VB
work_tpiqgspaqvfeng2fovbximt4lm	71	10	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	71	11	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	71	12	allele	allele	NNP
work_tpiqgspaqvfeng2fovbximt4lm	71	13	fre-	fre-	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	14	quencies	quencie	NNS
work_tpiqgspaqvfeng2fovbximt4lm	71	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	71	16	0.2	0.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	71	17	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	71	18	0.4	0.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	71	19	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	71	20	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	71	21	initial	initial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	71	22	sample	sample	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	23	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	71	24	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	71	25	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	71	26	429	429	CD
work_tpiqgspaqvfeng2fovbximt4lm	71	27	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	71	28	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	71	29	accounting	account	VBG
work_tpiqgspaqvfeng2fovbximt4lm	71	30	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	71	31	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	71	32	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	33	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	71	34	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	71	35	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	36	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	71	37	phenotypic	phenotypic	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	38	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	71	39	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	71	40	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	71	41	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	71	42	10−7	10−7	CD
work_tpiqgspaqvfeng2fovbximt4lm	71	43	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	72	1	To	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	72	2	determine	determine	VB
work_tpiqgspaqvfeng2fovbximt4lm	72	3	whether	whether	IN
work_tpiqgspaqvfeng2fovbximt4lm	72	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	5	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	6	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	72	7	of-	of-	CD
work_tpiqgspaqvfeng2fovbximt4lm	72	8	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	9	CYP2C19	cyp2c19	VB
work_tpiqgspaqvfeng2fovbximt4lm	72	10	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	72	11	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	72	12	variant	variant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	72	13	could	could	MD
work_tpiqgspaqvfeng2fovbximt4lm	72	14	account	account	VB
work_tpiqgspaqvfeng2fovbximt4lm	72	15	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	72	16	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	17	chromosome	chromosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	18	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	72	19	association	association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	72	20	signal	signal	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	72	22	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	72	23	estimated	estimate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	72	24	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	25	in-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	72	26	dependent	dependent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	72	27	effects	effect	NNS
work_tpiqgspaqvfeng2fovbximt4lm	72	28	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	72	29	both	both	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	30	rs12777823	rs12777823	NNP
work_tpiqgspaqvfeng2fovbximt4lm	72	31	—	—	:
work_tpiqgspaqvfeng2fovbximt4lm	72	32	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	33	most	most	RBS
work_tpiqgspaqvfeng2fovbximt4lm	72	34	highly	highly	RB
work_tpiqgspaqvfeng2fovbximt4lm	72	35	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	72	36	SNP	SNP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	72	37	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	72	38	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	39	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	40	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	72	41	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	72	42	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	43	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	44	—	—	:
work_tpiqgspaqvfeng2fovbximt4lm	72	45	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	72	46	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	47	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	72	48	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	72	49	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	72	50	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	51	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	72	52	plate-	plate-	NNS
work_tpiqgspaqvfeng2fovbximt4lm	72	53	let	let	VBN
work_tpiqgspaqvfeng2fovbximt4lm	72	54	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	55	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	72	56	including	include	VBG
work_tpiqgspaqvfeng2fovbximt4lm	72	57	both	both	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	58	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	72	59	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	72	60	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	72	61	simultaneously	simultaneously	RB
work_tpiqgspaqvfeng2fovbximt4lm	72	62	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	73	1	Pairwise	pairwise	VB
work_tpiqgspaqvfeng2fovbximt4lm	73	2	link-	link-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	73	3	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	73	4	disequilibrium	disequilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	73	5	correlation	correlation	NN
work_tpiqgspaqvfeng2fovbximt4lm	73	6	statis-	statis-	NN
work_tpiqgspaqvfeng2fovbximt4lm	73	7	tics	tics	NNP
work_tpiqgspaqvfeng2fovbximt4lm	73	8	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	73	9	|D’|	|d’|	RB
work_tpiqgspaqvfeng2fovbximt4lm	73	10	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	73	11	r2	r2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	73	12	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	73	13	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	73	14	computed	compute	VBN
work_tpiqgspaqvfeng2fovbximt4lm	73	15	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	73	16	Haploview	Haploview	NNP
work_tpiqgspaqvfeng2fovbximt4lm	73	17	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	73	18	http://www.broad.mit	http://www.broad.mit	ADD
work_tpiqgspaqvfeng2fovbximt4lm	73	19	.edu	.edu	NFP
work_tpiqgspaqvfeng2fovbximt4lm	73	20	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	73	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	74	1	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	2	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	74	4	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	5	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	6	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	74	7	estimated	estimate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	74	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	74	9	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	74	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	74	11	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	12	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	74	13	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	74	14	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	74	15	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	74	16	preclopidogrel	preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	17	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	74	18	post-	post-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	19	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	20	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	21	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	74	22	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	74	23	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	74	24	ag-	ag-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	74	25	gregation	gregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	74	26	under	under	IN
work_tpiqgspaqvfeng2fovbximt4lm	74	27	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	74	28	additive	additive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	74	29	genetic	genetic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	74	30	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	74	31	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	74	32	classifying	classify	VBG
work_tpiqgspaqvfeng2fovbximt4lm	74	33	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	74	34	ac-	ac-	DT
work_tpiqgspaqvfeng2fovbximt4lm	74	35	cording	cord	VBG
work_tpiqgspaqvfeng2fovbximt4lm	74	36	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	74	37	whether	whether	IN
work_tpiqgspaqvfeng2fovbximt4lm	74	38	they	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	74	39	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	74	40	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	74	41	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	74	42	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	74	43	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	74	44	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	74	45	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	74	46	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	74	47	alleles	allele	NNS
work_tpiqgspaqvfeng2fovbximt4lm	74	48	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	75	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	75	2	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	3	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	4	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	75	5	es-	es-	RB
work_tpiqgspaqvfeng2fovbximt4lm	75	6	timated	timate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	75	7	using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	75	8	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	9	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	10	variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	11	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	12	adjustment	adjustment	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	13	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	14	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	75	16	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	17	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	75	18	race	race	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	75	20	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	21	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	75	22	Peri	Peri	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	23	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	75	24	Procedural	Procedural	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	25	Myocardial	Myocardial	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	26	Infarc-	Infarc-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	27	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	28	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	75	29	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	30	Reactivity	Reactivity	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	75	32	Thrombin	Thrombin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	33	Gen-	Gen-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	34	eration	eration	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	75	36	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	75	37	Clot	Clot	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	38	Strength	Strength	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	39	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	75	40	Differen-	Differen-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	41	tial	tial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	75	42	Effects	Effects	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	75	43	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	44	Eptifibatide	Eptifibatide	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	45	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	46	Bivalirudin	Bivalirudin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	47	vs	vs	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	48	Bivalirudin	Bivalirudin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	49	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	50	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	75	51	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	52	Loading	Loading	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	53	With	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	54	Eptifibatide	eptifibatide	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	55	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	75	56	Arrest	arrest	VB
work_tpiqgspaqvfeng2fovbximt4lm	75	57	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	75	58	Reactivity	Reactivity	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	59	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	60	Platelets	platelet	NNS
work_tpiqgspaqvfeng2fovbximt4lm	75	61	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	75	62	CLEAR	CLEAR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	63	PLATELETS–1	PLATELETS–1	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	64	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	75	65	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	66	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	75	67	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	75	68	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	75	69	treat-	treat-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	75	70	ment	ment	JJ
work_tpiqgspaqvfeng2fovbximt4lm	75	71	group	group	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	72	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	75	73	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	75	74	dose	dose	VBP
work_tpiqgspaqvfeng2fovbximt4lm	75	75	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	75	76	use	use	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	77	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	75	78	eptifibatide	eptifibatide	NN
work_tpiqgspaqvfeng2fovbximt4lm	75	79	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	75	80	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	76	1	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	76	2	similarly	similarly	RB
work_tpiqgspaqvfeng2fovbximt4lm	76	3	compared	compare	VBD
work_tpiqgspaqvfeng2fovbximt4lm	76	4	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	76	5	ag-	ag-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	76	6	gregation	gregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	76	7	values	value	NNS
work_tpiqgspaqvfeng2fovbximt4lm	76	8	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	76	9	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	76	10	who	who	WP
work_tpiqgspaqvfeng2fovbximt4lm	76	11	did	do	VBD
work_tpiqgspaqvfeng2fovbximt4lm	76	12	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	76	13	did	do	VBD
work_tpiqgspaqvfeng2fovbximt4lm	76	14	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	76	15	experience	experience	VB
work_tpiqgspaqvfeng2fovbximt4lm	76	16	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	76	17	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	76	18	while	while	IN
work_tpiqgspaqvfeng2fovbximt4lm	76	19	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	76	20	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	76	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	77	1	Lastly	lastly	RB
work_tpiqgspaqvfeng2fovbximt4lm	77	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	77	3	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	77	4	constructed	construct	VBD
work_tpiqgspaqvfeng2fovbximt4lm	77	5	survival	survival	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	6	curves	curve	NNS
work_tpiqgspaqvfeng2fovbximt4lm	77	7	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	77	8	com-	com-	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	9	pare	pare	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	10	1-year	1-year	CD
work_tpiqgspaqvfeng2fovbximt4lm	77	11	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	77	12	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	13	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	77	14	free	free	JJ
work_tpiqgspaqvfeng2fovbximt4lm	77	15	survival	survival	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	16	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	77	17	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	77	18	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	77	19	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	77	20	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	77	21	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	77	22	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	77	23	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	77	24	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	77	25	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	77	26	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	77	27	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	77	28	w	w	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	29	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	30	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	31	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	77	32	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	33	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	77	34	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	77	35	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	77	36	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	77	37	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	77	38	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	77	39	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	77	40	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	77	41	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	77	42	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	77	43	CYP2C19	cyp2c19	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	44	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	77	45	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	77	46	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	77	47	allele	allele	NNP
work_tpiqgspaqvfeng2fovbximt4lm	77	48	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	78	1	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	78	2	analyzed	analyze	VBD
work_tpiqgspaqvfeng2fovbximt4lm	78	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	78	4	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	78	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	78	6	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	78	7	allele	allele	NN
work_tpiqgspaqvfeng2fovbximt4lm	78	8	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	78	9	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	78	10	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	78	11	re-	re-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	78	12	lation	lation	NN
work_tpiqgspaqvfeng2fovbximt4lm	78	13	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	78	14	ongoing	ongoing	JJ
work_tpiqgspaqvfeng2fovbximt4lm	78	15	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	78	16	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	78	17	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	78	18	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	78	19	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	78	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	78	21	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	78	22	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	78	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	79	1	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	79	2	used	use	VBD
work_tpiqgspaqvfeng2fovbximt4lm	79	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	79	4	proportional	proportional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	79	5	hazards	hazard	NNS
work_tpiqgspaqvfeng2fovbximt4lm	79	6	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	7	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	79	8	esti-	esti-	XX
work_tpiqgspaqvfeng2fovbximt4lm	79	9	mate	mate	VB
work_tpiqgspaqvfeng2fovbximt4lm	79	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	79	11	relative	relative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	79	12	hazard	hazard	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	13	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	79	14	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	79	15	having	have	VBG
work_tpiqgspaqvfeng2fovbximt4lm	79	16	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	79	17	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	18	allele	allele	RB
work_tpiqgspaqvfeng2fovbximt4lm	79	19	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	79	20	subsequent	subsequent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	79	21	is-	is-	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	22	chemic	chemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	79	23	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	24	rates	rate	NNS
work_tpiqgspaqvfeng2fovbximt4lm	79	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	79	26	adjusting	adjust	VBG
work_tpiqgspaqvfeng2fovbximt4lm	79	27	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	79	28	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	29	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	79	30	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	79	32	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	79	33	race	race	NN
work_tpiqgspaqvfeng2fovbximt4lm	79	34	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	80	1	This	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	80	2	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	80	3	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	80	4	car-	car-	RB
work_tpiqgspaqvfeng2fovbximt4lm	80	5	ried	rie	VBN
work_tpiqgspaqvfeng2fovbximt4lm	80	6	out	out	RP
work_tpiqgspaqvfeng2fovbximt4lm	80	7	both	both	CC
work_tpiqgspaqvfeng2fovbximt4lm	80	8	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	80	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	80	10	without	without	IN
work_tpiqgspaqvfeng2fovbximt4lm	80	11	ADP-	ADP-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	12	CYTOCHROME	CYTOCHROME	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	13	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	14	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	80	15	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	80	16	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	80	17	CLOPIDOGREL	CLOPIDOGREL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	18	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	19	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	20	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	80	21	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	22	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	23	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	80	24	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	81	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	81	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	81	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	81	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	82	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	82	2	Reprinted	reprinted	JJ
work_tpiqgspaqvfeng2fovbximt4lm	82	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	82	4	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	82	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	82	6	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	82	7	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	82	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	82	9	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	82	10	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	82	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	82	12	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	82	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	83	1	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	83	2	851	851	CD
work_tpiqgspaqvfeng2fovbximt4lm	83	3	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	83	4	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	83	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	83	6	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	83	7	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	83	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	83	9	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	83	10	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	83	11	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	83	12	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	83	13	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	83	14	04/05/2021	04/05/2021	CD
work_tpiqgspaqvfeng2fovbximt4lm	83	15	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	83	16	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	83	17	included	include	VBD
work_tpiqgspaqvfeng2fovbximt4lm	83	18	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	83	19	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	83	20	mediator	mediator	NN
work_tpiqgspaqvfeng2fovbximt4lm	83	21	variable	variable	NN
work_tpiqgspaqvfeng2fovbximt4lm	83	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	84	1	S	S	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	2	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	3	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	4	v	v	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	5	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	6	v	v	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	7	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	8	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	9	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	10	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	11	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	12	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	13	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	14	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	15	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	16	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	17	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	18	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	19	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	20	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	21	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	22	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	23	f	f	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	24	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	25	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	26	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	27	b	b	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	28	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	29	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	30	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	84	31	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	84	32	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	33	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	84	34	also	also	RB
work_tpiqgspaqvfeng2fovbximt4lm	84	35	per-	per-	RB
work_tpiqgspaqvfeng2fovbximt4lm	84	36	formed	form	VBN
work_tpiqgspaqvfeng2fovbximt4lm	84	37	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	38	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	39	subset	subset	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	40	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	41	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	84	42	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	84	43	still	still	RB
work_tpiqgspaqvfeng2fovbximt4lm	84	44	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	84	45	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	46	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	47	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	48	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	49	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	50	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	51	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	84	52	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	53	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	84	54	year	year	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	55	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	56	follow	follow	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	57	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	84	58	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	59	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	84	60	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	61	132	132	CD
work_tpiqgspaqvfeng2fovbximt4lm	84	62	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	84	63	who	who	WP
work_tpiqgspaqvfeng2fovbximt4lm	84	64	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	84	65	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	84	66	receiving	receive	VBG
work_tpiqgspaqvfeng2fovbximt4lm	84	67	clopi-	clopi-	NNS
work_tpiqgspaqvfeng2fovbximt4lm	84	68	dogrel	dogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	84	69	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	70	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	84	71	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	72	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	73	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	74	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	84	75	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	76	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	84	77	year	year	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	78	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	84	79	follow	follow	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	80	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	84	81	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	84	82	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	85	1	RESULTS	RESULTS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	85	2	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	85	3	PAPI	papi	NN
work_tpiqgspaqvfeng2fovbximt4lm	85	4	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	85	5	By	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	85	6	design	design	NN
work_tpiqgspaqvfeng2fovbximt4lm	85	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	85	8	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	85	9	PAPI	papi	NN
work_tpiqgspaqvfeng2fovbximt4lm	85	10	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	85	11	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	85	12	generally	generally	RB
work_tpiqgspaqvfeng2fovbximt4lm	85	13	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	85	14	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	85	15	TABLE	TABLE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	85	16	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	85	17	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	85	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	86	1	There	there	EX
work_tpiqgspaqvfeng2fovbximt4lm	86	2	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	86	3	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	86	4	interindividual	interindividual	JJ
work_tpiqgspaqvfeng2fovbximt4lm	86	5	variability	variability	NN
work_tpiqgspaqvfeng2fovbximt4lm	86	6	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	86	7	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	86	8	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	86	9	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	86	10	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	86	11	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	86	12	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	86	13	baseline	baseline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	86	14	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	86	15	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	86	16	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	86	17	admin-	admin-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	86	18	istration	istration	NN
work_tpiqgspaqvfeng2fovbximt4lm	86	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	86	20	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	86	21	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	86	22	clear	clear	JJ
work_tpiqgspaqvfeng2fovbximt4lm	86	23	cutoff	cutoff	NN
work_tpiqgspaqvfeng2fovbximt4lm	86	24	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	86	25	de-	de-	VB
work_tpiqgspaqvfeng2fovbximt4lm	86	26	fine	fine	JJ
work_tpiqgspaqvfeng2fovbximt4lm	86	27	resistance	resistance	NN
work_tpiqgspaqvfeng2fovbximt4lm	86	28	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	86	29	FIGURE	FIGURE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	86	30	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	86	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	86	32	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	87	1	Poorer	poor	JJR
work_tpiqgspaqvfeng2fovbximt4lm	87	2	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	3	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	5	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	6	defined	define	VBN
work_tpiqgspaqvfeng2fovbximt4lm	87	7	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	8	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	9	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	87	10	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	87	11	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	12	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	13	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	14	days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	87	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	16	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	17	administration	administration	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	19	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	87	20	as-	as-	RB
work_tpiqgspaqvfeng2fovbximt4lm	87	21	sociated	sociate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	87	22	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	23	increasing	increase	VBG
work_tpiqgspaqvfeng2fovbximt4lm	87	24	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	25	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	26	3.8	3.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	27	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	28	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	29	variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	30	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	87	31	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	32	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	33	confidence	confidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	34	interval	interval	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	35	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	36	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	37	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	38	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	39	3.6%-4.1	3.6%-4.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	40	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	41	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	87	42	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	43	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	44	.001	.001	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	45	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	46	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	47	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	87	48	BMI	BMI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	49	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	50	2.3	2.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	51	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	52	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	53	variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	54	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	87	55	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	56	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	57	CI	ci	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	58	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	59	2.2%-	2.2%-	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	60	2.4	2.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	61	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	62	;	;	,
work_tpiqgspaqvfeng2fovbximt4lm	87	63	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	64	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	87	65	.005	.005	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	66	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	67	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	68	higher	high	JJR
work_tpiqgspaqvfeng2fovbximt4lm	87	69	triglyceride	triglyceride	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	70	lev-	lev-	''
work_tpiqgspaqvfeng2fovbximt4lm	87	71	els	els	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	72	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	73	1.3	1.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	74	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	75	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	76	variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	77	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	87	78	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	79	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	80	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	81	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	82	1.28%-	1.28%-	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	83	1.35	1.35	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	84	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	85	;	;	,
work_tpiqgspaqvfeng2fovbximt4lm	87	86	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	87	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	87	88	.01	.01	NFP
work_tpiqgspaqvfeng2fovbximt4lm	87	89	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	90	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	91	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	87	92	nominally	nominally	RB
work_tpiqgspaqvfeng2fovbximt4lm	87	93	lower	low	JJR
work_tpiqgspaqvfeng2fovbximt4lm	87	94	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	87	95	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	96	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	87	97	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	87	98	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	99	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	100	cho-	cho-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	101	lesterol	lesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	102	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	103	1.0	1.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	104	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	105	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	87	106	variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	107	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	87	108	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	109	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	110	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	87	111	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	87	112	0.98%-1.03	0.98%-1.03	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	113	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	114	;	;	,
work_tpiqgspaqvfeng2fovbximt4lm	87	115	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	87	116	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	87	117	.04	.04	NFP
work_tpiqgspaqvfeng2fovbximt4lm	87	118	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	119	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	120	TABLE	TABLE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	87	121	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	87	122	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	87	123	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	88	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	88	2	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	88	3	explained	explain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	88	4	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	88	5	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	88	6	variables	variable	NNS
work_tpiqgspaqvfeng2fovbximt4lm	88	7	combined	combine	VBN
work_tpiqgspaqvfeng2fovbximt4lm	88	8	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	88	9	less	less	JJR
work_tpiqgspaqvfeng2fovbximt4lm	88	10	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	88	11	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	88	12	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	88	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	89	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	89	2	heri-	heri-	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	3	tability	tability	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	89	5	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	89	6	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	89	7	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	89	8	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	9	ag-	ag-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	89	10	gregation	gregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	11	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	89	12	baseline	baseline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	89	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	89	14	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	89	15	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	16	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	89	17	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	18	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	89	19	0.33	0.33	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	20	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	89	21	SE	SE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	89	22	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	89	23	0.13	0.13	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	24	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	89	25	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	26	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	27	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	89	28	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	89	29	0.08	0.08	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	30	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	89	31	0.58	0.58	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	32	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	89	33	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	34	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	89	35	.005	.005	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	36	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	89	37	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	89	38	0.73	0.73	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	39	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	89	40	SE	SE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	89	41	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	89	42	0.12	0.12	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	43	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	89	44	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	45	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	46	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	89	47	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	89	48	0.49	0.49	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	49	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	89	50	0.97	0.97	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	51	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	89	52	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	53	�	�	,
work_tpiqgspaqvfeng2fovbximt4lm	89	54	.001	.001	CD
work_tpiqgspaqvfeng2fovbximt4lm	89	55	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	89	56	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	89	57	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	89	58	spectively	spectively	RB
work_tpiqgspaqvfeng2fovbximt4lm	89	59	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	89	60	suggesting	suggest	VBG
work_tpiqgspaqvfeng2fovbximt4lm	89	61	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	89	62	substantial	substantial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	89	63	ge-	ge-	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	64	netic	netic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	89	65	component	component	NN
work_tpiqgspaqvfeng2fovbximt4lm	89	66	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	90	1	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	90	2	genome	genome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	90	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	90	4	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	90	5	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	6	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	7	revealed	reveal	VBD
work_tpiqgspaqvfeng2fovbximt4lm	90	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	90	9	cluster	cluster	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	90	11	13	13	CD
work_tpiqgspaqvfeng2fovbximt4lm	90	12	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	90	13	spanning	span	VBG
work_tpiqgspaqvfeng2fovbximt4lm	90	14	1.5	1.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	90	15	megabases	megabase	NNS
work_tpiqgspaqvfeng2fovbximt4lm	90	16	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	90	17	chromosome	chromosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	18	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	90	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	90	20	showing	show	VBG
work_tpiqgspaqvfeng2fovbximt4lm	90	21	strong	strong	JJ
work_tpiqgspaqvfeng2fovbximt4lm	90	22	evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	23	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	90	24	associa-	associa-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	90	25	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	26	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	90	27	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	28	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	29	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	90	30	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	90	31	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	32	values	value	NNS
work_tpiqgspaqvfeng2fovbximt4lm	90	33	�	�	NNS
work_tpiqgspaqvfeng2fovbximt4lm	90	34	10−7	10−7	CD
work_tpiqgspaqvfeng2fovbximt4lm	90	35	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	90	36	FIGURE	FIGURE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	90	37	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	90	38	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	90	39	eTable	etable	JJ
work_tpiqgspaqvfeng2fovbximt4lm	90	40	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	90	41	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	90	42	Q	Q	NNP
work_tpiqgspaqvfeng2fovbximt4lm	90	43	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	90	44	Q	Q	NNP
work_tpiqgspaqvfeng2fovbximt4lm	90	45	plot	plot	NN
work_tpiqgspaqvfeng2fovbximt4lm	90	46	shown	show	VBN
work_tpiqgspaqvfeng2fovbximt4lm	90	47	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	90	48	eFigure	eFigure	NNP
work_tpiqgspaqvfeng2fovbximt4lm	90	49	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	90	50	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	91	1	These	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	91	2	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	91	3	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	91	4	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	91	5	strong	strong	JJ
work_tpiqgspaqvfeng2fovbximt4lm	91	6	linkage	linkage	NN
work_tpiqgspaqvfeng2fovbximt4lm	91	7	disequi-	disequi-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	91	8	librium	librium	NN
work_tpiqgspaqvfeng2fovbximt4lm	91	9	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	91	10	each	each	DT
work_tpiqgspaqvfeng2fovbximt4lm	91	11	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	91	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	91	13	eg	eg	UH
work_tpiqgspaqvfeng2fovbximt4lm	91	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	91	15	pairwise	pairwise	NNP
work_tpiqgspaqvfeng2fovbximt4lm	91	16	r2=	r2=	NNP
work_tpiqgspaqvfeng2fovbximt4lm	91	17	0.35	0.35	CD
work_tpiqgspaqvfeng2fovbximt4lm	91	18	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	91	19	0.99	0.99	CD
work_tpiqgspaqvfeng2fovbximt4lm	91	20	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	91	21	rs12777823	rs12777823	NNP
work_tpiqgspaqvfeng2fovbximt4lm	91	22	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	91	23	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	91	24	most	most	RBS
work_tpiqgspaqvfeng2fovbximt4lm	91	25	significantly	significantly	RB
work_tpiqgspaqvfeng2fovbximt4lm	91	26	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	91	27	SNP	SNP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	91	28	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	91	29	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	91	30	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	91	31	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	91	32	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	92	1	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	92	2	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	92	3	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	92	4	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	92	5	−	−	NNP
work_tpiqgspaqvfeng2fovbximt4lm	92	6	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	92	7	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	92	8	f	f	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	9	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	10	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	92	11	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	92	12	h	h	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	13	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	92	14	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	92	15	d	d	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	16	d	d	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	17	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	18	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	19	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	92	20	v	v	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	21	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	92	22	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	92	23	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	92	24	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	93	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	2	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	93	3	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	93	4	homo-	homo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	5	z	z	XX
work_tpiqgspaqvfeng2fovbximt4lm	93	6	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	7	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	8	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	9	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	10	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	11	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	12	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	13	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	14	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	15	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	16	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	17	m	m	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	18	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	19	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	20	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	21	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	22	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	23	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	24	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	25	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	26	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	27	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	28	o	o	XX
work_tpiqgspaqvfeng2fovbximt4lm	93	29	f	f	XX
work_tpiqgspaqvfeng2fovbximt4lm	93	30	rs12777823	rs12777823	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	31	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	93	32	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	33	poorest	poor	JJS
work_tpiqgspaqvfeng2fovbximt4lm	93	34	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	35	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	93	36	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	93	38	while	while	IN
work_tpiqgspaqvfeng2fovbximt4lm	93	39	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	40	300	300	CD
work_tpiqgspaqvfeng2fovbximt4lm	93	41	homo-	homo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	42	zygous	zygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	93	43	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	93	44	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	45	major	major	JJ
work_tpiqgspaqvfeng2fovbximt4lm	93	46	allele	allele	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	47	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	93	48	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	49	best	good	JJS
work_tpiqgspaqvfeng2fovbximt4lm	93	50	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	51	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	93	52	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	53	117	117	CD
work_tpiqgspaqvfeng2fovbximt4lm	93	54	heterozygous	heterozygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	93	55	p	p	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	56	a	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	57	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	58	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	59	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	60	c	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	61	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	62	p	p	VBP
work_tpiqgspaqvfeng2fovbximt4lm	93	63	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	64	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	65	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	66	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	67	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	68	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	69	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	70	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	71	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	72	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	93	73	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	74	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	75	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	76	m	m	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	77	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	78	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	79	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	93	80	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	81	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	82	e	e	NN
work_tpiqgspaqvfeng2fovbximt4lm	93	83	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	93	84	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	93	85	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	93	86	homozygous	homozygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	93	87	groups	group	NNS
work_tpiqgspaqvfeng2fovbximt4lm	93	88	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	94	1	None	none	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	94	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	94	4	chromosome	chromosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	5	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	94	6	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	94	7	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	94	8	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	94	9	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	10	aggre-	aggre-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	94	11	gation	gation	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	12	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	94	13	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	94	14	administra-	administra-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	94	15	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	16	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	94	17	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	94	18	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	94	19	baseline	baseline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	94	20	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	21	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	22	measures	measure	NNS
work_tpiqgspaqvfeng2fovbximt4lm	94	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	94	24	con-	con-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	94	25	sistent	sistent	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	26	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	94	27	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	94	28	locus	locus	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	29	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	94	30	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	94	31	true	true	JJ
work_tpiqgspaqvfeng2fovbximt4lm	94	32	de-	de-	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	33	terminant	terminant	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	34	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	94	35	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	36	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	94	37	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	95	1	No	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	95	2	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	95	3	genomic	genomic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	95	4	region	region	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	5	revealed	reveal	VBD
work_tpiqgspaqvfeng2fovbximt4lm	95	6	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	95	7	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	8	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	9	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	10	c	c	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	11	i	i	PRP
work_tpiqgspaqvfeng2fovbximt4lm	95	12	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	95	13	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	14	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	15	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	16	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	17	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	18	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	19	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	20	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	95	21	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	95	22	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	23	s	s	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	24	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	25	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	26	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	95	27	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	28	m	m	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	29	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	30	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	31	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	32	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	33	exceeded	exceed	VBN
work_tpiqgspaqvfeng2fovbximt4lm	95	34	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	35	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	95	36	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	95	37	significance	significance	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	38	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	95	39	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	95	40	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	95	41	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	95	42	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	96	1	0	0	NFP
work_tpiqgspaqvfeng2fovbximt4lm	96	2	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	3	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	96	4	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	96	5	−	−	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	6	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	96	7	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	96	8	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	96	9	F	f	NN
work_tpiqgspaqvfeng2fovbximt4lm	96	10	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	96	11	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	12	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	13	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	14	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	15	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	96	16	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	96	17	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	96	18	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	19	eTable	eTable	NNP
work_tpiqgspaqvfeng2fovbximt4lm	96	20	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	96	21	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	96	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	97	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	97	2	full	full	JJ
work_tpiqgspaqvfeng2fovbximt4lm	97	3	results	result	NNS
work_tpiqgspaqvfeng2fovbximt4lm	97	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	97	5	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	97	6	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	7	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	97	8	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	97	9	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	10	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	11	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	97	12	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	97	13	v	v	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	14	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	97	15	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	16	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	17	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	97	18	b	b	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	19	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	20	e	e	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	21	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	97	22	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	23	h	h	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	24	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	25	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	26	p	p	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	27	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	97	28	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	97	29	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	97	30	m	m	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	31	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	32	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	33	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	34	c	c	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	35	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	97	36	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	37	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	38	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	97	39	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	98	1	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	98	2	m	m	NNP
work_tpiqgspaqvfeng2fovbximt4lm	98	3	a	a	NNP
work_tpiqgspaqvfeng2fovbximt4lm	98	4	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	98	5	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	98	6	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	98	7	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	98	8	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	98	9	d	d	NN
work_tpiqgspaqvfeng2fovbximt4lm	98	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	99	1	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	2	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	3	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	4	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	99	5	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	6	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	7	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	8	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	99	9	c	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	99	10	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	99	11	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	99	12	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	99	13	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	14	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	99	15	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	99	16	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	99	17	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	18	/supplementalInfo.asp	/supplementalInfo.asp	NNP
work_tpiqgspaqvfeng2fovbximt4lm	99	19	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	100	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	2	cluster	cluster	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	100	4	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	100	5	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	100	6	chromo-	chromo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	7	some	some	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	8	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	100	9	most	most	RBS
work_tpiqgspaqvfeng2fovbximt4lm	100	10	significantly	significantly	RB
work_tpiqgspaqvfeng2fovbximt4lm	100	11	associ-	associ-	VBP
work_tpiqgspaqvfeng2fovbximt4lm	100	12	ated	ate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	100	13	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	100	14	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	100	15	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	16	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	100	17	lo-	lo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	100	18	cated	cat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	100	19	within	within	IN
work_tpiqgspaqvfeng2fovbximt4lm	100	20	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	100	21	immediately	immediately	RB
work_tpiqgspaqvfeng2fovbximt4lm	100	22	flanking	flank	VBG
work_tpiqgspaqvfeng2fovbximt4lm	100	23	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	24	CYP2C18–CYP2C19–CYP2C9	CYP2C18–CYP2C19–CYP2C9	NNP
work_tpiqgspaqvfeng2fovbximt4lm	100	25	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	100	26	CYP2C8	cyp2c8	JJ
work_tpiqgspaqvfeng2fovbximt4lm	100	27	gene	gene	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	28	cluster	cluster	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	29	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	100	30	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	100	31	encodes	encode	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	100	32	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	33	group	group	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	34	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	100	35	cytochrome	cytochrome	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	36	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	100	37	enzymes	enzyme	NNS
work_tpiqgspaqvfeng2fovbximt4lm	100	38	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	100	39	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	100	40	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	41	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	42	p	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	43	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	44	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	45	y	y	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	46	a	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	47	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	48	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	49	m	m	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	50	p	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	51	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	52	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	53	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	54	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	100	55	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	56	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	57	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	58	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	100	59	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	60	e	e	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	61	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	62	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	100	63	drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	64	metabolism	metabolism	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	65	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	100	66	including	include	VBG
work_tpiqgspaqvfeng2fovbximt4lm	100	67	conver-	conver-	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	68	Table	table	NN
work_tpiqgspaqvfeng2fovbximt4lm	100	69	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	100	70	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	101	1	Characteristics	Characteristics	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	101	3	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	101	4	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	5	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	6	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	101	7	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	8	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	9	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	101	10	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	11	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	12	Participants	Participants	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	101	13	Characteristic	Characteristic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	101	15	Units	unit	NNS
work_tpiqgspaqvfeng2fovbximt4lm	101	16	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	101	17	PAPI	papi	NN
work_tpiqgspaqvfeng2fovbximt4lm	101	18	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	101	19	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	20	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	21	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	101	22	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	23	Men	Men	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	101	24	Women	Women	NNP
work_tpiqgspaqvfeng2fovbximt4lm	101	25	Men	men	NN
work_tpiqgspaqvfeng2fovbximt4lm	101	26	Women	woman	NNS
work_tpiqgspaqvfeng2fovbximt4lm	101	27	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	101	28	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	102	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	102	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	4	214	214	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	6	49.9	49.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	7	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	8	215	215	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	9	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	10	50.1	50.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	11	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	12	136	136	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	14	59.9	59.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	15	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	16	91	91	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	17	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	18	40.1	40.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	19	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	20	Age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	102	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	102	22	mean	mean	VB
work_tpiqgspaqvfeng2fovbximt4lm	102	23	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	24	SD	SD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	102	25	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	102	27	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	102	28	43.9	43.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	29	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	30	13.2	13.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	32	47.3	47.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	33	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	34	14.4	14.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	35	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	36	62.5	62.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	37	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	38	11.4	11.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	39	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	40	67.0	67.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	41	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	42	11.0	11.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	102	43	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	102	44	White	White	NNP
work_tpiqgspaqvfeng2fovbximt4lm	102	45	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	102	46	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	102	47	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	103	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	103	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	4	214	214	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	6	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	7	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	8	215	215	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	9	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	10	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	11	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	12	93	93	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	14	68.4	68.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	15	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	16	47	47	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	17	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	18	51.6	51.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	19	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	20	Body	body	NN
work_tpiqgspaqvfeng2fovbximt4lm	103	21	mass	mass	NN
work_tpiqgspaqvfeng2fovbximt4lm	103	22	index	index	NN
work_tpiqgspaqvfeng2fovbximt4lm	103	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	103	24	mean	mean	NNP
work_tpiqgspaqvfeng2fovbximt4lm	103	25	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	26	SD	sd	NN
work_tpiqgspaqvfeng2fovbximt4lm	103	27	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	28	b	b	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	29	26.0	26.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	30	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	31	3.7	3.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	32	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	33	28.3	28.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	34	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	35	5.6	5.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	36	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	37	30.1	30.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	38	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	39	6.3	6.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	40	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	41	30.9	30.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	42	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	43	7.1	7.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	44	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	45	Blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	103	46	pressure	pressure	NN
work_tpiqgspaqvfeng2fovbximt4lm	103	47	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	103	48	mean	mean	VBP
work_tpiqgspaqvfeng2fovbximt4lm	103	49	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	50	SD	SD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	103	51	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	52	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	103	53	mm	mm	NNP
work_tpiqgspaqvfeng2fovbximt4lm	103	54	Hg	Hg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	103	55	Systolic	Systolic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	103	56	116.6	116.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	57	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	58	12.0	12.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	59	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	60	117.4	117.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	61	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	62	14.0	14.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	63	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	64	138.0	138.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	65	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	66	19.9	19.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	67	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	68	144.6	144.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	69	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	70	19.9	19.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	71	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	72	Diastolic	Diastolic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	103	73	70.8	70.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	74	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	75	7.4	7.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	76	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	77	69.7	69.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	78	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	79	7.5	7.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	80	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	81	73.6	73.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	82	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	83	13.8	13.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	84	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	85	70.3	70.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	86	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	87	14.2	14.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	103	88	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	103	89	Hypertension	Hypertension	NNP
work_tpiqgspaqvfeng2fovbximt4lm	103	90	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	103	91	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	103	92	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	104	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	104	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	4	c	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	104	5	11	11	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	6	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	7	5.1	5.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	8	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	9	13	13	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	10	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	11	6.0	6.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	12	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	13	102	102	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	14	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	15	75.0	75.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	16	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	17	72	72	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	19	79.1	79.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	20	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	21	Lipids	Lipids	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	104	22	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	104	23	mean	mean	VB
work_tpiqgspaqvfeng2fovbximt4lm	104	24	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	25	SD	SD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	26	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	27	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	104	28	mg	mg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	29	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	104	30	dL	dL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	31	Total	Total	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	32	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	104	33	206.0	206.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	34	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	35	44.8	44.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	36	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	37	217.9	217.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	38	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	39	52.2	52.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	40	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	41	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	42	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	43	LDL	LDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	44	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	104	45	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	46	137.7	137.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	47	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	48	41.5	41.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	49	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	50	141.0	141.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	51	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	52	48.9	48.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	53	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	54	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	55	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	56	HDL	HDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	57	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	104	58	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	59	54.7	54.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	60	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	61	15.0	15.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	62	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	63	61.6	61.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	64	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	65	15.2	15.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	66	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	67	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	68	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	69	Triglycerides	Triglycerides	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	70	d	d	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	71	68.1	68.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	72	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	73	40.4	40.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	74	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	75	76.0	76.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	76	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	77	39.4	39.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	104	78	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	104	79	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	80	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	81	Hypercholesterolemia	Hypercholesterolemia	NNP
work_tpiqgspaqvfeng2fovbximt4lm	104	82	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	104	83	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	104	84	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	105	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	105	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	4	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	105	5	52	52	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	6	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	7	24.3	24.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	8	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	9	59	59	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	10	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	11	27.4	27.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	12	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	13	111	111	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	14	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	15	81.6	81.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	16	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	17	72	72	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	19	79.1	79.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	105	20	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	105	21	Taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	105	22	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	105	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	105	24	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	105	25	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	106	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	106	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	4	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	6	2.8	2.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	7	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	8	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	9	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	10	1.4	1.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	11	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	12	136	136	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	14	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	15	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	16	91	91	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	17	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	18	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	106	19	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	106	20	Self	self	NN
work_tpiqgspaqvfeng2fovbximt4lm	106	21	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	106	22	reported	report	VBN
work_tpiqgspaqvfeng2fovbximt4lm	106	23	diabetes	diabete	NNS
work_tpiqgspaqvfeng2fovbximt4lm	106	24	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	106	25	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	106	26	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	107	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	4	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	6	0.5	0.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	7	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	8	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	9	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	10	0.9	0.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	11	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	12	39	39	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	14	28.7	28.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	15	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	16	44	44	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	17	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	18	48.4	48.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	19	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	20	Hematocrit	Hematocrit	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	107	22	mean	mean	VB
work_tpiqgspaqvfeng2fovbximt4lm	107	23	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	24	SD	SD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	25	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	107	27	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	28	41.3	41.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	29	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	30	2.4	2.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	32	37.7	37.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	33	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	34	2.3	2.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	35	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	36	41.8	41.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	37	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	38	5.0	5.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	39	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	40	37.9	37.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	41	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	42	4.5	4.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	43	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	44	White	white	JJ
work_tpiqgspaqvfeng2fovbximt4lm	107	45	blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	46	cell	cell	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	47	count	count	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	48	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	107	49	median	median	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	50	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	51	IQR	IQR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	52	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	53	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	107	54	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	55	1000/µL	1000/µl	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	56	5.8	5.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	57	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	58	5.1	5.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	59	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	107	60	6.7	6.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	61	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	62	5.8	5.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	63	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	64	5.1	5.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	65	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	107	66	6.8	6.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	67	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	68	6.8	6.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	69	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	70	5.7	5.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	71	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	107	72	8.2	8.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	73	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	74	7.5	7.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	75	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	76	6.0	6.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	77	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	107	78	9.2	9.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	79	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	80	Platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	81	count	count	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	82	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	107	83	mean	mean	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	84	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	85	SD	SD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	86	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	87	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	107	88	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	107	89	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	90	000/µL	000/µl	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	91	240.9	240.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	92	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	93	43.7	43.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	94	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	95	248.1	248.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	96	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	97	50.3	50.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	98	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	99	223.6	223.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	100	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	101	68.5	68.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	102	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	103	252.2	252.2	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	104	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	105	71.4	71.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	107	106	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	107	107	Current	current	JJ
work_tpiqgspaqvfeng2fovbximt4lm	107	108	smoker	smoker	NN
work_tpiqgspaqvfeng2fovbximt4lm	107	109	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	107	110	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	107	111	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	108	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	2	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	4	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	5	38	38	CD
work_tpiqgspaqvfeng2fovbximt4lm	108	6	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	7	17.8	17.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	108	8	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	9	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	108	10	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	108	11	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	12	29.4	29.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	108	13	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	14	18	18	CD
work_tpiqgspaqvfeng2fovbximt4lm	108	15	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	16	19.8	19.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	108	17	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	108	18	Abbreviations	abbreviation	NNS
work_tpiqgspaqvfeng2fovbximt4lm	108	19	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	108	20	HDL	HDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	21	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	108	22	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	108	24	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	108	25	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	108	26	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	27	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	28	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	29	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	108	30	IQR	IQR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	108	32	interquartile	interquartile	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	33	range	range	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	34	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	108	35	LDL	LDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	36	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	108	37	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	38	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	108	39	low	low	JJ
work_tpiqgspaqvfeng2fovbximt4lm	108	40	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	108	41	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	42	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	43	cho-	cho-	RB
work_tpiqgspaqvfeng2fovbximt4lm	108	44	lesterol	lesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	108	45	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	108	46	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	47	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	108	48	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	108	49	available	available	JJ
work_tpiqgspaqvfeng2fovbximt4lm	108	50	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	108	51	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	52	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	108	53	Pharmacogenomics	Pharmacogenomics	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	108	54	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	108	55	Anti	Anti	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	56	-	-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	57	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	58	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	108	59	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	109	1	SI	SI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	2	conversion	conversion	NN
work_tpiqgspaqvfeng2fovbximt4lm	109	3	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	109	4	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	109	5	To	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	109	6	convert	convert	VB
work_tpiqgspaqvfeng2fovbximt4lm	109	7	HDL	HDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	8	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	109	9	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	109	11	LDL	LDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	109	13	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	109	15	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	109	16	total	total	JJ
work_tpiqgspaqvfeng2fovbximt4lm	109	17	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	109	18	values	value	NNS
work_tpiqgspaqvfeng2fovbximt4lm	109	19	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	20	mmol	mmol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	21	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	109	22	L	L	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	109	24	multiply	multiply	JJ
work_tpiqgspaqvfeng2fovbximt4lm	109	25	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	26	0.0259	0.0259	CD
work_tpiqgspaqvfeng2fovbximt4lm	109	27	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	109	28	triglyc-	triglyc-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	109	29	eride	eride	JJ
work_tpiqgspaqvfeng2fovbximt4lm	109	30	values	value	NNS
work_tpiqgspaqvfeng2fovbximt4lm	109	31	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	32	mmol	mmol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	33	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	109	34	L	L	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	109	36	multiply	multiply	JJ
work_tpiqgspaqvfeng2fovbximt4lm	109	37	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	38	0.0113	0.0113	CD
work_tpiqgspaqvfeng2fovbximt4lm	109	39	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	109	40	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	109	41	For	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	42	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	43	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	109	44	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	109	45	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	109	46	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	109	47	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	109	48	withdrawn	withdraw	VBN
work_tpiqgspaqvfeng2fovbximt4lm	109	49	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	50	prescription	prescription	NN
work_tpiqgspaqvfeng2fovbximt4lm	109	51	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	109	52	nonprescription	nonprescription	NN
work_tpiqgspaqvfeng2fovbximt4lm	109	53	medications	medication	NNS
work_tpiqgspaqvfeng2fovbximt4lm	109	54	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	109	55	vitamins	vitamin	NNS
work_tpiqgspaqvfeng2fovbximt4lm	109	56	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	109	57	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	109	58	supplements	supplement	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	109	59	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	109	60	days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	109	61	prior	prior	RB
work_tpiqgspaqvfeng2fovbximt4lm	109	62	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	63	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	109	64	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	65	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	109	66	duration	duration	NN
work_tpiqgspaqvfeng2fovbximt4lm	109	67	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	109	68	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	109	69	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	109	70	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	110	1	Participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	110	2	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	110	3	prescription	prescription	NN
work_tpiqgspaqvfeng2fovbximt4lm	110	4	antihypertensive	antihypertensive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	110	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	110	6	lipid-	lipid-	NN
work_tpiqgspaqvfeng2fovbximt4lm	110	7	lowering	lowering	NN
work_tpiqgspaqvfeng2fovbximt4lm	110	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	110	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	110	10	diabetes	diabetes	NN
work_tpiqgspaqvfeng2fovbximt4lm	110	11	medications	medication	NNS
work_tpiqgspaqvfeng2fovbximt4lm	110	12	accounted	account	VBD
work_tpiqgspaqvfeng2fovbximt4lm	110	13	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	110	14	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	110	15	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	110	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	110	17	1.6	1.6	CD
work_tpiqgspaqvfeng2fovbximt4lm	110	18	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	110	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	110	20	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	110	21	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	110	22	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	110	23	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	110	24	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	110	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	110	26	respectively	respectively	RB
work_tpiqgspaqvfeng2fovbximt4lm	110	27	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	111	1	b	b	LS
work_tpiqgspaqvfeng2fovbximt4lm	111	2	Calculated	calculate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	111	3	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	111	4	weight	weight	NN
work_tpiqgspaqvfeng2fovbximt4lm	111	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	111	6	kilograms	kilogram	NNS
work_tpiqgspaqvfeng2fovbximt4lm	111	7	divided	divide	VBN
work_tpiqgspaqvfeng2fovbximt4lm	111	8	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	111	9	height	height	NN
work_tpiqgspaqvfeng2fovbximt4lm	111	10	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	111	11	meters	meter	NNS
work_tpiqgspaqvfeng2fovbximt4lm	111	12	squared	square	VBD
work_tpiqgspaqvfeng2fovbximt4lm	111	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	112	1	c	c	LS
work_tpiqgspaqvfeng2fovbximt4lm	112	2	Defined	define	VBN
work_tpiqgspaqvfeng2fovbximt4lm	112	3	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	112	4	systolic	systolic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	112	5	blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	112	6	pressure	pressure	NN
work_tpiqgspaqvfeng2fovbximt4lm	112	7	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	112	8	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	112	9	140	140	CD
work_tpiqgspaqvfeng2fovbximt4lm	112	10	mm	mm	NNP
work_tpiqgspaqvfeng2fovbximt4lm	112	11	Hg	hg	PRP
work_tpiqgspaqvfeng2fovbximt4lm	112	12	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	112	13	diastolic	diastolic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	112	14	blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	112	15	pressure	pressure	NN
work_tpiqgspaqvfeng2fovbximt4lm	112	16	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	112	17	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	112	18	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	112	19	mm	mm	NNS
work_tpiqgspaqvfeng2fovbximt4lm	112	20	Hg	Hg	NNS
work_tpiqgspaqvfeng2fovbximt4lm	112	21	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	112	22	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	112	23	prescription	prescription	NN
work_tpiqgspaqvfeng2fovbximt4lm	112	24	medication	medication	NN
work_tpiqgspaqvfeng2fovbximt4lm	112	25	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	112	26	previously	previously	RB
work_tpiqgspaqvfeng2fovbximt4lm	112	27	diagnosed	diagnose	VBN
work_tpiqgspaqvfeng2fovbximt4lm	112	28	hypertension	hypertension	NN
work_tpiqgspaqvfeng2fovbximt4lm	112	29	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	113	1	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	113	2	Logarithm	Logarithm	NNP
work_tpiqgspaqvfeng2fovbximt4lm	113	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	113	4	transformed	transform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	113	5	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	113	6	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	113	7	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	113	8	back	back	NN
work_tpiqgspaqvfeng2fovbximt4lm	113	9	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	113	10	transformed	transform	VBN
work_tpiqgspaqvfeng2fovbximt4lm	113	11	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	113	12	presentation	presentation	NN
work_tpiqgspaqvfeng2fovbximt4lm	113	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	114	1	e	e	LS
work_tpiqgspaqvfeng2fovbximt4lm	114	2	Defined	define	VBN
work_tpiqgspaqvfeng2fovbximt4lm	114	3	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	114	4	LDL	LDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	114	5	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	114	6	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	114	7	level	level	NN
work_tpiqgspaqvfeng2fovbximt4lm	114	8	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	114	9	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	114	10	160	160	CD
work_tpiqgspaqvfeng2fovbximt4lm	114	11	mg	mg	NNP
work_tpiqgspaqvfeng2fovbximt4lm	114	12	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	114	13	dL	dL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	114	14	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	114	15	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	114	16	prescription	prescription	NN
work_tpiqgspaqvfeng2fovbximt4lm	114	17	medication	medication	NN
work_tpiqgspaqvfeng2fovbximt4lm	114	18	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	114	19	previously	previously	RB
work_tpiqgspaqvfeng2fovbximt4lm	114	20	diagnosed	diagnose	VBN
work_tpiqgspaqvfeng2fovbximt4lm	114	21	hyper-	hyper-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	114	22	cholesterolemia	cholesterolemia	NN
work_tpiqgspaqvfeng2fovbximt4lm	114	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	115	1	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	115	2	Self	self	NN
work_tpiqgspaqvfeng2fovbximt4lm	115	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	115	4	reported	report	VBN
work_tpiqgspaqvfeng2fovbximt4lm	115	5	history	history	NN
work_tpiqgspaqvfeng2fovbximt4lm	115	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	115	7	smoking	smoking	NN
work_tpiqgspaqvfeng2fovbximt4lm	115	8	cigarette	cigarette	NN
work_tpiqgspaqvfeng2fovbximt4lm	115	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	115	10	pipe	pipe	NN
work_tpiqgspaqvfeng2fovbximt4lm	115	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	115	12	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	115	13	cigar	cigar	NN
work_tpiqgspaqvfeng2fovbximt4lm	115	14	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	116	1	CYTOCHROME	cytochrome	VB
work_tpiqgspaqvfeng2fovbximt4lm	116	2	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	116	3	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	116	4	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	116	5	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	116	6	CLOPIDOGREL	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	116	7	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	116	8	852	852	CD
work_tpiqgspaqvfeng2fovbximt4lm	116	9	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	116	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	116	11	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	116	12	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	116	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	116	14	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	116	15	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	116	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	116	17	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	116	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	117	1	8	8	LS
work_tpiqgspaqvfeng2fovbximt4lm	117	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	117	3	Reprinted	Reprinted	NNP
work_tpiqgspaqvfeng2fovbximt4lm	117	4	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	117	5	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	117	6	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	117	7	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	117	8	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	117	9	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	117	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	118	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	118	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	118	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	118	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	119	1	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	119	2	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	119	4	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	5	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	6	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	7	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	8	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	9	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	10	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	11	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	12	04/05/2021	04/05/2021	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	13	sion	sion	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	14	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	15	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	16	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	17	its	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	119	18	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	19	metabo-	metabo-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	20	lite.4,5,17,18,32	lite.4,5,17,18,32	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	21	-	-	:
work_tpiqgspaqvfeng2fovbximt4lm	119	22	35	35	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	23	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	24	guanine	guanine	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	25	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	26	adenine	adenine	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	27	mutation	mutation	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	28	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	29	exon	exon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	30	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	31	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	32	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	33	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	119	34	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	35	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	36	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	37	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	38	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	39	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	40	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	41	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	42	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	43	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	119	44	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	45	l	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	46	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	47	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	48	k	k	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	49	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	50	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	51	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	52	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	53	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	54	s	s	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	55	CYP2C19	cyp2c19	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	56	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	119	57	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	58	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	119	59	creates	create	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	119	60	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	61	aberrant	aberrant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	62	splice	splice	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	63	site	site	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	64	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	119	65	leads	lead	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	119	66	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	67	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	68	altered	altered	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	69	reading	reading	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	70	frame	frame	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	71	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	72	amino	amino	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	73	acid	acid	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	74	215	215	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	75	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	119	76	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	77	prema-	prema-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	78	ture	ture	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	79	stop	stop	VB
work_tpiqgspaqvfeng2fovbximt4lm	119	80	codon	codon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	81	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	119	82	amino	amino	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	83	acids	acid	NNS
work_tpiqgspaqvfeng2fovbximt4lm	119	84	down-	down-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	85	stream	stream	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	86	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	119	87	producing	produce	VBG
work_tpiqgspaqvfeng2fovbximt4lm	119	88	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	89	nonfunctional	nonfunctional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	119	90	truncated	truncate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	119	91	protein	protein	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	92	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	119	93	lack	lack	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	94	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	95	translation	translation	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	96	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	119	97	sulting	sulte	VBG
work_tpiqgspaqvfeng2fovbximt4lm	119	98	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	119	99	nonsense	nonsense	NN
work_tpiqgspaqvfeng2fovbximt4lm	119	100	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	119	101	mediated	mediate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	119	102	mes-	mes-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	103	senger	senger	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	104	RNA	RNA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	105	decay	decay	NNP
work_tpiqgspaqvfeng2fovbximt4lm	119	106	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	119	107	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	119	108	both	both	DT
work_tpiqgspaqvfeng2fovbximt4lm	119	109	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	120	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	120	2	frequency	frequency	NN
work_tpiqgspaqvfeng2fovbximt4lm	120	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	120	4	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	120	5	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	120	6	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	120	7	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	120	8	0.17	0.17	CD
work_tpiqgspaqvfeng2fovbximt4lm	120	9	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	120	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	120	11	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	120	12	PAPI	papi	NN
work_tpiqgspaqvfeng2fovbximt4lm	120	13	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	120	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	120	15	similar	similar	JJ
work_tpiqgspaqvfeng2fovbximt4lm	120	16	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	120	17	that	that	DT
work_tpiqgspaqvfeng2fovbximt4lm	120	18	found	find	VBN
work_tpiqgspaqvfeng2fovbximt4lm	120	19	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	120	20	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	120	21	white	white	JJ
work_tpiqgspaqvfeng2fovbximt4lm	120	22	populations	population	NNS
work_tpiqgspaqvfeng2fovbximt4lm	120	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	121	1	CYP2C19	CYP2C19	NFP
work_tpiqgspaqvfeng2fovbximt4lm	121	2	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	121	3	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	121	4	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	121	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	121	6	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	121	7	linkage	linkage	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	8	disequilibrium	disequilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	9	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	121	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	121	11	clus-	clus-	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	12	ter	ter	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	121	14	SNPs	SNPs	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	15	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	121	16	chromosome	chromosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	17	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	121	18	identified	identify	VBN
work_tpiqgspaqvfeng2fovbximt4lm	121	19	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	121	20	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	121	21	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	22	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	121	23	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	121	24	asso-	asso-	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	25	c	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	26	i	i	PRP
work_tpiqgspaqvfeng2fovbximt4lm	121	27	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	121	28	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	29	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	30	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	121	31	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	32	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	33	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	34	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	35	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	36	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	37	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	121	38	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	39	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	40	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	121	41	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	121	42	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	121	43	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	121	44	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	121	45	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	122	1	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	122	2	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	122	3	w	w	NN
work_tpiqgspaqvfeng2fovbximt4lm	122	4	i	i	PRP
work_tpiqgspaqvfeng2fovbximt4lm	122	5	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	122	6	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	122	7	rs12777823	rs12777823	NNP
work_tpiqgspaqvfeng2fovbximt4lm	122	8	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	122	9	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	123	1	CYP2C19	CYP2C19	NFP
work_tpiqgspaqvfeng2fovbximt4lm	123	2	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	123	3	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	123	4	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	123	5	associ-	associ-	RB
work_tpiqgspaqvfeng2fovbximt4lm	123	6	ated	ate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	123	7	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	123	8	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	123	9	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	123	10	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	123	11	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	12	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	13	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	123	14	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	123	15	adminis-	adminis-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	123	16	tration	tration	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	17	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	123	18	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	123	19	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	123	20	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	123	21	degree	degree	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	22	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	123	23	statisti-	statisti-	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	24	cal	cal	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	25	significance	significance	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	26	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	123	27	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	28	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	123	29	4.3	4.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	123	30	�	�	NNS
work_tpiqgspaqvfeng2fovbximt4lm	123	31	10−11	10−11	CD
work_tpiqgspaqvfeng2fovbximt4lm	123	32	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	123	33	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	123	34	additive	additive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	123	35	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	123	36	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	123	37	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	123	38	FIGURE	FIGURE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	123	39	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	123	40	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	123	41	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	124	1	ADP-	ADP-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	2	stimulated	stimulate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	124	3	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	4	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	5	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	124	6	reduced	reduce	VBN
work_tpiqgspaqvfeng2fovbximt4lm	124	7	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	124	8	40.7	40.7	CD
work_tpiqgspaqvfeng2fovbximt4lm	124	9	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	124	11	47.1	47.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	124	12	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	124	14	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	124	15	65.4	65.4	CD
work_tpiqgspaqvfeng2fovbximt4lm	124	16	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	17	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	124	18	baseline	baseline	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	19	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	124	20	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	21	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	124	22	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	23	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	24	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	124	25	p	p	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	26	a	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	27	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	28	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	29	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	30	c	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	31	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	32	p	p	VBP
work_tpiqgspaqvfeng2fovbximt4lm	124	33	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	124	34	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	35	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	36	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	37	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	38	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	39	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	40	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	41	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	124	42	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	124	43	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	124	44	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	124	45	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	124	46	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	47	d	d	NN
work_tpiqgspaqvfeng2fovbximt4lm	124	48	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	124	49	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	124	50	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	124	51	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	124	52	alleles	allele	NNS
work_tpiqgspaqvfeng2fovbximt4lm	124	53	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	124	54	respectively	respectively	RB
work_tpiqgspaqvfeng2fovbximt4lm	124	55	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	125	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	125	2	CYP2C19	CYP2C19	NNS
work_tpiqgspaqvfeng2fovbximt4lm	125	3	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	125	4	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	125	5	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	125	7	present	present	JJ
work_tpiqgspaqvfeng2fovbximt4lm	125	8	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	125	9	its	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	125	10	heterozygous	heterozygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	125	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	125	12	homozygous	homozygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	125	13	state	state	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	14	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	125	15	30.8	30.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	125	16	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	17	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	125	18	2.1	2.1	CD
work_tpiqgspaqvfeng2fovbximt4lm	125	19	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	125	21	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	125	22	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	125	23	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	24	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	125	26	accounted	account	VBD
work_tpiqgspaqvfeng2fovbximt4lm	125	27	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	125	28	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	125	29	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	30	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	125	31	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	125	32	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	33	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	125	34	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	125	35	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	125	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	126	1	When	when	WRB
work_tpiqgspaqvfeng2fovbximt4lm	126	2	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	126	3	included	include	VBD
work_tpiqgspaqvfeng2fovbximt4lm	126	4	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	126	5	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	126	6	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	7	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	126	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	126	9	covariate	covariate	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	126	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	126	12	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	13	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	126	14	chromosome	chromosome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	126	15	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	16	SNP	SNP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	126	17	rs12777823	rs12777823	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	18	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	126	19	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	20	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	21	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	126	22	mark-	mark-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	126	23	edly	edly	RB
work_tpiqgspaqvfeng2fovbximt4lm	126	24	attenuated	attenuate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	126	25	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	126	26	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	27	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	126	28	1.5	1.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	29	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	126	30	10−13	10−13	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	31	with-	with-	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	32	out	out	RP
work_tpiqgspaqvfeng2fovbximt4lm	126	33	adjustment	adjustment	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	34	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	126	35	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	126	36	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	126	37	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	38	geno-	geno-	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	39	type	type	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	40	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	126	41	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	42	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	126	43	2.5	2.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	44	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	126	45	10−3	10−3	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	46	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	126	47	adjustment	adjustment	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	48	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	126	49	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	126	50	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	126	51	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	126	52	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	126	53	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	126	54	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	127	1	These	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	127	2	f	f	XX
work_tpiqgspaqvfeng2fovbximt4lm	127	3	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	4	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	127	5	d	d	XX
work_tpiqgspaqvfeng2fovbximt4lm	127	6	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	7	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	8	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	9	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	10	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	11	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	12	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	13	w	w	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	14	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	15	h	h	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	16	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	127	17	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	18	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	19	h	h	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	20	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	21	l	l	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	22	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	23	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	24	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	25	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	127	26	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	27	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	28	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	127	29	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	30	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	31	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	32	c	c	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	33	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	34	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	35	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	36	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	37	C	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	38	Y	Y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	39	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	40	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	127	41	C	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	42	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	127	43	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	127	44	*	*	SYM
work_tpiqgspaqvfeng2fovbximt4lm	127	45	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	127	46	m	m	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	47	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	48	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	49	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	127	50	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	51	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	52	o	o	XX
work_tpiqgspaqvfeng2fovbximt4lm	127	53	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	54	accounts	account	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	127	55	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	127	56	most	most	JJS
work_tpiqgspaqvfeng2fovbximt4lm	127	57	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	127	58	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	127	59	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	127	60	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	127	61	origi-	origi-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	127	62	nal	nal	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	63	10q24	10q24	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	64	association	association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	127	65	signal	signal	NN
work_tpiqgspaqvfeng2fovbximt4lm	127	66	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	128	1	Other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	128	2	previously	previously	RB
work_tpiqgspaqvfeng2fovbximt4lm	128	3	described	describe	VBN
work_tpiqgspaqvfeng2fovbximt4lm	128	4	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	128	5	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	6	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	128	7	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	128	8	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	128	9	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	10	variants	variant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	128	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	128	12	CYP2C19	cyp2c19	VB
work_tpiqgspaqvfeng2fovbximt4lm	128	13	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	128	14	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	128	15	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	128	16	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	128	17	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	128	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	128	19	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	128	20	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	128	21	polymorphic	polymorphic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	128	22	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	128	23	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	128	24	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	128	25	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	128	27	but	but	CC
work_tpiqgspaqvfeng2fovbximt4lm	128	28	there	there	EX
work_tpiqgspaqvfeng2fovbximt4lm	128	29	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	128	30	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	128	31	ad-	ad-	RB
work_tpiqgspaqvfeng2fovbximt4lm	128	32	ditional	ditional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	128	33	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	34	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	128	35	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	128	36	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	128	37	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	128	38	nearby	nearby	JJ
work_tpiqgspaqvfeng2fovbximt4lm	128	39	gene	gene	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	40	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	128	41	further	further	RB
work_tpiqgspaqvfeng2fovbximt4lm	128	42	contributing	contribute	VBG
work_tpiqgspaqvfeng2fovbximt4lm	128	43	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	128	44	relatively	relatively	RB
work_tpiqgspaqvfeng2fovbximt4lm	128	45	small	small	JJ
work_tpiqgspaqvfeng2fovbximt4lm	128	46	effects	effect	NNS
work_tpiqgspaqvfeng2fovbximt4lm	128	47	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	128	48	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	49	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	128	50	accounting	accounting	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	51	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	128	52	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	128	53	remainder	remainder	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	54	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	128	55	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	128	56	as-	as-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	128	57	sociation	sociation	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	58	signal	signal	NN
work_tpiqgspaqvfeng2fovbximt4lm	128	59	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	129	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	129	2	gain	gain	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	129	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	129	5	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	129	6	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	7	variant	variant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	129	8	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	129	9	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	129	10	17	17	CD
work_tpiqgspaqvfeng2fovbximt4lm	129	11	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	129	12	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	129	13	allele	allele	NNP
work_tpiqgspaqvfeng2fovbximt4lm	129	14	fre-	fre-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	129	15	quency	quency	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	16	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	129	17	0.25	0.25	CD
work_tpiqgspaqvfeng2fovbximt4lm	129	18	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	129	19	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	129	20	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	129	21	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	129	22	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	129	23	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	129	24	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	129	25	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	129	26	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	27	aggrega-	aggrega-	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	28	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	29	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	129	30	either	either	CC
work_tpiqgspaqvfeng2fovbximt4lm	129	31	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	129	32	baseline	baseline	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	33	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	129	34	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	129	35	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	36	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	129	37	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	129	38	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	129	39	eTable	eTable	NNP
work_tpiqgspaqvfeng2fovbximt4lm	129	40	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	129	41	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	129	42	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	130	1	Predictors	predictor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	130	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	130	3	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	130	5	BMI	BMI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	130	7	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	130	8	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	130	9	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	130	10	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	130	11	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	130	12	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	13	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	14	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	15	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	130	16	triglycerides	triglyceride	NNS
work_tpiqgspaqvfeng2fovbximt4lm	130	17	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	130	18	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	130	19	heritability	heritability	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	20	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	130	21	h2=	h2=	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	22	0.83	0.83	CD
work_tpiqgspaqvfeng2fovbximt4lm	130	23	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	130	24	SE	SE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	130	26	0.12	0.12	CD
work_tpiqgspaqvfeng2fovbximt4lm	130	27	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	130	28	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	130	29	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	30	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	31	.001	.001	CD
work_tpiqgspaqvfeng2fovbximt4lm	130	32	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	130	33	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	130	34	ADP-	ADP-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	35	stimulated	stimulate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	130	36	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	37	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	38	dur-	dur-	VBG
work_tpiqgspaqvfeng2fovbximt4lm	130	39	ing	ing	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	40	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	130	41	administration	administration	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	42	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	130	43	very	very	RB
work_tpiqgspaqvfeng2fovbximt4lm	130	44	similar	similar	JJ
work_tpiqgspaqvfeng2fovbximt4lm	130	45	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	130	46	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	130	47	single	single	JJ
work_tpiqgspaqvfeng2fovbximt4lm	130	48	324-mg	324-mg	CD
work_tpiqgspaqvfeng2fovbximt4lm	130	49	dose	dose	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	50	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	130	51	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	130	52	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	130	53	added	add	VBN
work_tpiqgspaqvfeng2fovbximt4lm	130	54	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	131	1	Addition	addition	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	131	3	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	4	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	131	5	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	131	6	resulted	result	VBD
work_tpiqgspaqvfeng2fovbximt4lm	131	7	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	131	8	potent	potent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	131	9	inhibition	inhibition	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	131	11	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	12	aggrega-	aggrega-	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	13	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	14	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	131	15	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	16	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	131	17	arachidonic	arachidonic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	131	18	acid	acid	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	131	20	indicating	indicate	VBG
work_tpiqgspaqvfeng2fovbximt4lm	131	21	effective	effective	JJ
work_tpiqgspaqvfeng2fovbximt4lm	131	22	inhibition	inhibition	NN
work_tpiqgspaqvfeng2fovbximt4lm	131	23	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	131	24	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	131	25	cyclooxygenase	cyclooxygenase	NNP
work_tpiqgspaqvfeng2fovbximt4lm	131	26	pathway	pathway	NNP
work_tpiqgspaqvfeng2fovbximt4lm	131	27	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	132	1	CYP2C19	CYP2C19	NFP
work_tpiqgspaqvfeng2fovbximt4lm	132	2	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	132	3	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	132	4	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	132	5	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	132	6	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	132	7	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	132	8	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	132	9	aspirin-	aspirin-	RB
work_tpiqgspaqvfeng2fovbximt4lm	132	10	induced	induced	JJ
work_tpiqgspaqvfeng2fovbximt4lm	132	11	inhibition	inhibition	NN
work_tpiqgspaqvfeng2fovbximt4lm	132	12	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	132	13	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	132	14	aggrega-	aggrega-	NN
work_tpiqgspaqvfeng2fovbximt4lm	132	15	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	132	16	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	132	17	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	132	18	pathway	pathway	NN
work_tpiqgspaqvfeng2fovbximt4lm	132	19	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	132	20	eTable	eTable	NNP
work_tpiqgspaqvfeng2fovbximt4lm	132	21	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	132	22	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	132	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	133	1	How-	How-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	2	ever	ever	RB
work_tpiqgspaqvfeng2fovbximt4lm	133	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	133	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	133	5	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	6	observed	observe	VBD
work_tpiqgspaqvfeng2fovbximt4lm	133	7	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	133	8	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	9	Y	Y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	10	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	11	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	133	12	C	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	13	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	133	14	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	133	15	*	*	SYM
work_tpiqgspaqvfeng2fovbximt4lm	133	16	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	133	17	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	18	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	19	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	133	20	o	o	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	21	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	22	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	23	p	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	24	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	25	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	133	26	n	n	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	27	d	d	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	28	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	29	D	D	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	30	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	31	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	133	32	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	133	33	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	34	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	35	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	133	36	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	37	persisted	persist	VBN
work_tpiqgspaqvfeng2fovbximt4lm	133	38	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	133	39	administra-	administra-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	133	40	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	41	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	133	42	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	43	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	133	44	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	45	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	133	46	7.9	7.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	133	47	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	48	10−13	10−13	CD
work_tpiqgspaqvfeng2fovbximt4lm	133	49	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	133	50	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	133	51	sug-	sug-	XX
work_tpiqgspaqvfeng2fovbximt4lm	133	52	gesting	geste	VBG
work_tpiqgspaqvfeng2fovbximt4lm	133	53	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	133	54	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	133	55	drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	56	combination	combination	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	57	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	133	58	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	133	59	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	133	60	standard	standard	JJ
work_tpiqgspaqvfeng2fovbximt4lm	133	61	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	133	62	care	care	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	63	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	133	64	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	133	65	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	133	66	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	133	67	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	133	68	syndromes	syndrome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	133	69	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	133	70	following	follow	VBG
work_tpiqgspaqvfeng2fovbximt4lm	133	71	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	133	72	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	133	73	does	do	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	133	74	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	133	75	overcome	overcome	VB
work_tpiqgspaqvfeng2fovbximt4lm	133	76	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	133	77	Figure	figure	NN
work_tpiqgspaqvfeng2fovbximt4lm	133	78	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	133	79	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	134	1	Distribution	distribution	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	3	Adenosine	Adenosine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	4	Diphosphate	Diphosphate	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	134	6	ADP)–Stimulated	ADP)–Stimulated	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	7	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	134	8	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	9	µmol	µmol	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	10	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	134	11	L	l	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	12	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	134	13	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	14	Aggregation	Aggregation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	15	Before	before	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	16	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	134	17	After	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	18	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	19	Days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	134	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	21	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	22	Administration	Administration	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	23	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	24	429	429	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	25	Members	Members	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	134	26	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	27	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	134	28	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	134	29	Pharmacogenomics	Pharmacogenomics	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	134	30	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	31	Anti	Anti	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	32	-	-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	33	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	34	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	35	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	134	36	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	37	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	134	38	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	39	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	40	15	15	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	41	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	42	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	43	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	44	25	25	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	45	35	35	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	46	30	30	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	47	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	48	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	49	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	134	50	Stimulated	Stimulated	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	51	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	52	Aggregation	Aggregation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	53	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	134	54	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	55	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	56	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	57	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	58	S	S	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	59	tu	tu	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	60	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	61	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	62	G	G	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	63	ro	ro	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	64	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	65	p	p	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	66	Postclopidogrel	Postclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	67	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	68	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	69	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	70	30	30	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	71	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	72	50	50	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	73	60	60	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	74	70	70	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	75	80	80	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	76	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	77	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	78	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	79	15	15	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	80	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	81	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	82	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	83	25	25	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	84	35	35	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	85	30	30	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	86	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	87	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	88	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	134	89	Stimulated	Stimulated	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	90	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	91	Aggregation	Aggregation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	92	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	134	93	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	94	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	95	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	96	f	f	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	97	S	S	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	98	tu	tu	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	99	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	100	y	y	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	101	G	G	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	102	ro	ro	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	103	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	104	p	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	105	Preclopidogrel	Preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	134	106	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	107	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	108	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	109	30	30	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	110	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	111	50	50	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	112	60	60	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	113	70	70	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	114	80	80	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	115	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	116	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	134	117	Class	class	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	118	intervals	interval	NNS
work_tpiqgspaqvfeng2fovbximt4lm	134	119	include	include	VBP
work_tpiqgspaqvfeng2fovbximt4lm	134	120	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	134	121	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	134	122	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	123	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	134	124	lower	low	JJR
work_tpiqgspaqvfeng2fovbximt4lm	134	125	limit	limit	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	126	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	134	127	equal	equal	JJ
work_tpiqgspaqvfeng2fovbximt4lm	134	128	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	129	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	134	130	upper	upper	JJ
work_tpiqgspaqvfeng2fovbximt4lm	134	131	limit	limit	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	132	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	134	133	each	each	DT
work_tpiqgspaqvfeng2fovbximt4lm	134	134	interval	interval	NN
work_tpiqgspaqvfeng2fovbximt4lm	134	135	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	135	1	Table	table	NN
work_tpiqgspaqvfeng2fovbximt4lm	135	2	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	135	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	136	1	Multivariate	Multivariate	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	2	Analysis	Analysis	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	136	4	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	5	Response	Response	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	6	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	136	7	Measured	measure	VBN
work_tpiqgspaqvfeng2fovbximt4lm	136	8	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	136	9	Adenosine	Adenosine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	10	Diphosphate	Diphosphate	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	11	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	136	12	Stimulated	Stimulated	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	13	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	14	Aggregation	Aggregation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	15	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	136	16	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	17	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	18	Participants	Participants	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	136	19	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	20	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	136	21	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	136	22	429	429	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	23	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	24	Characteristic	Characteristic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	25	�	�	''
work_tpiqgspaqvfeng2fovbximt4lm	136	26	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	27	SE	SE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	28	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	29	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	30	Value	value	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	31	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	136	32	Variance	variance	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	33	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	136	34	Significant	Significant	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	35	Predictors	Predictors	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	136	36	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	136	37	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	38	Age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	39	0.19	0.19	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	40	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	41	0.04	0.04	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	42	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	43	�	�	ADD
work_tpiqgspaqvfeng2fovbximt4lm	136	44	.001	.001	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	45	3.8	3.8	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	46	Sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	47	1.73	1.73	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	48	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	49	1.15	1.15	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	50	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	51	b	b	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	52	.13	.13	NFP
work_tpiqgspaqvfeng2fovbximt4lm	136	53	Body	body	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	54	mass	mass	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	55	index	index	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	56	0.35	0.35	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	57	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	58	0.12	0.12	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	59	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	60	.005	.005	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	61	2.3	2.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	62	Lipids	Lipids	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	136	63	Total	total	JJ
work_tpiqgspaqvfeng2fovbximt4lm	136	64	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	65	0.01	0.01	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	66	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	67	0.01	0.01	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	68	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	69	.27	.27	NFP
work_tpiqgspaqvfeng2fovbximt4lm	136	70	HDL	hdl	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	71	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	136	72	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	73	−0.08	−0.08	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	74	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	75	0.04	0.04	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	76	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	77	.04	.04	NFP
work_tpiqgspaqvfeng2fovbximt4lm	136	78	1.0	1.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	79	LDL	LDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	80	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	136	81	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	82	0.02	0.02	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	83	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	84	0.01	0.01	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	85	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	86	.17	.17	NFP
work_tpiqgspaqvfeng2fovbximt4lm	136	87	Log	log	VB
work_tpiqgspaqvfeng2fovbximt4lm	136	88	triglycerides	triglyceride	NNS
work_tpiqgspaqvfeng2fovbximt4lm	136	89	0.03	0.03	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	90	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	91	0.01	0.01	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	92	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	93	.01	.01	NFP
work_tpiqgspaqvfeng2fovbximt4lm	136	94	1.3	1.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	95	Blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	96	pressure	pressure	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	97	Systolic	Systolic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	98	0.0	0.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	99	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	100	0.05	0.05	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	101	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	102	.21	.21	NFP
work_tpiqgspaqvfeng2fovbximt4lm	136	103	Diastolic	diastolic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	136	104	0.07	0.07	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	105	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	106	0.08	0.08	CD
work_tpiqgspaqvfeng2fovbximt4lm	136	107	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	136	108	.42	.42	NFP
work_tpiqgspaqvfeng2fovbximt4lm	136	109	Abbreviations	abbreviation	NNS
work_tpiqgspaqvfeng2fovbximt4lm	136	110	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	136	111	HDL	HDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	112	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	136	113	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	114	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	136	115	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	136	116	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	136	117	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	118	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	119	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	120	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	136	121	LDL	LDL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	122	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	136	123	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	124	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	136	125	low	low	JJ
work_tpiqgspaqvfeng2fovbximt4lm	136	126	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	136	127	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	128	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	129	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	130	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	136	131	PAPI	papi	NN
work_tpiqgspaqvfeng2fovbximt4lm	136	132	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	136	133	Pharma-	Pharma-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	134	cogenomics	cogenomic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	136	135	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	136	136	Anti	Anti	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	137	-	-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	138	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	139	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	136	140	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	137	1	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	137	2	Adjusted	Adjusted	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	3	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	137	4	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	137	6	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	137	8	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	137	9	preclopidogrel	preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	10	adenosine	adenosine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	11	diphosphate	diphosphate	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	12	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	137	13	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	137	14	µmol	µmol	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	15	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	137	16	L)–stimulated	L)–stimulated	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	17	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	18	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	19	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	137	20	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	21	adjusted	adjust	VBN
work_tpiqgspaqvfeng2fovbximt4lm	137	22	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	137	23	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	24	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	137	25	preclopidogrel	preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	26	platelet	platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	27	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	28	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	137	29	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	30	adjusted	adjust	VBN
work_tpiqgspaqvfeng2fovbximt4lm	137	31	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	137	32	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	33	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	137	34	preclopidogrel	preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	35	platelet	platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	137	36	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	137	37	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	138	1	b	b	LS
work_tpiqgspaqvfeng2fovbximt4lm	138	2	Indicates	indicate	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	138	3	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	138	4	women	woman	NNS
work_tpiqgspaqvfeng2fovbximt4lm	138	5	tend	tend	VBP
work_tpiqgspaqvfeng2fovbximt4lm	138	6	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	138	7	respond	respond	VB
work_tpiqgspaqvfeng2fovbximt4lm	138	8	less	less	RBR
work_tpiqgspaqvfeng2fovbximt4lm	138	9	well	well	RB
work_tpiqgspaqvfeng2fovbximt4lm	138	10	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	138	11	men	man	NNS
work_tpiqgspaqvfeng2fovbximt4lm	138	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	139	1	CYTOCHROME	cytochrome	VB
work_tpiqgspaqvfeng2fovbximt4lm	139	2	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	139	3	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	139	4	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	139	5	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	139	6	CLOPIDOGREL	CLOPIDOGREL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	139	7	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	139	8	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	139	9	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	139	10	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	139	11	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	139	12	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	139	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	140	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	140	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	140	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	140	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	141	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	141	2	Reprinted	reprinted	JJ
work_tpiqgspaqvfeng2fovbximt4lm	141	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	141	4	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	141	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	141	6	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	141	7	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	141	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	141	9	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	141	10	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	141	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	141	12	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	141	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	142	1	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	142	2	853	853	CD
work_tpiqgspaqvfeng2fovbximt4lm	142	3	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	142	4	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	142	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	142	6	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	142	7	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	142	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	142	9	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	142	10	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	142	11	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	142	12	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	142	13	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	142	14	04/05/2021	04/05/2021	CD
work_tpiqgspaqvfeng2fovbximt4lm	142	15	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	142	16	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	142	17	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	142	18	CYP2C19	cyp2c19	NN
work_tpiqgspaqvfeng2fovbximt4lm	142	19	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	142	20	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	142	21	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	142	22	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	142	23	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	142	24	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	142	25	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	143	1	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	143	2	addition	addition	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	3	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	143	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	143	5	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	143	6	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	143	7	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	143	8	vari-	vari-	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	9	ant	ant	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	143	11	Simon	Simon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	143	12	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	143	13	al25	al25	NNP
work_tpiqgspaqvfeng2fovbximt4lm	143	14	identified	identify	VBD
work_tpiqgspaqvfeng2fovbximt4lm	143	15	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	143	16	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	17	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	143	18	ABCB1	abcb1	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	19	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	143	20	GeneID	GeneID	NNP
work_tpiqgspaqvfeng2fovbximt4lm	143	21	403879	403879	CD
work_tpiqgspaqvfeng2fovbximt4lm	143	22	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	143	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	143	24	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	143	25	en-	en-	RB
work_tpiqgspaqvfeng2fovbximt4lm	143	26	codes	code	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	143	27	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	143	28	transporter	transporter	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	29	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	143	30	modulates	modulate	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	143	31	clo-	clo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	143	32	pidogrel	pidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	143	33	absorption	absorption	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	34	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	143	35	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	143	36	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	143	37	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	143	38	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	143	39	poorer	poor	JJR
work_tpiqgspaqvfeng2fovbximt4lm	143	40	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	143	41	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	143	42	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	143	43	pa-	pa-	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	44	tients	tient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	143	45	receiving	receive	VBG
work_tpiqgspaqvfeng2fovbximt4lm	143	46	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	143	47	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	144	1	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	144	2	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	144	3	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	144	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	144	5	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	144	6	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	144	7	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	144	8	rs1045642	rs1045642	NNP
work_tpiqgspaqvfeng2fovbximt4lm	144	9	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	144	10	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	144	11	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	144	12	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	144	13	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	144	14	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	144	15	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	144	16	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	144	17	plate-	plate-	NNS
work_tpiqgspaqvfeng2fovbximt4lm	144	18	let	let	VBD
work_tpiqgspaqvfeng2fovbximt4lm	144	19	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	144	20	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	144	21	baseline	baseline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	144	22	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	144	23	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	144	24	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	144	25	pidogrel	pidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	144	26	treatment	treatment	NN
work_tpiqgspaqvfeng2fovbximt4lm	144	27	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	144	28	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	144	29	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	144	30	.60	.60	NFP
work_tpiqgspaqvfeng2fovbximt4lm	144	31	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	144	32	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	145	1	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	2	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	4	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	5	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	6	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	145	7	next	next	RB
work_tpiqgspaqvfeng2fovbximt4lm	145	8	sought	seek	VBD
work_tpiqgspaqvfeng2fovbximt4lm	145	9	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	145	10	replicate	replicate	VB
work_tpiqgspaqvfeng2fovbximt4lm	145	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	145	12	ex-	ex-	RB
work_tpiqgspaqvfeng2fovbximt4lm	145	13	tend	tend	VB
work_tpiqgspaqvfeng2fovbximt4lm	145	14	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	145	15	findings	finding	NNS
work_tpiqgspaqvfeng2fovbximt4lm	145	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	17	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	145	18	group	group	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	19	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	20	indi-	indi-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	21	viduals	vidual	NNS
work_tpiqgspaqvfeng2fovbximt4lm	145	22	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	23	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	145	24	general	general	JJ
work_tpiqgspaqvfeng2fovbximt4lm	145	25	US	US	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	26	popula-	popula-	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	27	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	28	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	29	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	145	30	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	145	31	indication	indication	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	32	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	33	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	34	who	who	WP
work_tpiqgspaqvfeng2fovbximt4lm	145	35	underwent	undergo	VBD
work_tpiqgspaqvfeng2fovbximt4lm	145	36	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	37	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	145	38	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	145	39	recruited	recruit	VBN
work_tpiqgspaqvfeng2fovbximt4lm	145	40	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	41	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	145	42	cardiac	cardiac	JJ
work_tpiqgspaqvfeng2fovbximt4lm	145	43	catheter-	catheter-	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	44	ization	ization	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	45	laboratory	laboratory	NN
work_tpiqgspaqvfeng2fovbximt4lm	145	46	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	145	47	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	145	48	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	146	1	Char-	char-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	146	2	acteristics	acteristic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	146	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	146	4	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	146	5	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	146	6	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	146	7	shown	show	VBN
work_tpiqgspaqvfeng2fovbximt4lm	146	8	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	146	9	Table	table	NN
work_tpiqgspaqvfeng2fovbximt4lm	146	10	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	146	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	147	1	Similar	similar	JJ
work_tpiqgspaqvfeng2fovbximt4lm	147	2	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	147	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	147	4	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	147	5	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	147	6	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	147	7	group	group	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	147	9	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	147	10	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	147	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	147	12	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	147	13	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	147	14	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	147	15	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	16	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	147	17	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	147	18	differ-	differ-	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	19	ence	ence	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	20	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	147	21	baseline	baseline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	147	22	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	23	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	24	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	147	25	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	26	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	147	27	.58	.58	NFP
work_tpiqgspaqvfeng2fovbximt4lm	147	28	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	147	29	but	but	CC
work_tpiqgspaqvfeng2fovbximt4lm	147	30	demonstrated	demonstrate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	147	31	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	147	32	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	147	33	sidual	sidual	JJ
work_tpiqgspaqvfeng2fovbximt4lm	147	34	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	35	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	36	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	147	37	clopi-	clopi-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	147	38	dogrel	dogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	39	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	40	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	147	41	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	42	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	147	43	.02	.02	NFP
work_tpiqgspaqvfeng2fovbximt4lm	147	44	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	147	45	compared	compare	VBN
work_tpiqgspaqvfeng2fovbximt4lm	147	46	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	147	47	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	147	48	without	without	IN
work_tpiqgspaqvfeng2fovbximt4lm	147	49	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	147	50	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	51	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	147	52	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	147	53	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	147	54	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	55	al-	al-	VBP
work_tpiqgspaqvfeng2fovbximt4lm	147	56	lele	lele	RB
work_tpiqgspaqvfeng2fovbximt4lm	147	57	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	147	58	Figure	figure	NN
work_tpiqgspaqvfeng2fovbximt4lm	147	59	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	147	60	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	147	61	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	148	1	After	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	148	2	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	3	year	year	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	148	5	follow-	follow-	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	6	up	up	RP
work_tpiqgspaqvfeng2fovbximt4lm	148	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	148	8	carriers	carrier	NNS
work_tpiqgspaqvfeng2fovbximt4lm	148	9	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	148	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	148	11	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	148	12	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	148	13	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	14	geno-	geno-	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	15	type	type	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	16	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	148	17	higher	high	JJR
work_tpiqgspaqvfeng2fovbximt4lm	148	18	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	148	19	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	20	rates	rate	NNS
work_tpiqgspaqvfeng2fovbximt4lm	148	21	compared	compare	VBN
work_tpiqgspaqvfeng2fovbximt4lm	148	22	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	148	23	noncarriers	noncarrier	NNS
work_tpiqgspaqvfeng2fovbximt4lm	148	24	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	148	25	20.9	20.9	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	26	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	27	vs	vs	IN
work_tpiqgspaqvfeng2fovbximt4lm	148	28	10.0	10.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	29	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	30	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	148	31	hazard	hazard	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	32	ratio	ratio	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	33	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	148	34	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	35	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	148	36	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	148	37	2.42	2.42	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	38	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	148	39	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	40	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	41	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	148	42	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	148	43	1.18	1.18	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	44	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	148	45	4.99	4.99	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	46	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	148	47	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	148	48	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	148	49	.02	.02	NFP
work_tpiqgspaqvfeng2fovbximt4lm	148	50	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	148	51	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	148	52	FIGURE	FIGURE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	148	53	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	148	54	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	148	55	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	149	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	149	2	increased	increased	JJ
work_tpiqgspaqvfeng2fovbximt4lm	149	3	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	4	rate	rate	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	5	conferred	confer	VBN
work_tpiqgspaqvfeng2fovbximt4lm	149	6	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	149	7	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	149	8	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	149	9	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	149	10	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	11	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	12	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	149	13	limited	limit	VBN
work_tpiqgspaqvfeng2fovbximt4lm	149	14	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	149	15	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	149	16	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	17	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	149	18	still	still	RB
work_tpiqgspaqvfeng2fovbximt4lm	149	19	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	149	20	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	21	when	when	WRB
work_tpiqgspaqvfeng2fovbximt4lm	149	22	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	149	23	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	24	occurred	occur	VBD
work_tpiqgspaqvfeng2fovbximt4lm	149	25	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	149	26	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	27	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	149	28	3.40	3.40	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	29	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	149	30	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	31	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	32	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	149	33	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	149	34	1.36	1.36	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	35	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	149	36	8.46	8.46	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	37	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	149	38	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	39	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	149	40	.004	.004	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	41	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	149	42	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	149	43	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	149	44	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	149	45	in-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	149	46	crease	crease	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	47	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	149	48	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	49	rate	rate	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	50	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	149	51	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	149	52	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	149	53	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	149	54	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	55	when	when	WRB
work_tpiqgspaqvfeng2fovbximt4lm	149	56	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	149	57	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	58	occurred	occur	VBD
work_tpiqgspaqvfeng2fovbximt4lm	149	59	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	149	60	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	149	61	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	62	year	year	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	63	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	149	64	follow	follow	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	65	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	149	66	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	67	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	149	68	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	69	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	149	70	1.39	1.39	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	71	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	149	72	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	73	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	74	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	149	75	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	149	76	0.39	0.39	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	77	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	149	78	4.88	4.88	CD
work_tpiqgspaqvfeng2fovbximt4lm	149	79	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	149	80	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	149	81	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	149	82	.60	.60	NFP
work_tpiqgspaqvfeng2fovbximt4lm	149	83	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	149	84	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	150	1	Inclusion	inclusion	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	150	3	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	150	4	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	150	5	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	150	6	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	7	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	8	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	150	9	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	150	10	covariate	covariate	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	11	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	150	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	150	13	regression	regression	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	14	model	model	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	15	markedly	markedly	RB
work_tpiqgspaqvfeng2fovbximt4lm	150	16	reduced	reduce	VBD
work_tpiqgspaqvfeng2fovbximt4lm	150	17	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	150	18	relation	relation	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	19	be-	be-	XX
work_tpiqgspaqvfeng2fovbximt4lm	150	20	tween	tween	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	21	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	150	22	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	150	23	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	150	24	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	150	25	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	26	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	150	27	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	150	28	outcome	outcome	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	29	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	150	30	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	150	32	1.58	1.58	CD
work_tpiqgspaqvfeng2fovbximt4lm	150	33	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	150	34	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	150	35	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	36	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	150	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	150	38	0.68	0.68	CD
work_tpiqgspaqvfeng2fovbximt4lm	150	39	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	150	40	3.66	3.66	CD
work_tpiqgspaqvfeng2fovbximt4lm	150	41	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	150	42	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	43	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	150	44	.29	.29	NFP
work_tpiqgspaqvfeng2fovbximt4lm	150	45	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	150	46	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	150	47	suggesting	suggest	VBG
work_tpiqgspaqvfeng2fovbximt4lm	150	48	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	150	49	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	150	50	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	51	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	52	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	150	53	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	150	54	out-	out-	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	55	comes	come	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	150	56	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	150	57	mediated	mediate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	150	58	through	through	IN
work_tpiqgspaqvfeng2fovbximt4lm	150	59	decreased	decrease	VBN
work_tpiqgspaqvfeng2fovbximt4lm	150	60	inhibition	inhibition	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	61	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	150	62	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	63	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	150	64	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	151	1	Figure	figure	NN
work_tpiqgspaqvfeng2fovbximt4lm	151	2	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	151	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	152	1	Genome	genome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	152	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	152	3	Wide	Wide	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	4	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	5	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	152	7	Adenosine	Adenosine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	8	Diphosphate	Diphosphate	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	9	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	152	10	Stimulated	Stimulated	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	11	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	12	Aggregation	Aggregation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	13	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	152	14	Response	Response	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	15	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	152	16	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	17	−l	−l	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	18	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	19	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	20	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	21	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	22	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	23	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	24	V	v	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	25	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	26	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	27	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	28	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	29	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	30	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	31	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	32	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	33	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	34	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	35	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	36	14	14	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	37	22212019181716151413121110987654321	22212019181716151413121110987654321	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	38	−l	−l	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	39	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	40	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	41	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	42	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	43	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	44	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	45	V	v	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	46	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	47	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	48	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	49	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	50	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	51	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	52	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	53	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	54	14	14	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	55	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	56	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	57	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	58	96	96	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	59	600	600	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	60	000	000	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	61	96	96	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	62	900	900	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	63	00095	00095	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	64	700	700	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	65	00095	00095	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	66	400	400	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	67	000	000	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	68	96	96	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	69	000	000	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	70	000	000	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	71	96	96	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	72	300	300	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	73	000	000	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	74	A	A	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	75	Chromosome	Chromosome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	76	CYP2C18-CYP2C19-CYP2C9-CYP2C8	CYP2C18-CYP2C19-CYP2C9-CYP2C8	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	77	cluster	cluster	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	78	Chromosome	Chromosome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	79	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	80	location	location	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	81	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	152	82	bp	bp	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	83	PDE6C	PDE6C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	84	LGI1	LGI1	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	85	PIPSL	PIPSL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	86	NOC3L	noc3l	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	87	HELLS	HELLS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	88	CYP2C19	CYP2C19	:
work_tpiqgspaqvfeng2fovbximt4lm	152	89	CYP2C8	CYP2C8	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	90	CYP2C9CYP2C18TBC1D12PLCE1TMEM20C10orf4	cyp2c9cyp2c18tbc1d12plce1tmem20c10orf4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	91	C	c	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	92	B	B	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	93	Linkage	Linkage	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	94	disequilibrium	disequilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	95	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	96	r2	r2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	97	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	98	0	0	NFP
work_tpiqgspaqvfeng2fovbximt4lm	152	99	10.5	10.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	100	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	101	rs	rs	CC
work_tpiqgspaqvfeng2fovbximt4lm	152	102	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	103	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	104	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	105	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	106	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	107	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	108	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	109	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	110	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	111	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	112	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	113	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	114	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	115	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	116	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	117	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	118	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	119	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	120	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	121	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	122	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	123	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	124	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	125	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	126	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	127	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	128	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	129	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	130	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	131	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	132	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	133	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	134	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	135	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	136	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	137	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	138	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	139	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	140	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	141	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	142	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	143	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	144	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	145	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	146	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	147	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	148	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	149	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	150	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	151	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	152	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	153	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	154	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	155	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	156	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	157	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	158	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	159	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	160	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	161	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	162	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	163	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	164	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	165	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	166	rs	rs	CC
work_tpiqgspaqvfeng2fovbximt4lm	152	167	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	168	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	169	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	170	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	171	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	172	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	173	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	174	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	175	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	176	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	177	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	178	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	179	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	180	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	181	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	182	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	183	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	184	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	185	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	186	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	187	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	188	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	189	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	190	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	191	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	192	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	193	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	194	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	195	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	196	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	197	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	198	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	199	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	200	rs	rs	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	201	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	202	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	203	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	204	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	205	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	206	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	207	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	208	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	209	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	210	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	211	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	212	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	213	7	7	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	214	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	215	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	216	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	217	11	11	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	218	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	219	13	13	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	220	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	221	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	152	222	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	152	223	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	224	plotted	plot	VBN
work_tpiqgspaqvfeng2fovbximt4lm	152	225	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	152	226	−log	−log	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	227	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	228	value	value	NN
work_tpiqgspaqvfeng2fovbximt4lm	152	229	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	152	230	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	152	231	individual	individual	JJ
work_tpiqgspaqvfeng2fovbximt4lm	152	232	single	single	JJ
work_tpiqgspaqvfeng2fovbximt4lm	152	233	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	152	234	nucleotide	nucleotide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	152	235	polymorphisms	polymorphism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	152	236	distributed	distribute	VBN
work_tpiqgspaqvfeng2fovbximt4lm	152	237	across	across	IN
work_tpiqgspaqvfeng2fovbximt4lm	152	238	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	152	239	22	22	CD
work_tpiqgspaqvfeng2fovbximt4lm	152	240	autosomes	autosome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	152	241	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	153	1	Horizontal	horizontal	JJ
work_tpiqgspaqvfeng2fovbximt4lm	153	2	dotted	dotted	JJ
work_tpiqgspaqvfeng2fovbximt4lm	153	3	line	line	NN
work_tpiqgspaqvfeng2fovbximt4lm	153	4	indicates	indicate	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	153	5	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	153	6	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	153	7	1.0	1.0	CD
work_tpiqgspaqvfeng2fovbximt4lm	153	8	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	153	9	10−7	10−7	CD
work_tpiqgspaqvfeng2fovbximt4lm	153	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	154	1	B	B	NNP
work_tpiqgspaqvfeng2fovbximt4lm	154	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	154	3	Enlargement	enlargement	NN
work_tpiqgspaqvfeng2fovbximt4lm	154	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	154	5	1.5-megabase	1.5-megabase	CD
work_tpiqgspaqvfeng2fovbximt4lm	154	6	region	region	NN
work_tpiqgspaqvfeng2fovbximt4lm	154	7	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	154	8	chro-	chro-	NN
work_tpiqgspaqvfeng2fovbximt4lm	154	9	mosome	mosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	154	10	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	154	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	155	1	Genes	gene	NNS
work_tpiqgspaqvfeng2fovbximt4lm	155	2	encoded	encode	VBD
work_tpiqgspaqvfeng2fovbximt4lm	155	3	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	155	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	155	5	region	region	NN
work_tpiqgspaqvfeng2fovbximt4lm	155	6	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	155	7	shown	show	VBN
work_tpiqgspaqvfeng2fovbximt4lm	155	8	below	below	IN
work_tpiqgspaqvfeng2fovbximt4lm	155	9	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	155	10	plot	plot	NN
work_tpiqgspaqvfeng2fovbximt4lm	155	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	156	1	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	156	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	156	3	Linkage	linkage	NN
work_tpiqgspaqvfeng2fovbximt4lm	156	4	disequilibrium	disequilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	156	5	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	156	6	r2	r2	NN
work_tpiqgspaqvfeng2fovbximt4lm	156	7	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	156	8	among	among	IN
work_tpiqgspaqvfeng2fovbximt4lm	156	9	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	156	10	13	13	CD
work_tpiqgspaqvfeng2fovbximt4lm	156	11	single	single	JJ
work_tpiqgspaqvfeng2fovbximt4lm	156	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	156	13	nucleotide	nucleotide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	156	14	polymorphisms	polymorphism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	156	15	showing	show	VBG
work_tpiqgspaqvfeng2fovbximt4lm	156	16	genome	genome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	156	17	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	156	18	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	156	19	significance	significance	NN
work_tpiqgspaqvfeng2fovbximt4lm	156	20	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	156	21	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	156	22	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	156	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	157	1	In-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	157	2	creasing	creasing	NN
work_tpiqgspaqvfeng2fovbximt4lm	157	3	shades	shade	NNS
work_tpiqgspaqvfeng2fovbximt4lm	157	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	157	5	gray	gray	JJ
work_tpiqgspaqvfeng2fovbximt4lm	157	6	represent	represent	NN
work_tpiqgspaqvfeng2fovbximt4lm	157	7	increasing	increase	VBG
work_tpiqgspaqvfeng2fovbximt4lm	157	8	linkage	linkage	NN
work_tpiqgspaqvfeng2fovbximt4lm	157	9	disequilibrium	disequilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	157	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	157	11	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	157	12	white	white	NNP
work_tpiqgspaqvfeng2fovbximt4lm	157	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	157	14	r2=	r2=	CD
work_tpiqgspaqvfeng2fovbximt4lm	157	15	0	0	NFP
work_tpiqgspaqvfeng2fovbximt4lm	157	16	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	157	17	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	157	18	black	black	NNP
work_tpiqgspaqvfeng2fovbximt4lm	157	19	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	157	20	r2=	r2=	NNP
work_tpiqgspaqvfeng2fovbximt4lm	157	21	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	157	22	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	157	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	158	1	CYTOCHROME	cytochrome	VB
work_tpiqgspaqvfeng2fovbximt4lm	158	2	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	158	3	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	158	4	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	158	5	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	158	6	CLOPIDOGREL	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	158	7	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	158	8	854	854	CD
work_tpiqgspaqvfeng2fovbximt4lm	158	9	JAMA	JAMA	NNS
work_tpiqgspaqvfeng2fovbximt4lm	158	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	158	11	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	158	12	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	158	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	158	14	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	158	15	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	158	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	158	17	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	158	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	159	1	8	8	LS
work_tpiqgspaqvfeng2fovbximt4lm	159	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	159	3	Reprinted	Reprinted	NNP
work_tpiqgspaqvfeng2fovbximt4lm	159	4	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	159	5	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	159	6	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	159	7	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	159	8	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	159	9	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	159	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	160	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	160	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	160	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	160	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	161	1	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	161	2	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	161	4	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	161	5	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	6	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	161	7	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	161	8	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	161	9	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	161	10	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	161	11	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	12	04/05/2021	04/05/2021	CD
work_tpiqgspaqvfeng2fovbximt4lm	161	13	COMMENT	comment	VB
work_tpiqgspaqvfeng2fovbximt4lm	161	14	Our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	161	15	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	17	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	161	18	relatively	relatively	RB
work_tpiqgspaqvfeng2fovbximt4lm	161	19	large	large	JJ
work_tpiqgspaqvfeng2fovbximt4lm	161	20	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	161	21	drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	22	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	161	23	naive	naive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	161	24	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	25	indicates	indicate	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	161	26	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	27	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	28	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	29	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	30	defined	define	VBN
work_tpiqgspaqvfeng2fovbximt4lm	161	31	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	32	ADP-	ADP-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	161	33	stimulated	stimulate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	161	34	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	35	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	36	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	161	37	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	161	38	nor-	nor-	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	39	mally	mally	RB
work_tpiqgspaqvfeng2fovbximt4lm	161	40	distributed	distribute	VBN
work_tpiqgspaqvfeng2fovbximt4lm	161	41	trait	trait	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	42	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	161	43	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	161	44	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	161	45	clear	clear	JJ
work_tpiqgspaqvfeng2fovbximt4lm	161	46	cutoff	cutoff	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	47	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	161	48	define	define	VB
work_tpiqgspaqvfeng2fovbximt4lm	161	49	resistance	resistance	NN
work_tpiqgspaqvfeng2fovbximt4lm	161	50	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	162	1	Others	other	NNS
work_tpiqgspaqvfeng2fovbximt4lm	162	2	have	have	VBP
work_tpiqgspaqvfeng2fovbximt4lm	162	3	reported	report	VBN
work_tpiqgspaqvfeng2fovbximt4lm	162	4	similar	similar	JJ
work_tpiqgspaqvfeng2fovbximt4lm	162	5	findings	finding	NNS
work_tpiqgspaqvfeng2fovbximt4lm	162	6	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	162	7	patient	patient	JJ
work_tpiqgspaqvfeng2fovbximt4lm	162	8	populations	population	NNS
work_tpiqgspaqvfeng2fovbximt4lm	162	9	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	162	10	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	162	11	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	162	12	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	162	13	ath-	ath-	RB
work_tpiqgspaqvfeng2fovbximt4lm	162	14	erosclerotic	erosclerotic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	162	15	burden	burden	NN
work_tpiqgspaqvfeng2fovbximt4lm	162	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	162	17	medication	medication	NN
work_tpiqgspaqvfeng2fovbximt4lm	162	18	us-	us-	CD
work_tpiqgspaqvfeng2fovbximt4lm	162	19	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	162	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	162	21	concurrent	concurrent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	162	22	illnesses	illness	NNS
work_tpiqgspaqvfeng2fovbximt4lm	162	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	162	24	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	162	25	compli-	compli-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	162	26	ance	ance	NN
work_tpiqgspaqvfeng2fovbximt4lm	162	27	—	—	:
work_tpiqgspaqvfeng2fovbximt4lm	162	28	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	162	29	potential	potential	JJ
work_tpiqgspaqvfeng2fovbximt4lm	162	30	confounding	confound	VBG
work_tpiqgspaqvfeng2fovbximt4lm	162	31	influences	influence	NNS
work_tpiqgspaqvfeng2fovbximt4lm	162	32	affecting	affect	VBG
work_tpiqgspaqvfeng2fovbximt4lm	162	33	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	162	34	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	162	35	sponse	sponse	NN
work_tpiqgspaqvfeng2fovbximt4lm	162	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	163	1	Thus	thus	RB
work_tpiqgspaqvfeng2fovbximt4lm	163	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	163	3	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	163	4	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	163	5	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	163	6	likely	likely	RB
work_tpiqgspaqvfeng2fovbximt4lm	163	7	caused	cause	VBN
work_tpiqgspaqvfeng2fovbximt4lm	163	8	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	163	9	multiple	multiple	JJ
work_tpiqgspaqvfeng2fovbximt4lm	163	10	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	163	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	163	12	in-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	163	13	cluding	clude	VBG
work_tpiqgspaqvfeng2fovbximt4lm	163	14	potentially	potentially	RB
work_tpiqgspaqvfeng2fovbximt4lm	163	15	genetic	genetic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	163	16	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	163	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	164	1	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	164	2	found	find	VBD
work_tpiqgspaqvfeng2fovbximt4lm	164	3	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	4	increased	increase	VBN
work_tpiqgspaqvfeng2fovbximt4lm	164	5	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	164	7	BMI	BMI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	164	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	164	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	164	10	tri-	tri-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	164	11	glyceride	glyceride	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	12	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	164	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	164	14	decreased	decrease	VBN
work_tpiqgspaqvfeng2fovbximt4lm	164	15	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	164	16	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	17	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	164	18	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	164	19	density	density	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	20	lipoprotein	lipoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	21	cholesterol	cholesterol	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	22	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	164	23	predictors	predictor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	164	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	25	poorer	poor	JJR
work_tpiqgspaqvfeng2fovbximt4lm	164	26	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	27	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	164	28	sponse	sponse	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	29	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	164	30	however	however	RB
work_tpiqgspaqvfeng2fovbximt4lm	164	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	164	32	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	164	33	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	164	34	com-	com-	RB
work_tpiqgspaqvfeng2fovbximt4lm	164	35	bined	bin	VBN
work_tpiqgspaqvfeng2fovbximt4lm	164	36	account	account	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	37	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	38	less	less	JJR
work_tpiqgspaqvfeng2fovbximt4lm	164	39	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	40	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	164	41	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	42	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	43	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	164	44	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	45	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	164	46	suggesting	suggest	VBG
work_tpiqgspaqvfeng2fovbximt4lm	164	47	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	164	48	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	164	49	undiscov-	undiscov-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	164	50	ered	ered	JJ
work_tpiqgspaqvfeng2fovbximt4lm	164	51	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	164	52	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	164	53	contribute	contribute	VBP
work_tpiqgspaqvfeng2fovbximt4lm	164	54	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	55	varia-	varia-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	164	56	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	57	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	164	58	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	164	59	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	164	60	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	165	1	Since	since	IN
work_tpiqgspaqvfeng2fovbximt4lm	165	2	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	165	3	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	165	4	persons	person	NNS
work_tpiqgspaqvfeng2fovbximt4lm	165	5	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	165	6	related	relate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	165	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	165	8	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	165	9	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	165	10	uniquely	uniquely	RB
work_tpiqgspaqvfeng2fovbximt4lm	165	11	able	able	JJ
work_tpiqgspaqvfeng2fovbximt4lm	165	12	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	165	13	estimate	estimate	VB
work_tpiqgspaqvfeng2fovbximt4lm	165	14	heri-	heri-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	165	15	tability	tability	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	16	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	165	17	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	18	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	19	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	165	20	de-	de-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	165	21	termining	termine	VBG
work_tpiqgspaqvfeng2fovbximt4lm	165	22	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	165	23	extent	extent	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	165	25	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	26	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	165	27	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	165	28	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	165	29	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	165	30	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	31	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	32	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	165	33	could	could	MD
work_tpiqgspaqvfeng2fovbximt4lm	165	34	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	165	35	attributed	attribute	VBN
work_tpiqgspaqvfeng2fovbximt4lm	165	36	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	165	37	familial	familial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	165	38	re-	re-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	165	39	latedness	latedness	NN
work_tpiqgspaqvfeng2fovbximt4lm	165	40	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	166	1	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	166	2	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	166	3	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	166	4	highly	highly	RB
work_tpiqgspaqvfeng2fovbximt4lm	166	5	heritable	heritable	JJ
work_tpiqgspaqvfeng2fovbximt4lm	166	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	167	1	Indeed	indeed	RB
work_tpiqgspaqvfeng2fovbximt4lm	167	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	167	3	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	167	4	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	167	5	agnos-	agnos-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	167	6	tic	tic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	167	7	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	167	8	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	167	9	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	167	10	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	167	11	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	167	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	167	13	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	167	14	found	find	VBD
work_tpiqgspaqvfeng2fovbximt4lm	167	15	compelling	compelling	JJ
work_tpiqgspaqvfeng2fovbximt4lm	167	16	evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	167	17	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	167	18	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	167	19	ma-	ma-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	167	20	jor	jor	NNP
work_tpiqgspaqvfeng2fovbximt4lm	167	21	locus	locus	NN
work_tpiqgspaqvfeng2fovbximt4lm	167	22	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	167	23	chromosome	chromosome	NN
work_tpiqgspaqvfeng2fovbximt4lm	167	24	10q24	10q24	CD
work_tpiqgspaqvfeng2fovbximt4lm	167	25	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	167	26	influences	influence	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	167	27	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	167	28	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	167	29	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	168	1	This	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	168	2	locus	locus	NN
work_tpiqgspaqvfeng2fovbximt4lm	168	3	extends	extend	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	168	4	across	across	IN
work_tpiqgspaqvfeng2fovbximt4lm	168	5	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	168	6	CYP2C18	cyp2c18	XX
work_tpiqgspaqvfeng2fovbximt4lm	168	7	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	168	8	CYP2C19–CYP2C9–CYP2C8	cyp2c19–cyp2c9–cyp2c8	NN
work_tpiqgspaqvfeng2fovbximt4lm	168	9	gene	gene	NN
work_tpiqgspaqvfeng2fovbximt4lm	168	10	clus-	clus-	NN
work_tpiqgspaqvfeng2fovbximt4lm	168	11	ter	ter	NN
work_tpiqgspaqvfeng2fovbximt4lm	168	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	169	1	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	169	2	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	169	3	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	169	4	strong	strong	JJ
work_tpiqgspaqvfeng2fovbximt4lm	169	5	biological	biological	JJ
work_tpiqgspaqvfeng2fovbximt4lm	169	6	candidate	candidate	NN
work_tpiqgspaqvfeng2fovbximt4lm	169	7	because	because	IN
work_tpiqgspaqvfeng2fovbximt4lm	169	8	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	169	9	enzyme	enzyme	NNS
work_tpiqgspaqvfeng2fovbximt4lm	169	10	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	169	11	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	169	12	key	key	JJ
work_tpiqgspaqvfeng2fovbximt4lm	169	13	activator	activator	NN
work_tpiqgspaqvfeng2fovbximt4lm	169	14	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	169	15	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	169	16	antiplatelet	antiplatelet	JJ
work_tpiqgspaqvfeng2fovbximt4lm	169	17	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	169	18	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	169	19	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	169	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	170	1	Indeed	indeed	RB
work_tpiqgspaqvfeng2fovbximt4lm	170	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	170	3	follow	follow	VB
work_tpiqgspaqvfeng2fovbximt4lm	170	4	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	170	5	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	6	geno-	geno-	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	7	typing	typing	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	8	indicated	indicate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	170	9	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	170	10	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	170	11	common	common	JJ
work_tpiqgspaqvfeng2fovbximt4lm	170	12	loss-	loss-	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	170	14	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	170	15	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	16	CYP2C19	cyp2c19	VB
work_tpiqgspaqvfeng2fovbximt4lm	170	17	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	170	18	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	170	19	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	20	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	170	21	as-	as-	RB
work_tpiqgspaqvfeng2fovbximt4lm	170	22	sociated	sociate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	170	23	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	170	24	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	25	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	26	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	170	27	could	could	MD
work_tpiqgspaqvfeng2fovbximt4lm	170	28	account	account	VB
work_tpiqgspaqvfeng2fovbximt4lm	170	29	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	170	30	most	most	JJS
work_tpiqgspaqvfeng2fovbximt4lm	170	31	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	170	32	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	170	33	associa-	associa-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	170	34	tion	tion	NNP
work_tpiqgspaqvfeng2fovbximt4lm	170	35	signal	signal	NNP
work_tpiqgspaqvfeng2fovbximt4lm	170	36	detected	detect	VBN
work_tpiqgspaqvfeng2fovbximt4lm	170	37	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	170	38	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	170	39	initial	initial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	170	40	ge-	ge-	XX
work_tpiqgspaqvfeng2fovbximt4lm	170	41	nome	nome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	170	42	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	170	43	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	170	44	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	45	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	170	46	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	171	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	171	2	CYP2C19	CYP2C19	NNS
work_tpiqgspaqvfeng2fovbximt4lm	171	3	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	171	4	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	171	5	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	171	6	accounts	account	NNS
work_tpiqgspaqvfeng2fovbximt4lm	171	7	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	171	8	ap-	ap-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	171	9	proximately	proximately	RB
work_tpiqgspaqvfeng2fovbximt4lm	171	10	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	171	11	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	171	12	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	171	13	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	171	14	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	171	15	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	171	16	clo-	clo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	171	17	pidogrel	pidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	171	18	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	171	19	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	172	1	With	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	172	2	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	172	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	172	4	BMI	BMI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	172	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	172	6	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	172	7	lipid	lipid	NN
work_tpiqgspaqvfeng2fovbximt4lm	172	8	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	172	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	172	10	approximately	approximately	RB
work_tpiqgspaqvfeng2fovbximt4lm	172	11	22	22	CD
work_tpiqgspaqvfeng2fovbximt4lm	172	12	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	172	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	172	14	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	172	15	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	172	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	172	17	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	172	18	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	172	19	can	can	MD
work_tpiqgspaqvfeng2fovbximt4lm	172	20	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	172	21	explained	explain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	172	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	173	1	Although	although	IN
work_tpiqgspaqvfeng2fovbximt4lm	173	2	substantial	substantial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	173	3	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	173	4	highly	highly	RB
work_tpiqgspaqvfeng2fovbximt4lm	173	5	sig-	sig-	RB
work_tpiqgspaqvfeng2fovbximt4lm	173	6	nificant	nificant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	173	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	173	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	173	9	majority	majority	NN
work_tpiqgspaqvfeng2fovbximt4lm	173	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	173	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	173	12	variation	variation	NN
work_tpiqgspaqvfeng2fovbximt4lm	173	13	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	173	14	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	173	15	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	173	16	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	173	17	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	173	18	re-	re-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	173	19	mains	main	NNS
work_tpiqgspaqvfeng2fovbximt4lm	173	20	unexplained	unexplained	JJ
work_tpiqgspaqvfeng2fovbximt4lm	173	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	174	1	Presumably	presumably	RB
work_tpiqgspaqvfeng2fovbximt4lm	174	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	174	3	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	174	4	unmeasured	unmeasured	JJ
work_tpiqgspaqvfeng2fovbximt4lm	174	5	factors	factor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	174	6	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	174	7	influence	influence	VBP
work_tpiqgspaqvfeng2fovbximt4lm	174	8	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	174	9	pidogrel	pidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	174	10	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	174	11	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	174	12	including	include	VBG
work_tpiqgspaqvfeng2fovbximt4lm	174	13	poten-	poten-	NN
work_tpiqgspaqvfeng2fovbximt4lm	174	14	tially	tially	RB
work_tpiqgspaqvfeng2fovbximt4lm	174	15	additional	additional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	174	16	genetic	genetic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	174	17	variants	variant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	174	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	174	19	given	give	VBN
work_tpiqgspaqvfeng2fovbximt4lm	174	20	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	174	21	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	174	22	heritability	heritability	NN
work_tpiqgspaqvfeng2fovbximt4lm	174	23	estimate	estimate	NN
work_tpiqgspaqvfeng2fovbximt4lm	174	24	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	174	25	remain	remain	VBP
work_tpiqgspaqvfeng2fovbximt4lm	174	26	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	174	27	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	174	28	identified	identify	VBN
work_tpiqgspaqvfeng2fovbximt4lm	174	29	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	175	1	CYP2C19	CYP2C19	NFP
work_tpiqgspaqvfeng2fovbximt4lm	175	2	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	175	3	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	175	4	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	175	5	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	175	6	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	175	7	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	175	8	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	175	9	preclopido-	preclopido-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	175	10	grel	grel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	175	11	platelet	platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	175	12	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	175	13	measures	measure	NNS
work_tpiqgspaqvfeng2fovbximt4lm	175	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	175	15	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	175	16	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	175	17	postclopidogrel	postclopidogrel	JJ
work_tpiqgspaqvfeng2fovbximt4lm	175	18	measures	measure	NNS
work_tpiqgspaqvfeng2fovbximt4lm	175	19	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	175	20	as-	as-	RB
work_tpiqgspaqvfeng2fovbximt4lm	175	21	sociated	sociate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	175	22	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	175	23	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	175	24	even	even	RB
work_tpiqgspaqvfeng2fovbximt4lm	175	25	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	175	26	ad-	ad-	RB
work_tpiqgspaqvfeng2fovbximt4lm	175	27	justing	juste	VBG
work_tpiqgspaqvfeng2fovbximt4lm	175	28	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	175	29	preclopidogrel	preclopidogrel	JJ
work_tpiqgspaqvfeng2fovbximt4lm	175	30	measures	measure	NNS
work_tpiqgspaqvfeng2fovbximt4lm	175	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	175	32	indicating	indicate	VBG
work_tpiqgspaqvfeng2fovbximt4lm	175	33	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	175	34	true	true	JJ
work_tpiqgspaqvfeng2fovbximt4lm	175	35	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	175	36	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	175	37	clo-	clo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	175	38	pidogrel	pidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	175	39	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	175	40	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	176	1	Due	due	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	2	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	176	3	linkage	linkage	VB
work_tpiqgspaqvfeng2fovbximt4lm	176	4	dis-	dis-	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	5	equilibrium	equilibrium	NN
work_tpiqgspaqvfeng2fovbximt4lm	176	6	across	across	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	7	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	176	8	region	region	NN
work_tpiqgspaqvfeng2fovbximt4lm	176	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	176	10	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	176	11	can-	can-	VBP
work_tpiqgspaqvfeng2fovbximt4lm	176	12	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	176	13	rule	rule	VB
work_tpiqgspaqvfeng2fovbximt4lm	176	14	out	out	RP
work_tpiqgspaqvfeng2fovbximt4lm	176	15	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	16	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	176	17	variant	variant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	176	18	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	176	19	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	20	CYP2C19	cyp2c19	VB
work_tpiqgspaqvfeng2fovbximt4lm	176	21	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	176	22	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	176	23	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	176	24	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	176	25	causative	causative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	176	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	176	27	but	but	CC
work_tpiqgspaqvfeng2fovbximt4lm	176	28	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	176	29	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	176	30	unlikely	unlikely	JJ
work_tpiqgspaqvfeng2fovbximt4lm	176	31	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	32	light	light	NN
work_tpiqgspaqvfeng2fovbximt4lm	176	33	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	34	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	176	35	unequivocal	unequivocal	JJ
work_tpiqgspaqvfeng2fovbximt4lm	176	36	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	176	37	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	38	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	176	39	mutation	mutation	NN
work_tpiqgspaqvfeng2fovbximt4lm	176	40	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	176	41	enzyme	enzyme	NNS
work_tpiqgspaqvfeng2fovbximt4lm	176	42	pro-	pro-	NN
work_tpiqgspaqvfeng2fovbximt4lm	176	43	duction	duction	NN
work_tpiqgspaqvfeng2fovbximt4lm	176	44	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	177	1	Furthermore	furthermore	RB
work_tpiqgspaqvfeng2fovbximt4lm	177	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	177	3	it	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	177	4	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	177	5	possible	possible	JJ
work_tpiqgspaqvfeng2fovbximt4lm	177	6	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	177	7	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	177	8	variants	variant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	177	9	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	177	10	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	177	11	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	177	12	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	177	13	CYP2C	CYP2C	VBN
work_tpiqgspaqvfeng2fovbximt4lm	177	14	genes	gene	NNS
work_tpiqgspaqvfeng2fovbximt4lm	177	15	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	177	16	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	177	17	locus	locus	NN
work_tpiqgspaqvfeng2fovbximt4lm	177	18	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	177	19	also	also	RB
work_tpiqgspaqvfeng2fovbximt4lm	177	20	con-	con-	VB
work_tpiqgspaqvfeng2fovbximt4lm	177	21	tribute	tribute	NN
work_tpiqgspaqvfeng2fovbximt4lm	177	22	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	177	23	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	177	24	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	177	25	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	178	1	Our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	178	2	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	178	3	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	178	4	unique	unique	JJ
work_tpiqgspaqvfeng2fovbximt4lm	178	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	178	6	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	178	7	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	178	8	used	use	VBD
work_tpiqgspaqvfeng2fovbximt4lm	178	9	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	178	10	agnostic	agnostic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	178	11	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	178	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	178	13	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	178	14	approach	approach	NN
work_tpiqgspaqvfeng2fovbximt4lm	178	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	179	1	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	2	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	179	3	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	4	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	179	5	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	6	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	7	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	179	9	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	179	10	detected	detect	VBD
work_tpiqgspaqvfeng2fovbximt4lm	179	11	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	179	12	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	13	region	region	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	14	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	179	15	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	16	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	17	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	18	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	19	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	179	20	exceeding	exceed	VBG
work_tpiqgspaqvfeng2fovbximt4lm	179	21	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	179	22	genome	genome	RB
work_tpiqgspaqvfeng2fovbximt4lm	179	23	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	179	24	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	25	level	level	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	26	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	27	statistical	statistical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	28	signifi-	signifi-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	29	cance	cance	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	30	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	179	31	suggesting	suggest	VBG
work_tpiqgspaqvfeng2fovbximt4lm	179	32	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	33	common	common	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	34	vari-	vari-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	35	ants	ant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	179	36	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	37	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	38	parts	part	NNS
work_tpiqgspaqvfeng2fovbximt4lm	179	39	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	40	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	179	41	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	42	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	179	43	similar	similar	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	44	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	179	45	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	179	46	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	47	size	size	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	48	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	179	49	un-	un-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	179	50	Figure	figure	NN
work_tpiqgspaqvfeng2fovbximt4lm	179	51	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	179	52	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	180	1	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	3	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	4	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	180	5	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	180	6	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	180	7	rs4244285	rs4244285	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	8	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	180	9	Loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	180	10	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	180	11	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	180	13	Function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	180	14	Variant	Variant	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	15	With	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	16	Adenosine	Adenosine	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	17	Diphosphate	Diphosphate	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	18	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	180	19	Stimulated	Stimulated	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	20	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	21	Aggregation	Aggregation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	22	Before	before	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	23	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	180	24	After	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	25	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	26	Administration	Administration	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	27	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	28	Participants	Participants	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	180	29	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	30	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	180	31	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	180	32	Pharmacogenomics	Pharmacogenomics	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	33	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	34	Antiplatelet	Antiplatelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	35	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	36	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	180	37	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	38	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	180	39	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	40	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	180	41	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	42	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	43	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	180	44	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	45	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	46	Preclopidogrel	Preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	180	47	60	60	CD
work_tpiqgspaqvfeng2fovbximt4lm	180	48	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	180	49	80	80	CD
work_tpiqgspaqvfeng2fovbximt4lm	180	50	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	180	51	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	180	52	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	180	53	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	180	54	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	181	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	181	2	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	181	3	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	181	4	la	la	NNP
work_tpiqgspaqvfeng2fovbximt4lm	181	5	te	te	NNP
work_tpiqgspaqvfeng2fovbximt4lm	181	6	le	le	NNP
work_tpiqgspaqvfeng2fovbximt4lm	181	7	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	181	8	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	181	9	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	181	10	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	181	11	re	re	NN
work_tpiqgspaqvfeng2fovbximt4lm	181	12	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	181	13	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	181	14	io	io	NNP
work_tpiqgspaqvfeng2fovbximt4lm	181	15	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	181	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	181	17	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	181	18	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	181	19	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	182	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	182	2	CYP2C19∗2	CYP2C19∗2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	182	3	Alleles	Alleles	NNP
work_tpiqgspaqvfeng2fovbximt4lm	182	4	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	5	102	102	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	6	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	7	37	37	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	8	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	9	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	10	60	60	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	11	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	12	80	80	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	13	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	14	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	15	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	182	16	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	182	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	183	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	183	2	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	183	3	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	4	la	la	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	5	te	te	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	6	le	le	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	7	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	8	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	183	9	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	183	10	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	183	11	re	re	NN
work_tpiqgspaqvfeng2fovbximt4lm	183	12	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	183	13	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	183	14	io	io	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	15	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	183	17	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	183	18	Postclopidogrel	Postclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	183	19	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	183	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	184	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	184	2	CYP2C19∗2	CYP2C19∗2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	184	3	Alleles	Alleles	NNP
work_tpiqgspaqvfeng2fovbximt4lm	184	4	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	5	288	288	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	6	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	7	132	132	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	8	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	9	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	10	Preclopidogrel	Preclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	184	11	60	60	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	12	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	13	80	80	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	14	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	15	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	184	16	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	184	17	=	=	NNS
work_tpiqgspaqvfeng2fovbximt4lm	184	18	.58	.58	NFP
work_tpiqgspaqvfeng2fovbximt4lm	184	19	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	184	20	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	184	21	.92	.92	NFP
work_tpiqgspaqvfeng2fovbximt4lm	184	22	0	0	NFP
work_tpiqgspaqvfeng2fovbximt4lm	184	23	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	184	24	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	185	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	185	2	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	185	3	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	185	4	la	la	NNP
work_tpiqgspaqvfeng2fovbximt4lm	185	5	te	te	NNP
work_tpiqgspaqvfeng2fovbximt4lm	185	6	le	le	NNP
work_tpiqgspaqvfeng2fovbximt4lm	185	7	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	185	8	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	185	9	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	185	10	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	185	11	re	re	NN
work_tpiqgspaqvfeng2fovbximt4lm	185	12	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	185	13	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	185	14	io	io	NNP
work_tpiqgspaqvfeng2fovbximt4lm	185	15	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	185	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	185	17	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	185	18	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	185	19	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	186	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	186	2	CYP2C19∗2	CYP2C19∗2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	186	3	Alleles	Alleles	NNP
work_tpiqgspaqvfeng2fovbximt4lm	186	4	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	5	288	288	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	6	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	7	132	132	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	8	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	9	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	10	60	60	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	11	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	12	80	80	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	13	100	100	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	14	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	15	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	186	16	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	186	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	187	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	187	2	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	187	3	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	4	la	la	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	5	te	te	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	6	le	le	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	7	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	8	A	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	187	9	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	187	10	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	187	11	re	re	NN
work_tpiqgspaqvfeng2fovbximt4lm	187	12	g	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	187	13	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	187	14	io	io	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	15	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	187	17	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	187	18	Postclopidogrel	Postclopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	187	19	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	187	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	188	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	188	2	CYP2C19∗2	CYP2C19∗2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	3	Alleles	Alleles	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	4	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	5	131	131	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	6	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	7	54	54	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	8	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	9	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	10	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	188	11	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	12	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	13	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	14	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	188	16	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	17	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	18	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	19	=	=	:
work_tpiqgspaqvfeng2fovbximt4lm	188	20	.02	.02	.
work_tpiqgspaqvfeng2fovbximt4lm	188	21	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	22	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	188	23	4.3	4.3	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	24	×	×	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	25	10–11	10–11	CD
work_tpiqgspaqvfeng2fovbximt4lm	188	26	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	188	27	horizontal	horizontal	JJ
work_tpiqgspaqvfeng2fovbximt4lm	188	28	line	line	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	29	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	188	30	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	188	31	middle	middle	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	32	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	188	33	each	each	DT
work_tpiqgspaqvfeng2fovbximt4lm	188	34	box	box	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	35	indicates	indicate	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	188	36	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	188	37	median	median	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	38	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	188	39	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	188	40	top	top	JJ
work_tpiqgspaqvfeng2fovbximt4lm	188	41	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	188	42	bottom	bottom	JJ
work_tpiqgspaqvfeng2fovbximt4lm	188	43	borders	border	NNS
work_tpiqgspaqvfeng2fovbximt4lm	188	44	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	188	45	each	each	DT
work_tpiqgspaqvfeng2fovbximt4lm	188	46	box	box	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	47	indicate	indicate	VBP
work_tpiqgspaqvfeng2fovbximt4lm	188	48	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	188	49	interquartile	interquartile	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	50	range	range	NN
work_tpiqgspaqvfeng2fovbximt4lm	188	51	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	188	52	IQR	IQR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	188	53	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	188	54	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	189	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	189	2	whiskers	whisker	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	3	above	above	IN
work_tpiqgspaqvfeng2fovbximt4lm	189	4	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	189	5	below	below	IN
work_tpiqgspaqvfeng2fovbximt4lm	189	6	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	189	7	box	box	NN
work_tpiqgspaqvfeng2fovbximt4lm	189	8	indicate	indicate	VBP
work_tpiqgspaqvfeng2fovbximt4lm	189	9	plus	plus	JJ
work_tpiqgspaqvfeng2fovbximt4lm	189	10	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	189	11	minus	minus	CC
work_tpiqgspaqvfeng2fovbximt4lm	189	12	1.5	1.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	189	13	IQRs	iqr	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	189	15	respectively	respectively	RB
work_tpiqgspaqvfeng2fovbximt4lm	189	16	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	189	17	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	189	18	points	point	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	19	beyond	beyond	IN
work_tpiqgspaqvfeng2fovbximt4lm	189	20	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	189	21	whiskers	whisker	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	22	indicate	indicate	VBP
work_tpiqgspaqvfeng2fovbximt4lm	189	23	outliers	outlier	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	24	beyond	beyond	IN
work_tpiqgspaqvfeng2fovbximt4lm	189	25	1.5	1.5	CD
work_tpiqgspaqvfeng2fovbximt4lm	189	26	IQRs	iqr	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	27	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	189	28	except	except	IN
work_tpiqgspaqvfeng2fovbximt4lm	189	29	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	189	30	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	189	31	carrying	carry	VBG
work_tpiqgspaqvfeng2fovbximt4lm	189	32	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	189	33	alleles	allele	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	34	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	189	35	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	189	36	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	189	37	data	data	NN
work_tpiqgspaqvfeng2fovbximt4lm	189	38	points	point	NNS
work_tpiqgspaqvfeng2fovbximt4lm	189	39	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	189	40	plotted	plot	VBN
work_tpiqgspaqvfeng2fovbximt4lm	189	41	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	190	1	CYTOCHROME	cytochrome	VB
work_tpiqgspaqvfeng2fovbximt4lm	190	2	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	190	3	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	190	4	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	190	5	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	190	6	CLOPIDOGREL	CLOPIDOGREL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	190	7	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	190	8	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	190	9	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	190	10	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	190	11	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	190	12	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	190	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	191	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	191	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	191	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	191	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	192	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	192	2	Reprinted	reprinted	JJ
work_tpiqgspaqvfeng2fovbximt4lm	192	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	192	4	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	192	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	192	6	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	192	7	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	192	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	192	9	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	192	10	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	192	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	192	12	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	192	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	193	1	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	193	2	855	855	CD
work_tpiqgspaqvfeng2fovbximt4lm	193	3	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	193	4	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	193	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	193	6	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	193	7	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	193	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	193	9	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	193	10	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	193	11	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	193	12	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	193	13	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	193	14	04/05/2021	04/05/2021	NN
work_tpiqgspaqvfeng2fovbximt4lm	193	15	likely	likely	JJ
work_tpiqgspaqvfeng2fovbximt4lm	193	16	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	194	1	However	however	RB
work_tpiqgspaqvfeng2fovbximt4lm	194	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	194	3	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	194	4	can	can	MD
work_tpiqgspaqvfeng2fovbximt4lm	194	5	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	194	6	rule	rule	VB
work_tpiqgspaqvfeng2fovbximt4lm	194	7	out	out	RP
work_tpiqgspaqvfeng2fovbximt4lm	194	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	194	9	possibility	possibility	NN
work_tpiqgspaqvfeng2fovbximt4lm	194	10	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	194	11	common	common	JJ
work_tpiqgspaqvfeng2fovbximt4lm	194	12	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	13	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	194	14	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	194	15	types	type	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	16	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	194	17	variants	variant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	18	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	194	19	eg	eg	UH
work_tpiqgspaqvfeng2fovbximt4lm	194	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	194	21	copy	copy	VBP
work_tpiqgspaqvfeng2fovbximt4lm	194	22	number	number	NN
work_tpiqgspaqvfeng2fovbximt4lm	194	23	vari-	vari-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	194	24	ants	ant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	194	26	insertions	insertion	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	27	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	194	28	deletions	deletion	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	29	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	194	30	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	194	31	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	194	32	rare	rare	JJ
work_tpiqgspaqvfeng2fovbximt4lm	194	33	vari-	vari-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	194	34	ants	ant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	35	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	194	36	large	large	JJ
work_tpiqgspaqvfeng2fovbximt4lm	194	37	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	194	38	size	size	NN
work_tpiqgspaqvfeng2fovbximt4lm	194	39	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	194	40	tagged	tag	VBN
work_tpiqgspaqvfeng2fovbximt4lm	194	41	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	194	42	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	194	43	SNPs	snp	NNS
work_tpiqgspaqvfeng2fovbximt4lm	194	44	genotyped	genotype	VBN
work_tpiqgspaqvfeng2fovbximt4lm	194	45	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	194	46	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	194	47	have	have	VB
work_tpiqgspaqvfeng2fovbximt4lm	194	48	been	be	VBN
work_tpiqgspaqvfeng2fovbximt4lm	194	49	missed	miss	VBN
work_tpiqgspaqvfeng2fovbximt4lm	194	50	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	195	1	Genome	genome	RB
work_tpiqgspaqvfeng2fovbximt4lm	195	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	195	3	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	195	4	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	195	5	studies	study	NNS
work_tpiqgspaqvfeng2fovbximt4lm	195	6	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	195	7	prone	prone	JJ
work_tpiqgspaqvfeng2fovbximt4lm	195	8	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	195	9	false	false	JJ
work_tpiqgspaqvfeng2fovbximt4lm	195	10	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	195	11	positive	positive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	195	12	results	result	NNS
work_tpiqgspaqvfeng2fovbximt4lm	195	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	195	14	owing	owe	VBG
work_tpiqgspaqvfeng2fovbximt4lm	195	15	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	195	16	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	195	17	large	large	JJ
work_tpiqgspaqvfeng2fovbximt4lm	195	18	number	number	NN
work_tpiqgspaqvfeng2fovbximt4lm	195	19	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	195	20	statistical	statistical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	195	21	tests	test	NNS
work_tpiqgspaqvfeng2fovbximt4lm	195	22	per-	per-	RB
work_tpiqgspaqvfeng2fovbximt4lm	195	23	formed	form	VBN
work_tpiqgspaqvfeng2fovbximt4lm	195	24	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	196	1	It	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	196	2	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	196	3	unlikely	unlikely	JJ
work_tpiqgspaqvfeng2fovbximt4lm	196	4	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	196	5	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	196	6	finding	finding	NN
work_tpiqgspaqvfeng2fovbximt4lm	196	7	represents	represent	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	196	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	196	9	false	false	JJ
work_tpiqgspaqvfeng2fovbximt4lm	196	10	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	196	11	positive	positive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	196	12	result	result	NN
work_tpiqgspaqvfeng2fovbximt4lm	196	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	196	14	be-	be-	XX
work_tpiqgspaqvfeng2fovbximt4lm	196	15	cause	cause	IN
work_tpiqgspaqvfeng2fovbximt4lm	196	16	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	196	17	replicated	replicate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	196	18	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	196	19	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	196	20	be-	be-	XX
work_tpiqgspaqvfeng2fovbximt4lm	196	21	tween	tween	NNP
work_tpiqgspaqvfeng2fovbximt4lm	196	22	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	196	23	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	196	24	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	196	25	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	196	26	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	196	27	ADP-	ADP-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	196	28	stimulated	stimulate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	196	29	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	196	30	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	196	31	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	196	32	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	196	33	independent	independent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	196	34	sample	sample	NN
work_tpiqgspaqvfeng2fovbximt4lm	196	35	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	197	1	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	197	2	addition	addition	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	3	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	197	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	197	5	replication	replication	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	197	7	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	197	8	initial	initial	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	9	association	association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	10	be-	be-	XX
work_tpiqgspaqvfeng2fovbximt4lm	197	11	tween	tween	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	12	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	13	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	197	14	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	197	15	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	16	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	197	17	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	18	pidogrel	pidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	19	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	197	21	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	197	22	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	23	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	24	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	197	25	cohort	cohort	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	26	demonstrates	demonstrate	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	197	27	general-	general-	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	28	izability	izability	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	29	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	197	30	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	197	31	outbred	outbreed	VBN
work_tpiqgspaqvfeng2fovbximt4lm	197	32	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	33	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	197	34	significant	significant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	197	35	atherosclerotic	atherosclerotic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	197	36	disease	disease	NN
work_tpiqgspaqvfeng2fovbximt4lm	197	37	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	198	1	Im-	im-	UH
work_tpiqgspaqvfeng2fovbximt4lm	198	2	portantly	portantly	RB
work_tpiqgspaqvfeng2fovbximt4lm	198	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	198	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	198	5	association	association	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	6	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	198	7	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	198	8	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	198	9	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	198	10	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	198	12	cardiovas-	cardiovas-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	198	13	cular	cular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	198	14	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	15	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	198	16	free	free	JJ
work_tpiqgspaqvfeng2fovbximt4lm	198	17	survival	survival	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	18	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	198	19	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	198	20	high-	high-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	198	21	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	22	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	23	provides	provide	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	198	24	evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	25	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	198	26	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	198	27	relevance	relevance	NN
work_tpiqgspaqvfeng2fovbximt4lm	198	28	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	199	1	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	199	2	limitation	limitation	NN
work_tpiqgspaqvfeng2fovbximt4lm	199	3	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	199	4	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	199	5	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	199	6	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	199	7	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	199	8	cohort	cohort	NN
work_tpiqgspaqvfeng2fovbximt4lm	199	9	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	199	10	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	199	11	mixed	mixed	JJ
work_tpiqgspaqvfeng2fovbximt4lm	199	12	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	199	13	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	199	14	received	receive	VBD
work_tpiqgspaqvfeng2fovbximt4lm	199	15	differing	differ	VBG
work_tpiqgspaqvfeng2fovbximt4lm	199	16	regi-	regi-	NN
work_tpiqgspaqvfeng2fovbximt4lm	199	17	mens	men	NNS
work_tpiqgspaqvfeng2fovbximt4lm	199	18	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	199	19	antiplatelet	antiplatelet	DT
work_tpiqgspaqvfeng2fovbximt4lm	199	20	agents	agent	NNS
work_tpiqgspaqvfeng2fovbximt4lm	199	21	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	199	22	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	199	23	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	199	24	setting	setting	NN
work_tpiqgspaqvfeng2fovbximt4lm	199	25	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	199	26	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	199	27	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	199	28	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	199	29	days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	199	30	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	199	31	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	200	1	However	however	RB
work_tpiqgspaqvfeng2fovbximt4lm	200	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	200	3	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	200	4	strati-	strati-	NN
work_tpiqgspaqvfeng2fovbximt4lm	200	5	fied	fie	VBD
work_tpiqgspaqvfeng2fovbximt4lm	200	6	analyses	analysis	NNS
work_tpiqgspaqvfeng2fovbximt4lm	200	7	did	do	VBD
work_tpiqgspaqvfeng2fovbximt4lm	200	8	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	200	9	detect	detect	VB
work_tpiqgspaqvfeng2fovbximt4lm	200	10	any	any	DT
work_tpiqgspaqvfeng2fovbximt4lm	200	11	signifi-	signifi-	NN
work_tpiqgspaqvfeng2fovbximt4lm	200	12	ca	can	MD
work_tpiqgspaqvfeng2fovbximt4lm	200	13	nt	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	200	14	effect	effect	VB
work_tpiqgspaqvfeng2fovbximt4lm	200	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	200	16	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	200	17	management	management	NN
work_tpiqgspaqvfeng2fovbximt4lm	200	18	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	200	19	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	200	20	longer	long	JJR
work_tpiqgspaqvfeng2fovbximt4lm	200	21	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	200	22	term	term	NN
work_tpiqgspaqvfeng2fovbximt4lm	200	23	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	200	24	investigated	investigate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	200	25	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	201	1	Furthermore	furthermore	RB
work_tpiqgspaqvfeng2fovbximt4lm	201	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	201	3	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	201	4	can	can	MD
work_tpiqgspaqvfeng2fovbximt4lm	201	5	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	201	6	rule	rule	VB
work_tpiqgspaqvfeng2fovbximt4lm	201	7	out	out	RP
work_tpiqgspaqvfeng2fovbximt4lm	201	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	201	9	possibility	possibility	NN
work_tpiqgspaqvfeng2fovbximt4lm	201	10	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	201	11	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	201	12	subset	subset	NN
work_tpiqgspaqvfeng2fovbximt4lm	201	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	201	14	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	201	15	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	201	16	nonadherent	nonadherent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	201	17	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	201	18	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	201	19	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	202	1	Our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	202	2	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	202	3	show	show	VBP
work_tpiqgspaqvfeng2fovbximt4lm	202	4	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	202	5	there	there	EX
work_tpiqgspaqvfeng2fovbximt4lm	202	6	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	202	7	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	202	8	relationship	relationship	NN
work_tpiqgspaqvfeng2fovbximt4lm	202	9	be-	be-	XX
work_tpiqgspaqvfeng2fovbximt4lm	202	10	tween	tween	NN
work_tpiqgspaqvfeng2fovbximt4lm	202	11	CYP2C19	CYP2C19	:
work_tpiqgspaqvfeng2fovbximt4lm	202	12	genotype	genotype	NNP
work_tpiqgspaqvfeng2fovbximt4lm	202	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	202	14	platelet	platelet	JJ
work_tpiqgspaqvfeng2fovbximt4lm	202	15	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	202	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	202	17	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	202	18	absence	absence	NN
work_tpiqgspaqvfeng2fovbximt4lm	202	19	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	202	20	clopido-	clopido-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	202	21	grel	grel	NN
work_tpiqgspaqvfeng2fovbximt4lm	202	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	203	1	Thus	thus	RB
work_tpiqgspaqvfeng2fovbximt4lm	203	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	203	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	203	4	differences	difference	NNS
work_tpiqgspaqvfeng2fovbximt4lm	203	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	203	6	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	7	ag-	ag-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	203	8	gregation	gregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	9	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	203	10	observed	observe	VBD
work_tpiqgspaqvfeng2fovbximt4lm	203	11	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	203	12	geno-	geno-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	203	13	types	type	NNS
work_tpiqgspaqvfeng2fovbximt4lm	203	14	once	once	IN
work_tpiqgspaqvfeng2fovbximt4lm	203	15	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	203	16	treatment	treatment	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	17	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	203	18	initiated	initiate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	203	19	strongly	strongly	RB
work_tpiqgspaqvfeng2fovbximt4lm	203	20	suggest	suggest	VB
work_tpiqgspaqvfeng2fovbximt4lm	203	21	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	203	22	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	203	23	large	large	JJ
work_tpiqgspaqvfeng2fovbximt4lm	203	24	proportion	proportion	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	25	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	203	26	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	203	27	population	population	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	28	did	do	VBD
work_tpiqgspaqvfeng2fovbximt4lm	203	29	in-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	203	30	deed	deed	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	31	adhere	adhere	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	32	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	203	33	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	203	34	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	35	regi-	regi-	NN
work_tpiqgspaqvfeng2fovbximt4lm	203	36	men	man	NNS
work_tpiqgspaqvfeng2fovbximt4lm	203	37	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	204	1	Lastly	lastly	RB
work_tpiqgspaqvfeng2fovbximt4lm	204	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	204	3	owing	owe	VBG
work_tpiqgspaqvfeng2fovbximt4lm	204	4	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	204	5	limitations	limitation	NNS
work_tpiqgspaqvfeng2fovbximt4lm	204	6	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	204	7	sample	sample	NN
work_tpiqgspaqvfeng2fovbximt4lm	204	8	size	size	NN
work_tpiqgspaqvfeng2fovbximt4lm	204	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	204	10	we	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	204	11	could	could	MD
work_tpiqgspaqvfeng2fovbximt4lm	204	12	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	204	13	determine	determine	VB
work_tpiqgspaqvfeng2fovbximt4lm	204	14	if	if	IN
work_tpiqgspaqvfeng2fovbximt4lm	204	15	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	204	16	genotype	genotype	NNP
work_tpiqgspaqvfeng2fovbximt4lm	204	17	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	204	18	related	relate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	204	19	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	204	20	ad-	ad-	CC
work_tpiqgspaqvfeng2fovbximt4lm	204	21	verse	verse	NN
work_tpiqgspaqvfeng2fovbximt4lm	204	22	bleeding	bleed	VBG
work_tpiqgspaqvfeng2fovbximt4lm	204	23	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	204	24	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	205	1	Using	use	VBG
work_tpiqgspaqvfeng2fovbximt4lm	205	2	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	205	3	candidate	candidate	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	4	gene	gene	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	5	approach	approach	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	205	7	Hu-	hu-	UH
work_tpiqgspaqvfeng2fovbximt4lm	205	8	lot	lot	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	9	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	205	10	al22	al22	NNP
work_tpiqgspaqvfeng2fovbximt4lm	205	11	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	205	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	205	13	first	first	JJ
work_tpiqgspaqvfeng2fovbximt4lm	205	14	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	205	15	report	report	VB
work_tpiqgspaqvfeng2fovbximt4lm	205	16	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	205	17	as-	as-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	205	18	sociation	sociation	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	19	between	between	IN
work_tpiqgspaqvfeng2fovbximt4lm	205	20	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	205	21	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	205	22	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	205	23	geno-	geno-	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	24	type	type	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	25	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	205	26	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	205	27	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	205	28	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	205	29	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	30	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	31	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	205	32	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	33	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	205	34	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	205	35	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	206	1	More	more	RBR
work_tpiqgspaqvfeng2fovbximt4lm	206	2	recently	recently	RB
work_tpiqgspaqvfeng2fovbximt4lm	206	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	4	CYP2C19	cyp2c19	VB
work_tpiqgspaqvfeng2fovbximt4lm	206	5	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	206	6	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	7	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	8	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	206	9	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	206	10	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	11	poorer	poor	JJR
work_tpiqgspaqvfeng2fovbximt4lm	206	12	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	13	out-	out-	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	14	comes	come	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	206	15	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	16	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	17	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	18	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	19	artery	artery	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	20	disease	disease	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	21	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	206	22	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	23	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	24	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	206	25	as-	as-	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	26	pirin.18,24	pirin.18,24	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	27	-	-	:
work_tpiqgspaqvfeng2fovbximt4lm	206	28	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	29	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	30	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	31	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	206	32	clopido-	clopido-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	33	grel	grel	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	34	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	206	35	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	36	following	follow	VBG
work_tpiqgspaqvfeng2fovbximt4lm	206	37	myocardial	myocardial	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	38	in-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	39	farction	farction	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	40	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	41	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	42	carrying	carry	VBG
work_tpiqgspaqvfeng2fovbximt4lm	206	43	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	44	CYP2C19	CYP2C19	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	45	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	206	46	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	47	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	48	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	206	49	more	more	RBR
work_tpiqgspaqvfeng2fovbximt4lm	206	50	likely	likely	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	51	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	52	experi-	experi-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	53	ence	ence	VB
work_tpiqgspaqvfeng2fovbximt4lm	206	54	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	55	second	second	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	56	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	57	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	58	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	59	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	60	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	61	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	62	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	206	63	3.69	3.69	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	64	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	206	65	similar	similar	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	66	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	67	that	that	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	68	found	find	VBN
work_tpiqgspaqvfeng2fovbximt4lm	206	69	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	70	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	206	71	study.24	study.24	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	72	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	73	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	74	Therapeutic	therapeutic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	75	Outcomes	Outcomes	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	206	76	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	77	Optimizing	optimize	VBG
work_tpiqgspaqvfeng2fovbximt4lm	206	78	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	79	Inhibition	inhibition	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	80	With	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	81	Pra-	Pra-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	82	sugrel	sugrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	83	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	206	84	Thrombolysis	Thrombolysis	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	85	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	86	Myocardial	Myocardial	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	87	In-	In-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	88	farction	farction	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	89	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	206	90	TRITON	TRITON	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	91	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	206	92	TIMI	TIMI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	93	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	206	94	38	38	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	95	trial	trial	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	96	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	97	pa-	pa-	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	98	tients	tient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	99	carrying	carry	VBG
work_tpiqgspaqvfeng2fovbximt4lm	206	100	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	101	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	102	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	206	103	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	104	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	105	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	206	106	lower	low	JJR
work_tpiqgspaqvfeng2fovbximt4lm	206	107	plasma	plasma	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	108	levels	level	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	109	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	110	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	111	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	112	me-	me-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	113	tabolite	tabolite	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	114	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	115	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	116	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	117	reduced	reduce	VBN
work_tpiqgspaqvfeng2fovbximt4lm	206	118	maxi-	maxi-	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	119	mal	mal	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	120	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	121	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	122	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	123	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	124	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	125	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	126	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	127	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	206	128	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	129	53	53	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	130	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	131	higher	high	JJR
work_tpiqgspaqvfeng2fovbximt4lm	206	132	compos-	compos-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	133	ite	ite	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	134	primary	primary	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	135	efficacy	efficacy	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	136	outcome	outcome	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	137	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	138	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	139	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	140	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	141	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	142	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	143	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	206	144	death.18	death.18	NNP
work_tpiqgspaqvfeng2fovbximt4lm	206	145	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	146	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	147	nationwide	nationwide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	148	French	french	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	149	registry	registry	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	150	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	151	pa-	pa-	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	152	tients	tient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	153	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	154	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	155	myocardial	myocardial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	156	infarction	infarction	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	157	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	206	158	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	159	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	160	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	161	poorer	poor	JJR
work_tpiqgspaqvfeng2fovbximt4lm	206	162	out-	out-	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	163	comes	come	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	206	164	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	206	165	observed	observe	VBN
work_tpiqgspaqvfeng2fovbximt4lm	206	166	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	167	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	168	who	who	WP
work_tpiqgspaqvfeng2fovbximt4lm	206	169	carried	carry	VBD
work_tpiqgspaqvfeng2fovbximt4lm	206	170	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	171	CYP2C19	cyp2c19	VBP
work_tpiqgspaqvfeng2fovbximt4lm	206	172	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	173	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	206	174	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	175	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	206	176	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	177	alleles	allele	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	178	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	206	179	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	180	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	181	1.98).25	1.98).25	CD
work_tpiqgspaqvfeng2fovbximt4lm	206	182	Unlike	unlike	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	183	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	206	184	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	185	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	206	186	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	187	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	188	studies	study	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	189	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	190	heterozygous	heterozygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	191	per-	per-	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	192	sons	son	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	193	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	194	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	195	French	french	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	196	registry	registry	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	197	did	do	VBD
work_tpiqgspaqvfeng2fovbximt4lm	206	198	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	206	199	appear	appear	VB
work_tpiqgspaqvfeng2fovbximt4lm	206	200	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	206	201	have	have	VB
work_tpiqgspaqvfeng2fovbximt4lm	206	202	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	203	significantly	significantly	RB
work_tpiqgspaqvfeng2fovbximt4lm	206	204	increased	increase	VBN
work_tpiqgspaqvfeng2fovbximt4lm	206	205	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	206	rate	rate	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	207	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	206	208	suggesting	suggest	VBG
work_tpiqgspaqvfeng2fovbximt4lm	206	209	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	210	more	more	RBR
work_tpiqgspaqvfeng2fovbximt4lm	206	211	modest	modest	JJ
work_tpiqgspaqvfeng2fovbximt4lm	206	212	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	213	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	214	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	215	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	216	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	217	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	218	re-	re-	RB
work_tpiqgspaqvfeng2fovbximt4lm	206	219	sponse	sponse	NN
work_tpiqgspaqvfeng2fovbximt4lm	206	220	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	206	221	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	206	222	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	206	223	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	207	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	207	2	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	207	3	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	207	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	207	5	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	207	6	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	207	7	CYP2C19	CYP2C19	NNS
work_tpiqgspaqvfeng2fovbximt4lm	207	8	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	207	9	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	207	10	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	207	11	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	207	12	common	common	JJ
work_tpiqgspaqvfeng2fovbximt4lm	207	13	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	207	14	diverse	diverse	JJ
work_tpiqgspaqvfeng2fovbximt4lm	207	15	popu-	popu-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	207	16	lations	lation	NNS
work_tpiqgspaqvfeng2fovbximt4lm	207	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	208	1	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	208	2	white	white	JJ
work_tpiqgspaqvfeng2fovbximt4lm	208	3	populations	population	NNS
work_tpiqgspaqvfeng2fovbximt4lm	208	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	208	5	approxi-	approxi-	VBD
work_tpiqgspaqvfeng2fovbximt4lm	208	6	mately	mately	RB
work_tpiqgspaqvfeng2fovbximt4lm	208	7	24	24	CD
work_tpiqgspaqvfeng2fovbximt4lm	208	8	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	208	9	have	have	VBP
work_tpiqgspaqvfeng2fovbximt4lm	208	10	at	at	RB
work_tpiqgspaqvfeng2fovbximt4lm	208	11	least	least	JJS
work_tpiqgspaqvfeng2fovbximt4lm	208	12	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	208	13	CYP2C19	cyp2c19	VBP
work_tpiqgspaqvfeng2fovbximt4lm	208	14	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	208	15	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	208	16	allele	allele	NNS
work_tpiqgspaqvfeng2fovbximt4lm	208	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	209	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	209	2	frequency	frequency	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	4	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	209	5	allele	allele	NNP
work_tpiqgspaqvfeng2fovbximt4lm	209	6	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	209	7	somewhat	somewhat	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	8	lower	low	JJR
work_tpiqgspaqvfeng2fovbximt4lm	209	9	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	10	Mexican	Mexican	NNP
work_tpiqgspaqvfeng2fovbximt4lm	209	11	Ameri-	Ameri-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	209	12	cans	can	NNS
work_tpiqgspaqvfeng2fovbximt4lm	209	13	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	209	14	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	209	15	18	18	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	16	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	17	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	18	at	at	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	19	least	least	JJS
work_tpiqgspaqvfeng2fovbximt4lm	209	20	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	21	CYP2C19	cyp2c19	VBP
work_tpiqgspaqvfeng2fovbximt4lm	209	22	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	209	23	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	24	allele	allele	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	25	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	209	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	209	27	higher	high	JJR
work_tpiqgspaqvfeng2fovbximt4lm	209	28	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	29	African	African	NNP
work_tpiqgspaqvfeng2fovbximt4lm	209	30	Americans	Americans	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	209	31	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	209	32	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	209	33	33	33	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	34	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	35	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	36	at	at	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	37	least	least	JJS
work_tpiqgspaqvfeng2fovbximt4lm	209	38	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	39	copy	copy	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	40	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	209	41	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	209	42	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	209	43	mark-	mark-	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	44	edly	edly	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	45	higher	higher	RBR
work_tpiqgspaqvfeng2fovbximt4lm	209	46	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	47	Asian	asian	JJ
work_tpiqgspaqvfeng2fovbximt4lm	209	48	populations	population	NNS
work_tpiqgspaqvfeng2fovbximt4lm	209	49	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	209	50	�	�	NNP
work_tpiqgspaqvfeng2fovbximt4lm	209	51	51	51	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	52	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	53	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	54	at	at	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	55	least	least	JJS
work_tpiqgspaqvfeng2fovbximt4lm	209	56	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	57	copy).36	copy).36	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	58	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	209	59	38	38	CD
work_tpiqgspaqvfeng2fovbximt4lm	209	60	Thus	thus	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	61	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	209	62	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	63	resistance	resistance	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	64	due	due	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	65	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	66	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	209	67	vari-	vari-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	209	68	ant	ant	NN
work_tpiqgspaqvfeng2fovbximt4lm	209	69	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	209	70	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	209	71	particularly	particularly	RB
work_tpiqgspaqvfeng2fovbximt4lm	209	72	important	important	JJ
work_tpiqgspaqvfeng2fovbximt4lm	209	73	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	209	74	Asian	asian	JJ
work_tpiqgspaqvfeng2fovbximt4lm	209	75	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	209	76	African	african	JJ
work_tpiqgspaqvfeng2fovbximt4lm	209	77	American	american	JJ
work_tpiqgspaqvfeng2fovbximt4lm	209	78	popula-	popula-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	209	79	tions	tion	NNS
work_tpiqgspaqvfeng2fovbximt4lm	209	80	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	210	1	However	however	RB
work_tpiqgspaqvfeng2fovbximt4lm	210	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	210	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	210	4	strength	strength	NN
work_tpiqgspaqvfeng2fovbximt4lm	210	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	210	6	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	210	7	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	210	8	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	210	9	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	210	10	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	210	11	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	210	12	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	210	13	clopido-	clopido-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	210	14	grel	grel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	210	15	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	210	16	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	210	17	depend	depend	VB
work_tpiqgspaqvfeng2fovbximt4lm	210	18	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	210	19	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	210	20	fac-	fac-	NN
work_tpiqgspaqvfeng2fovbximt4lm	210	21	tors	tor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	210	22	such	such	JJ
work_tpiqgspaqvfeng2fovbximt4lm	210	23	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	210	24	genetic	genetic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	210	25	background	background	NN
work_tpiqgspaqvfeng2fovbximt4lm	210	26	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	210	27	en-	en-	NN
work_tpiqgspaqvfeng2fovbximt4lm	210	28	vironmental	vironmental	JJ
work_tpiqgspaqvfeng2fovbximt4lm	210	29	exposures	exposure	NNS
work_tpiqgspaqvfeng2fovbximt4lm	210	30	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	210	31	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	210	32	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	210	33	differ	differ	VB
work_tpiqgspaqvfeng2fovbximt4lm	210	34	among	among	IN
work_tpiqgspaqvfeng2fovbximt4lm	210	35	ethnic	ethnic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	210	36	groups	group	NNS
work_tpiqgspaqvfeng2fovbximt4lm	210	37	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	211	1	Unfortu-	Unfortu-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	211	2	nately	nately	RB
work_tpiqgspaqvfeng2fovbximt4lm	211	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	211	4	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	211	5	sample	sample	NN
work_tpiqgspaqvfeng2fovbximt4lm	211	6	size	size	NN
work_tpiqgspaqvfeng2fovbximt4lm	211	7	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	211	8	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	211	9	suffi-	suffi-	VBG
work_tpiqgspaqvfeng2fovbximt4lm	211	10	cient	cient	NN
work_tpiqgspaqvfeng2fovbximt4lm	211	11	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	211	12	examine	examine	VB
work_tpiqgspaqvfeng2fovbximt4lm	211	13	ethnicity	ethnicity	NN
work_tpiqgspaqvfeng2fovbximt4lm	211	14	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	211	15	specific	specific	NN
work_tpiqgspaqvfeng2fovbximt4lm	211	16	dif-	dif-	DT
work_tpiqgspaqvfeng2fovbximt4lm	211	17	Figure	figure	NN
work_tpiqgspaqvfeng2fovbximt4lm	211	18	4	4	CD
work_tpiqgspaqvfeng2fovbximt4lm	211	19	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	212	1	Event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	212	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	212	3	Free	free	JJ
work_tpiqgspaqvfeng2fovbximt4lm	212	4	Survival	survival	NN
work_tpiqgspaqvfeng2fovbximt4lm	212	5	Over	over	IN
work_tpiqgspaqvfeng2fovbximt4lm	212	6	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	7	Year	Year	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	8	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	212	9	Follow	Follow	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	10	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	212	11	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	212	12	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	212	13	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	14	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	212	16	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	17	Patients	Patients	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	212	18	Treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	212	19	With	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	212	20	Clopidogrel	Clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	21	Following	follow	VBG
work_tpiqgspaqvfeng2fovbximt4lm	212	22	Percutaneous	Percutaneous	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	23	Coronary	Coronary	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	24	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	212	26	Stratified	stratify	VBN
work_tpiqgspaqvfeng2fovbximt4lm	212	27	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	212	28	CYP2C19	CYP2C19	NNS
work_tpiqgspaqvfeng2fovbximt4lm	212	29	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	212	30	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	31	Genotype	Genotype	NNP
work_tpiqgspaqvfeng2fovbximt4lm	212	32	50	50	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	33	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	34	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	35	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	36	30	30	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	37	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	38	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	39	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	212	40	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	212	41	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	213	1	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	213	2	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	213	3	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	213	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	214	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	214	2	CYP2C19∗2	CYP2C19∗2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	214	3	alleles	allele	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	214	4	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	5	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	6	158	158	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	7	67	67	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	8	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	9	154	154	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	10	Days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	214	11	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	214	12	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	214	13	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	214	14	E	e	NN
work_tpiqgspaqvfeng2fovbximt4lm	214	15	xp	xp	NN
work_tpiqgspaqvfeng2fovbximt4lm	214	16	er	er	UH
work_tpiqgspaqvfeng2fovbximt4lm	214	17	ie	ie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	214	18	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	214	19	ci	ci	NNP
work_tpiqgspaqvfeng2fovbximt4lm	214	20	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	214	21	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	214	22	E	e	NN
work_tpiqgspaqvfeng2fovbximt4lm	214	23	ve	ve	NN
work_tpiqgspaqvfeng2fovbximt4lm	214	24	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	214	25	t	t	NN
work_tpiqgspaqvfeng2fovbximt4lm	214	26	270	270	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	27	144	144	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	28	180	180	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	29	150	150	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	30	360	360	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	31	143	143	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	32	61	61	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	33	5356	5356	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	34	50	50	CD
work_tpiqgspaqvfeng2fovbximt4lm	214	35	No	no	NN
work_tpiqgspaqvfeng2fovbximt4lm	214	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	215	1	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	2	CYP2C19∗2	CYP2C19∗2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	3	alleles	allele	NNS
work_tpiqgspaqvfeng2fovbximt4lm	215	4	0	0	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	5	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	6	92	92	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	7	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	8	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	9	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	10	Days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	215	11	Patients	Patients	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	215	12	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	215	13	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	215	14	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	15	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	16	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	17	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	18	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	19	270	270	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	20	87	87	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	21	180	180	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	22	88	88	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	23	360	360	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	24	86	86	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	25	38	38	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	26	3638	3638	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	27	33	33	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	28	66	66	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	29	27	27	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	30	90	90	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	31	Days	day	NNS
work_tpiqgspaqvfeng2fovbximt4lm	215	32	Patients	Patients	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	215	33	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	215	34	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	35	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	36	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	37	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	38	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	39	270180	270180	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	40	360	360	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	41	64	64	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	42	5862	5862	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	43	57	57	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	44	23	23	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	45	1718	1718	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	46	16	16	CD
work_tpiqgspaqvfeng2fovbximt4lm	215	47	Postdischarge	Postdischarge	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	48	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	49	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	215	50	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	215	51	defined	define	VBN
work_tpiqgspaqvfeng2fovbximt4lm	215	52	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	53	myocardial	myocardial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	54	infarction	infarction	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	55	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	56	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	215	57	occurrence	occurrence	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	58	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	59	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	60	symptoms	symptom	NNS
work_tpiqgspaqvfeng2fovbximt4lm	215	61	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	215	62	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	215	63	troponin	troponin	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	64	I	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	215	65	value	value	VBP
work_tpiqgspaqvfeng2fovbximt4lm	215	66	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	215	67	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	68	upper	upper	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	69	limits	limit	NNS
work_tpiqgspaqvfeng2fovbximt4lm	215	70	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	71	normal	normal	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	72	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	73	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	215	74	ischemic	ischemic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	75	stroke	stroke	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	76	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	215	77	stent	stent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	78	thrombosis	thrombosis	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	79	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	80	definite	definite	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	81	stent	stent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	82	thrombosis	thrombosis	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	83	according	accord	VBG
work_tpiqgspaqvfeng2fovbximt4lm	215	84	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	85	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	215	86	Academic	Academic	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	87	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	88	Consortium	Consortium	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	89	criteria29	criteria29	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	90	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	91	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	215	92	unplanned	unplanned	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	93	target	target	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	94	vessel	vessel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	95	revasculariza-	revasculariza-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	96	tion	tion	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	97	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	98	revascularization	revascularization	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	99	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	100	vessel	vessel	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	101	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	215	102	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	103	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	104	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	105	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	106	enrollment	enrollment	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	107	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	108	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	215	109	unplanned	unplanned	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	110	nontarget	nontarget	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	111	vessel	vessel	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	112	revascular-	revascular-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	113	ization	ization	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	114	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	115	revascularization	revascularization	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	116	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	117	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	215	118	vessel	vessel	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	119	different	different	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	120	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	121	that	that	DT
work_tpiqgspaqvfeng2fovbximt4lm	215	122	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	215	123	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	124	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	125	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	126	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	127	enrollment	enrollment	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	128	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	129	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	215	130	hospitalization	hospitalization	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	131	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	132	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	133	ischemia	ischemia	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	134	without	without	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	135	revascularization	revascularization	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	136	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	137	hospitalization	hospitalization	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	138	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	139	chest	chest	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	140	pain	pain	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	141	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	142	evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	143	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	144	ischemia	ischemia	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	145	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	146	electrocardiogram	electrocardiogram	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	147	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	215	148	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	215	149	evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	150	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	151	myocardial	myocardial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	152	infarction	infarction	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	153	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	154	measured	measure	VBN
work_tpiqgspaqvfeng2fovbximt4lm	215	155	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	156	troponin	troponin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	215	157	I	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	215	158	value	value	VBP
work_tpiqgspaqvfeng2fovbximt4lm	215	159	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	215	160	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	215	161	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	215	162	death	death	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	163	sec-	sec-	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	164	ondary	ondary	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	165	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	215	166	any	any	DT
work_tpiqgspaqvfeng2fovbximt4lm	215	167	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	215	168	cause	cause	NN
work_tpiqgspaqvfeng2fovbximt4lm	215	169	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	216	1	Patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	216	2	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	216	3	further	further	RB
work_tpiqgspaqvfeng2fovbximt4lm	216	4	stratified	stratify	VBN
work_tpiqgspaqvfeng2fovbximt4lm	216	5	into	into	IN
work_tpiqgspaqvfeng2fovbximt4lm	216	6	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	216	7	who	who	WP
work_tpiqgspaqvfeng2fovbximt4lm	216	8	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	216	9	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	216	10	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	216	11	when	when	WRB
work_tpiqgspaqvfeng2fovbximt4lm	216	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	216	13	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	216	14	occurred	occur	VBD
work_tpiqgspaqvfeng2fovbximt4lm	216	15	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	216	16	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	216	17	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	216	18	year	year	NN
work_tpiqgspaqvfeng2fovbximt4lm	216	19	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	216	20	follow	follow	NN
work_tpiqgspaqvfeng2fovbximt4lm	216	21	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	216	22	up	up	NN
work_tpiqgspaqvfeng2fovbximt4lm	216	23	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	216	24	those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	216	25	who	who	WP
work_tpiqgspaqvfeng2fovbximt4lm	216	26	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	216	27	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	216	28	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	217	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	217	2	analyses	analysis	NNS
work_tpiqgspaqvfeng2fovbximt4lm	217	3	adjusted	adjust	VBN
work_tpiqgspaqvfeng2fovbximt4lm	217	4	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	217	5	age	age	NN
work_tpiqgspaqvfeng2fovbximt4lm	217	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	217	7	sex	sex	NN
work_tpiqgspaqvfeng2fovbximt4lm	217	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	217	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	217	10	race	race	NN
work_tpiqgspaqvfeng2fovbximt4lm	217	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	218	1	For	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	218	2	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	218	3	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	218	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	218	5	hazard	hazard	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	6	ratio	ratio	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	7	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	8	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	9	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	10	=	=	NFP
work_tpiqgspaqvfeng2fovbximt4lm	218	11	2.42	2.42	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	12	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	13	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	14	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	15	confidence	confidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	16	interval	interval	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	17	[	[	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	18	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	218	19	]	]	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	218	21	1.18	1.18	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	22	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	23	4.99	4.99	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	24	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	218	25	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	26	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	27	.02	.02	NFP
work_tpiqgspaqvfeng2fovbximt4lm	218	28	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	29	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	218	30	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	218	31	pa-	pa-	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	32	tients	tient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	218	33	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	218	34	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	35	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	218	36	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	37	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	218	38	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	39	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	218	40	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	41	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	42	3.40	3.40	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	43	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	44	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	45	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	46	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	218	47	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	218	48	1.36	1.36	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	49	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	50	8.46	8.46	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	51	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	218	52	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	53	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	54	.004	.004	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	55	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	56	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	218	57	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	218	58	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	218	59	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	218	60	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	218	61	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	62	pidogrel	pidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	63	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	218	64	time	time	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	65	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	218	66	event	event	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	67	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	218	68	HR	hr	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	69	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	70	1.39	1.39	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	71	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	72	95	95	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	73	%	%	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	74	CI	CI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	218	75	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	218	76	0.39	0.39	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	77	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	78	4.88	4.88	CD
work_tpiqgspaqvfeng2fovbximt4lm	218	79	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	218	80	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	218	81	=	=	SYM
work_tpiqgspaqvfeng2fovbximt4lm	218	82	.60	.60	NFP
work_tpiqgspaqvfeng2fovbximt4lm	218	83	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	218	84	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	219	1	CYTOCHROME	cytochrome	VB
work_tpiqgspaqvfeng2fovbximt4lm	219	2	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	219	3	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	219	4	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	219	5	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	219	6	CLOPIDOGREL	CLOPIDOGREL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	219	7	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	219	8	856	856	CD
work_tpiqgspaqvfeng2fovbximt4lm	219	9	JAMA	JAMA	NNS
work_tpiqgspaqvfeng2fovbximt4lm	219	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	219	11	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	219	12	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	219	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	219	14	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	219	15	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	219	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	219	17	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	219	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	220	1	8	8	LS
work_tpiqgspaqvfeng2fovbximt4lm	220	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	220	3	Reprinted	Reprinted	NNP
work_tpiqgspaqvfeng2fovbximt4lm	220	4	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	220	5	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	220	6	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	220	7	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	220	8	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	220	9	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	220	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	221	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	221	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	221	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	221	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	222	1	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	222	2	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	222	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	222	4	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	222	5	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	222	6	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	222	7	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	222	8	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	222	9	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	222	10	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	222	11	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	222	12	04/05/2021	04/05/2021	CD
work_tpiqgspaqvfeng2fovbximt4lm	222	13	ferences	ference	NNS
work_tpiqgspaqvfeng2fovbximt4lm	222	14	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	222	15	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	222	16	genotype	genotype	NNP
work_tpiqgspaqvfeng2fovbximt4lm	222	17	effects	effect	NNS
work_tpiqgspaqvfeng2fovbximt4lm	222	18	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	222	19	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	222	20	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	222	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	223	1	Additional	additional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	223	2	studies	study	NNS
work_tpiqgspaqvfeng2fovbximt4lm	223	3	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	223	4	diverse	diverse	JJ
work_tpiqgspaqvfeng2fovbximt4lm	223	5	populations	population	NNS
work_tpiqgspaqvfeng2fovbximt4lm	223	6	will	will	MD
work_tpiqgspaqvfeng2fovbximt4lm	223	7	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	223	8	necessary	necessary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	223	9	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	224	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	2	commonly	commonly	RB
work_tpiqgspaqvfeng2fovbximt4lm	224	3	prescribed	prescribe	VBN
work_tpiqgspaqvfeng2fovbximt4lm	224	4	proton	proton	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	5	pump	pump	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	6	inhibitors	inhibitor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	224	7	omeprazole	omeprazole	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	8	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	224	9	esomeprazole	esomeprazole	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	224	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	224	12	some	some	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	13	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	14	medica-	medica-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	15	tions	tion	NNS
work_tpiqgspaqvfeng2fovbximt4lm	224	16	commonly	commonly	RB
work_tpiqgspaqvfeng2fovbximt4lm	224	17	coprescribed	coprescribe	VBN
work_tpiqgspaqvfeng2fovbximt4lm	224	18	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	19	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	20	pidogrel	pidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	224	22	such	such	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	23	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	24	cimetidine	cimetidine	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	25	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	224	26	fluoxi-	fluoxi-	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	27	tine	tine	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	28	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	224	29	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	224	30	potent	potent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	31	inhibitors	inhibitor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	224	32	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	33	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	34	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	224	35	introducing	introduce	VBG
work_tpiqgspaqvfeng2fovbximt4lm	224	36	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	37	possibility	possibility	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	38	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	39	they	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	224	40	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	224	41	attenuate	attenuate	VB
work_tpiqgspaqvfeng2fovbximt4lm	224	42	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	43	antiplatelet	antiplatelet	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	44	activity	activity	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	45	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	46	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	47	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	224	48	especially	especially	RB
work_tpiqgspaqvfeng2fovbximt4lm	224	49	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	50	individuals	individual	NNS
work_tpiqgspaqvfeng2fovbximt4lm	224	51	heterozygous	heterozygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	52	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	224	53	homozygous	homozygous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	54	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	55	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	56	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	57	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	224	58	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	224	59	genotype.14,39	genotype.14,39	CD
work_tpiqgspaqvfeng2fovbximt4lm	224	60	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	224	61	41	41	CD
work_tpiqgspaqvfeng2fovbximt4lm	224	62	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	224	63	could	could	MD
work_tpiqgspaqvfeng2fovbximt4lm	224	64	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	224	65	test	test	VB
work_tpiqgspaqvfeng2fovbximt4lm	224	66	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	67	hypothesis	hypothesis	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	68	directly	directly	RB
work_tpiqgspaqvfeng2fovbximt4lm	224	69	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	224	70	be-	be-	XX
work_tpiqgspaqvfeng2fovbximt4lm	224	71	cause	cause	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	72	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	73	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	224	74	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	75	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	76	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	77	PAPI	PAPI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	78	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	79	were	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	224	80	drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	81	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	224	82	naive	naive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	83	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	224	84	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	224	85	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	86	num-	num-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	87	ber	ber	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	88	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	89	participants	participant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	224	90	taking	take	VBG
work_tpiqgspaqvfeng2fovbximt4lm	224	91	proton	proton	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	92	pump	pump	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	93	inhibitors	inhibitor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	224	94	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	95	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	224	96	Sinai	Sinai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	97	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	98	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	224	99	Bal-	Bal-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	224	100	timore	timore	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	101	sample	sample	NN
work_tpiqgspaqvfeng2fovbximt4lm	224	102	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	224	103	too	too	RB
work_tpiqgspaqvfeng2fovbximt4lm	224	104	small	small	JJ
work_tpiqgspaqvfeng2fovbximt4lm	224	105	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	225	1	CYP2C19	CYP2C19	:
work_tpiqgspaqvfeng2fovbximt4lm	225	2	genotype	genotype	NNP
work_tpiqgspaqvfeng2fovbximt4lm	225	3	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	225	4	prove	prove	VB
work_tpiqgspaqvfeng2fovbximt4lm	225	5	use-	use-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	225	6	ful	ful	JJ
work_tpiqgspaqvfeng2fovbximt4lm	225	7	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	225	8	helping	help	VBG
work_tpiqgspaqvfeng2fovbximt4lm	225	9	clinicians	clinician	NNS
work_tpiqgspaqvfeng2fovbximt4lm	225	10	choose	choose	VB
work_tpiqgspaqvfeng2fovbximt4lm	225	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	225	12	most	most	RBS
work_tpiqgspaqvfeng2fovbximt4lm	225	13	effective	effective	JJ
work_tpiqgspaqvfeng2fovbximt4lm	225	14	antiplatelet	antiplatelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	225	15	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	225	16	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	225	17	dose	dose	VBD
work_tpiqgspaqvfeng2fovbximt4lm	225	18	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	225	19	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	225	20	given	give	VBN
work_tpiqgspaqvfeng2fovbximt4lm	225	21	individual	individual	NN
work_tpiqgspaqvfeng2fovbximt4lm	225	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	226	1	Those	those	DT
work_tpiqgspaqvfeng2fovbximt4lm	226	2	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	226	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	226	4	CYP2C19	cyp2c19	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	5	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	226	6	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	226	7	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	8	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	226	9	benefit	benefit	VB
work_tpiqgspaqvfeng2fovbximt4lm	226	10	more	more	RBR
work_tpiqgspaqvfeng2fovbximt4lm	226	11	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	226	12	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	226	13	antiplatelet	antiplatelet	FW
work_tpiqgspaqvfeng2fovbximt4lm	226	14	regi-	regi-	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	15	men	man	NNS
work_tpiqgspaqvfeng2fovbximt4lm	226	16	that	that	WDT
work_tpiqgspaqvfeng2fovbximt4lm	226	17	does	do	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	226	18	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	226	19	include	include	VB
work_tpiqgspaqvfeng2fovbximt4lm	226	20	clopido-	clopido-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	226	21	grel	grel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	226	22	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	226	23	such	such	JJ
work_tpiqgspaqvfeng2fovbximt4lm	226	24	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	226	25	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	226	26	third	third	JJ
work_tpiqgspaqvfeng2fovbximt4lm	226	27	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	226	28	generation	generation	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	29	thienopyridine	thienopyridine	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	30	prasugrel	prasugrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	226	32	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	226	33	ticagrelor	ticagrelor	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	34	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	226	35	cangrelor	cangrelor	NN
work_tpiqgspaqvfeng2fovbximt4lm	226	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	227	1	Like	like	IN
work_tpiqgspaqvfeng2fovbximt4lm	227	2	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	227	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	227	4	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	227	5	agents	agent	NNS
work_tpiqgspaqvfeng2fovbximt4lm	227	6	inhibit	inhibit	VBP
work_tpiqgspaqvfeng2fovbximt4lm	227	7	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	227	8	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	227	9	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	227	10	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	227	11	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	227	12	but	but	CC
work_tpiqgspaqvfeng2fovbximt4lm	227	13	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	227	14	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	227	15	as	as	RB
work_tpiqgspaqvfeng2fovbximt4lm	227	16	dependent	dependent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	227	17	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	227	18	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	227	19	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	227	20	activation	activation	NN
work_tpiqgspaqvfeng2fovbximt4lm	227	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	228	1	Genotype-	Genotype-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	228	2	directed	direct	VBD
work_tpiqgspaqvfeng2fovbximt4lm	228	3	decisions	decision	NNS
work_tpiqgspaqvfeng2fovbximt4lm	228	4	regarding	regard	VBG
work_tpiqgspaqvfeng2fovbximt4lm	228	5	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	228	6	antiplatelet	antiplatelet	DT
work_tpiqgspaqvfeng2fovbximt4lm	228	7	agent	agent	NN
work_tpiqgspaqvfeng2fovbximt4lm	228	8	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	228	9	use	use	VB
work_tpiqgspaqvfeng2fovbximt4lm	228	10	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	228	11	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	228	12	specific	specific	JJ
work_tpiqgspaqvfeng2fovbximt4lm	228	13	patient	patient	NN
work_tpiqgspaqvfeng2fovbximt4lm	228	14	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	228	15	also	also	RB
work_tpiqgspaqvfeng2fovbximt4lm	228	16	have	have	VB
work_tpiqgspaqvfeng2fovbximt4lm	228	17	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	228	18	important	important	JJ
work_tpiqgspaqvfeng2fovbximt4lm	228	19	economic	economic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	228	20	impact	impact	NN
work_tpiqgspaqvfeng2fovbximt4lm	228	21	if	if	IN
work_tpiqgspaqvfeng2fovbximt4lm	228	22	costs	cost	NNS
work_tpiqgspaqvfeng2fovbximt4lm	228	23	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	228	24	equally	equally	RB
work_tpiqgspaqvfeng2fovbximt4lm	228	25	efficacious	efficacious	JJ
work_tpiqgspaqvfeng2fovbximt4lm	228	26	medications	medication	NNS
work_tpiqgspaqvfeng2fovbximt4lm	228	27	differ	differ	VBP
work_tpiqgspaqvfeng2fovbximt4lm	228	28	greatly	greatly	RB
work_tpiqgspaqvfeng2fovbximt4lm	228	29	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	229	1	Whether	whether	IN
work_tpiqgspaqvfeng2fovbximt4lm	229	2	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	229	3	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	229	4	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	229	5	carriers	carrier	NNS
work_tpiqgspaqvfeng2fovbximt4lm	229	6	may	may	MD
work_tpiqgspaqvfeng2fovbximt4lm	229	7	benefit	benefit	VB
work_tpiqgspaqvfeng2fovbximt4lm	229	8	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	229	9	increased	increase	VBN
work_tpiqgspaqvfeng2fovbximt4lm	229	10	dosing	dosing	NN
work_tpiqgspaqvfeng2fovbximt4lm	229	11	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	229	12	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	229	13	pidogrel	pidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	229	14	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	229	15	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	229	16	yet	yet	RB
work_tpiqgspaqvfeng2fovbximt4lm	229	17	known	know	VBN
work_tpiqgspaqvfeng2fovbximt4lm	229	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	230	1	CONCLUSIONS	conclusion	NNS
work_tpiqgspaqvfeng2fovbximt4lm	230	2	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	230	3	report	report	VBP
work_tpiqgspaqvfeng2fovbximt4lm	230	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	230	5	first	first	JJ
work_tpiqgspaqvfeng2fovbximt4lm	230	6	genome	genome	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	7	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	230	8	wide	wide	JJ
work_tpiqgspaqvfeng2fovbximt4lm	230	9	asso-	asso-	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	10	ciation	ciation	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	11	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	12	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	230	13	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	230	14	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	15	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	230	16	show	show	VBP
work_tpiqgspaqvfeng2fovbximt4lm	230	17	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	230	18	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	230	19	common	common	JJ
work_tpiqgspaqvfeng2fovbximt4lm	230	20	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	21	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	230	22	of-	of-	CD
work_tpiqgspaqvfeng2fovbximt4lm	230	23	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	24	CYP2C19	cyp2c19	VB
work_tpiqgspaqvfeng2fovbximt4lm	230	25	*	*	NFP
work_tpiqgspaqvfeng2fovbximt4lm	230	26	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	230	27	variant	variant	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	28	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	230	29	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	230	30	ma-	ma-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	230	31	jor	jor	NNP
work_tpiqgspaqvfeng2fovbximt4lm	230	32	determinant	determinant	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	33	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	230	34	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	230	35	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	230	36	stimulated	stimulate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	230	37	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	38	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	230	39	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	231	1	Individuals	individual	NNS
work_tpiqgspaqvfeng2fovbximt4lm	231	2	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	231	3	this	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	231	4	genotype	genotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	231	5	have	have	VBP
work_tpiqgspaqvfeng2fovbximt4lm	231	6	reduced	reduce	VBN
work_tpiqgspaqvfeng2fovbximt4lm	231	7	protec-	protec-	IN
work_tpiqgspaqvfeng2fovbximt4lm	231	8	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	231	9	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	231	10	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	231	11	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	231	12	preventing	prevent	VBG
work_tpiqgspaqvfeng2fovbximt4lm	231	13	car-	car-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	231	14	diovascular	diovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	231	15	disease	disease	NN
work_tpiqgspaqvfeng2fovbximt4lm	231	16	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	231	17	related	related	JJ
work_tpiqgspaqvfeng2fovbximt4lm	231	18	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	231	19	fol-	fol-	VBP
work_tpiqgspaqvfeng2fovbximt4lm	231	20	lowing	low	VBG
work_tpiqgspaqvfeng2fovbximt4lm	231	21	PCI	PCI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	231	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	232	1	Prospective	prospective	JJ
work_tpiqgspaqvfeng2fovbximt4lm	232	2	randomized	randomized	JJ
work_tpiqgspaqvfeng2fovbximt4lm	232	3	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	232	4	trials	trial	NNS
work_tpiqgspaqvfeng2fovbximt4lm	232	5	will	will	MD
work_tpiqgspaqvfeng2fovbximt4lm	232	6	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	232	7	necessary	necessary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	232	8	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	232	9	de-	de-	VB
work_tpiqgspaqvfeng2fovbximt4lm	232	10	termine	termine	VB
work_tpiqgspaqvfeng2fovbximt4lm	232	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	232	12	efficacy	efficacy	NN
work_tpiqgspaqvfeng2fovbximt4lm	232	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	232	14	CYP2C19	CYP2C19	:
work_tpiqgspaqvfeng2fovbximt4lm	232	15	geno-	geno-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	232	16	type	type	NN
work_tpiqgspaqvfeng2fovbximt4lm	232	17	–	–	:
work_tpiqgspaqvfeng2fovbximt4lm	232	18	directed	direct	VBD
work_tpiqgspaqvfeng2fovbximt4lm	232	19	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	232	20	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	232	21	evidence-	evidence-	FW
work_tpiqgspaqvfeng2fovbximt4lm	232	22	based	base	VBN
work_tpiqgspaqvfeng2fovbximt4lm	232	23	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	232	24	decision	decision	NN
work_tpiqgspaqvfeng2fovbximt4lm	232	25	making	make	VBG
work_tpiqgspaqvfeng2fovbximt4lm	232	26	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	233	1	Author	author	NN
work_tpiqgspaqvfeng2fovbximt4lm	233	2	Contributions	contribution	NNS
work_tpiqgspaqvfeng2fovbximt4lm	233	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	233	4	Drs	Drs	NNP
work_tpiqgspaqvfeng2fovbximt4lm	233	5	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	233	6	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	233	7	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	233	8	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	233	9	full	full	JJ
work_tpiqgspaqvfeng2fovbximt4lm	233	10	access	access	NN
work_tpiqgspaqvfeng2fovbximt4lm	233	11	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	233	12	all	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	233	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	233	14	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	233	15	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	233	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	233	17	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	233	18	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	233	19	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	233	20	take	take	VB
work_tpiqgspaqvfeng2fovbximt4lm	233	21	re-	re-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	233	22	sponsibility	sponsibility	NN
work_tpiqgspaqvfeng2fovbximt4lm	233	23	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	233	24	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	233	25	integrity	integrity	NN
work_tpiqgspaqvfeng2fovbximt4lm	233	26	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	233	27	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	233	28	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	233	29	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	233	30	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	233	31	ac-	ac-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	233	32	curacy	curacy	NN
work_tpiqgspaqvfeng2fovbximt4lm	233	33	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	233	34	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	233	35	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	233	36	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	233	37	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	234	1	Study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	234	2	concept	concept	NN
work_tpiqgspaqvfeng2fovbximt4lm	234	3	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	234	4	design	design	NN
work_tpiqgspaqvfeng2fovbximt4lm	234	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	234	6	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	234	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	234	8	Post	Post	NNP
work_tpiqgspaqvfeng2fovbximt4lm	234	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	234	10	Faraday	Faraday	NNP
work_tpiqgspaqvfeng2fovbximt4lm	234	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	234	12	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	234	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	234	14	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	234	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	235	1	Acquisition	acquisition	NN
work_tpiqgspaqvfeng2fovbximt4lm	235	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	235	3	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	235	4	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	235	5	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	7	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	9	Gandhi	Gandhi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	11	Horenstein	Horenstein	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	13	Damcott	Damcott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	15	Pakyz	Pakyz	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	17	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	19	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	235	21	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	235	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	236	1	Analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	236	2	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	236	3	interpretation	interpretation	NN
work_tpiqgspaqvfeng2fovbximt4lm	236	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	236	5	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	236	6	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	236	7	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	9	O’Connell	O’Connell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	11	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	13	Ryan	Ryan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	15	Damcott	Damcott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	17	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	19	Gibson	Gibson	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	21	Pollin	Pollin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	22	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	23	Post	Post	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	24	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	25	Parsa	Parsa	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	27	Mitchell	Mitchell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	28	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	29	Faraday	Faraday	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	30	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	31	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	32	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	236	33	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	236	34	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	237	1	Drafting	draft	VBG
work_tpiqgspaqvfeng2fovbximt4lm	237	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	237	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	237	4	manuscript	manuscript	NN
work_tpiqgspaqvfeng2fovbximt4lm	237	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	237	6	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	237	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	237	8	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	237	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	237	10	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	237	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	237	12	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	237	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	237	14	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	237	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	238	1	Critical	critical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	238	2	revision	revision	NN
work_tpiqgspaqvfeng2fovbximt4lm	238	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	238	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	238	5	manuscript	manuscript	NN
work_tpiqgspaqvfeng2fovbximt4lm	238	6	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	238	7	important	important	JJ
work_tpiqgspaqvfeng2fovbximt4lm	238	8	in-	in-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	238	9	tellectual	tellectual	JJ
work_tpiqgspaqvfeng2fovbximt4lm	238	10	content	content	NN
work_tpiqgspaqvfeng2fovbximt4lm	238	11	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	238	12	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	14	O’Connell	O’Connell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	16	Gandhi	Gandhi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	17	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	18	Ryan	Ryan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	19	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	20	Horenstein	Horenstein	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	22	Damcott	Damcott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	24	Pakyz	Pakyz	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	26	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	27	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	28	Gibson	Gibson	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	29	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	30	Pollin	Pollin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	31	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	32	Post	Post	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	33	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	34	Parsa	Parsa	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	36	Mitchell	Mitchell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	38	Faraday	Faraday	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	39	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	40	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	41	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	238	42	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	238	43	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	239	1	Statistical	statistical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	239	2	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	239	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	239	4	O’Connell	O’Connell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	239	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	239	6	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	239	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	239	8	Mitchell	Mitchell	NNP
work_tpiqgspaqvfeng2fovbximt4lm	239	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	239	10	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	239	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	240	1	Obtained	obtain	VBN
work_tpiqgspaqvfeng2fovbximt4lm	240	2	funding	funding	NN
work_tpiqgspaqvfeng2fovbximt4lm	240	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	240	4	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	240	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	240	6	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	240	7	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	241	1	Administrative	administrative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	241	2	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	3	technical	technical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	241	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	5	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	241	6	material	material	NN
work_tpiqgspaqvfeng2fovbximt4lm	241	7	support	support	NN
work_tpiqgspaqvfeng2fovbximt4lm	241	8	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	241	9	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	11	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	13	Ryan	Ryan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	14	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	15	Damcott	Damcott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	16	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	17	Pakyz	Pakyz	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	19	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	21	Gibson	Gibson	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	22	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	23	Herzog	Herzog	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	24	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	241	25	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	241	26	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	242	1	Study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	242	2	supervision	supervision	NN
work_tpiqgspaqvfeng2fovbximt4lm	242	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	242	4	Shuldiner	Shuldiner	NNP
work_tpiqgspaqvfeng2fovbximt4lm	242	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	242	6	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	242	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	242	8	Faraday	Faraday	NNP
work_tpiqgspaqvfeng2fovbximt4lm	242	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	242	10	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	242	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	243	1	Financial	financial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	243	2	Disclosures	disclosure	NNS
work_tpiqgspaqvfeng2fovbximt4lm	243	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	243	4	Dr	Dr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	243	5	Faraday	Faraday	NNP
work_tpiqgspaqvfeng2fovbximt4lm	243	6	reported	report	VBD
work_tpiqgspaqvfeng2fovbximt4lm	243	7	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	243	8	he	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	243	9	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	243	10	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	243	11	coinventor	coinventor	NN
work_tpiqgspaqvfeng2fovbximt4lm	243	12	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	243	13	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	243	14	patent	patent	NN
work_tpiqgspaqvfeng2fovbximt4lm	243	15	application	application	NN
work_tpiqgspaqvfeng2fovbximt4lm	243	16	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	243	17	novel	novel	JJ
work_tpiqgspaqvfeng2fovbximt4lm	243	18	anti-	anti-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	243	19	thrombotic	thrombotic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	243	20	agents	agent	NNS
work_tpiqgspaqvfeng2fovbximt4lm	243	21	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	243	22	their	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	243	23	methods	method	NNS
work_tpiqgspaqvfeng2fovbximt4lm	243	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	243	25	use	use	NN
work_tpiqgspaqvfeng2fovbximt4lm	243	26	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	244	1	Dr	Dr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	2	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	3	reported	report	VBD
work_tpiqgspaqvfeng2fovbximt4lm	244	4	receiving	receive	VBG
work_tpiqgspaqvfeng2fovbximt4lm	244	5	grant	grant	NN
work_tpiqgspaqvfeng2fovbximt4lm	244	6	support	support	NN
work_tpiqgspaqvfeng2fovbximt4lm	244	7	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	244	8	Schering-	Schering-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	9	Plough	Plough	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	11	AstraZeneca	AstraZeneca	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	13	Bayer	Bayer	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	14	Healthcare	Healthcare	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	16	Sanofi-	Sanofi-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	17	Aventis	Aventis	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	19	Portola	Portola	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	20	Pharmaceuticals	Pharmaceuticals	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	244	21	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	22	Daiichi	Daiichi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	23	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	244	24	Sankyo	Sankyo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	26	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	244	27	Lilly	Lilly	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	28	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	244	29	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	244	30	receiving	receive	VBG
work_tpiqgspaqvfeng2fovbximt4lm	244	31	honoraria	honoraria	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	32	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	244	33	consulting	consult	VBG
work_tpiqgspaqvfeng2fovbximt4lm	244	34	income	income	NN
work_tpiqgspaqvfeng2fovbximt4lm	244	35	from	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	244	36	Schering	Schering	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	37	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	244	38	Plough	Plough	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	39	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	40	AstraZeneca	AstraZeneca	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	41	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	42	Bayer	Bayer	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	43	Healthcare	Healthcare	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	44	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	45	Sanofi	Sanofi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	46	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	244	47	Aventis	Aventis	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	48	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	49	Portola	Portola	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	50	Pharmaceuticals	Pharmaceuticals	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	244	51	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	52	Daiichi-	Daiichi-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	53	Sankyo	Sankyo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	54	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	55	Lilly	Lilly	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	56	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	244	57	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	244	58	Pozen	Pozen	NNP
work_tpiqgspaqvfeng2fovbximt4lm	244	59	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	245	1	No	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	245	2	other	other	JJ
work_tpiqgspaqvfeng2fovbximt4lm	245	3	authors	author	NNS
work_tpiqgspaqvfeng2fovbximt4lm	245	4	reported	report	VBD
work_tpiqgspaqvfeng2fovbximt4lm	245	5	disclosures	disclosure	NNS
work_tpiqgspaqvfeng2fovbximt4lm	245	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	246	1	Funding	funding	NN
work_tpiqgspaqvfeng2fovbximt4lm	246	2	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	246	3	Support	support	NN
work_tpiqgspaqvfeng2fovbximt4lm	246	4	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	246	5	This	this	DT
work_tpiqgspaqvfeng2fovbximt4lm	246	6	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	246	7	was	be	VBD
work_tpiqgspaqvfeng2fovbximt4lm	246	8	supported	support	VBN
work_tpiqgspaqvfeng2fovbximt4lm	246	9	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	246	10	Na-	na-	IN
work_tpiqgspaqvfeng2fovbximt4lm	246	11	tional	tional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	246	12	Institutes	Institutes	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	246	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	246	14	Health	Health	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	15	grants	grant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	246	16	NIH	NIH	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	17	U01	U01	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	18	GM074518	GM074518	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	19	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	246	20	U01	U01	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	21	HL084756	HL084756	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	22	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	246	23	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	246	24	Clinical	Clinical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	25	Nutrition	Nutrition	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	26	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	27	Unit	Unit	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	28	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	246	29	Maryland	Maryland	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	30	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	246	31	P30	P30	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	32	DK072488	DK072488	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	33	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	246	34	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	246	35	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	246	36	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	37	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	246	38	Maryland	Maryland	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	39	General	General	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	40	Clinical	Clinical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	41	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	42	Center	Center	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	43	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	246	44	M01	M01	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	45	RR	RR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	46	16500	16500	CD
work_tpiqgspaqvfeng2fovbximt4lm	246	47	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	246	48	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	246	49	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	246	50	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	51	Veterans	Veterans	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	246	52	Administration	Administration	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	53	Geri-	Geri-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	54	atric	atric	NN
work_tpiqgspaqvfeng2fovbximt4lm	246	55	Research	Research	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	56	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	246	57	Education	Education	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	58	Clinical	Clinical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	59	Center	Center	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	60	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	246	61	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	246	62	Si-	Si-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	63	nai	nai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	64	Hospital	Hospital	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	65	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	246	66	Baltimore	Baltimore	NNP
work_tpiqgspaqvfeng2fovbximt4lm	246	67	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	247	1	Role	role	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	247	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	4	Sponsors	sponsor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	247	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	247	6	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	7	funding	funding	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	8	organizations	organization	NNS
work_tpiqgspaqvfeng2fovbximt4lm	247	9	had	have	VBD
work_tpiqgspaqvfeng2fovbximt4lm	247	10	no	no	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	11	role	role	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	12	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	247	13	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	14	design	design	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	15	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	247	16	conduct	conduct	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	17	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	247	18	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	19	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	20	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	247	21	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	22	collection	collection	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	247	24	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	25	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	247	26	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	247	27	interpretation	interpretation	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	28	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	247	29	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	30	data	datum	NNS
work_tpiqgspaqvfeng2fovbximt4lm	247	31	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	247	32	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	247	33	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	34	preparation	preparation	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	35	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	247	36	review	review	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	37	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	247	38	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	247	39	approval	approval	NN
work_tpiqgspaqvfeng2fovbximt4lm	247	40	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	247	41	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	247	42	manu-	manu-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	247	43	script	script	NNP
work_tpiqgspaqvfeng2fovbximt4lm	247	44	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	248	1	Additional	additional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	248	2	Information	information	NN
work_tpiqgspaqvfeng2fovbximt4lm	248	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	248	4	eMethods	emethod	NNS
work_tpiqgspaqvfeng2fovbximt4lm	248	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	248	6	eTables	etable	NNS
work_tpiqgspaqvfeng2fovbximt4lm	248	7	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	248	8	through	through	IN
work_tpiqgspaqvfeng2fovbximt4lm	248	9	3	3	CD
work_tpiqgspaqvfeng2fovbximt4lm	248	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	248	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	248	12	eFigures	eFigures	NNP
work_tpiqgspaqvfeng2fovbximt4lm	248	13	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	248	14	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	248	15	2	2	CD
work_tpiqgspaqvfeng2fovbximt4lm	248	16	are	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	248	17	available	available	JJ
work_tpiqgspaqvfeng2fovbximt4lm	248	18	at	at	IN
work_tpiqgspaqvfeng2fovbximt4lm	248	19	http://www	http://www	ADD
work_tpiqgspaqvfeng2fovbximt4lm	248	20	.jama.com	.jama.com	NNP
work_tpiqgspaqvfeng2fovbximt4lm	248	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	249	1	Additional	Additional	NNP
work_tpiqgspaqvfeng2fovbximt4lm	249	2	Contributions	Contributions	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	249	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	249	4	We	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	249	5	gratefully	gratefully	RB
work_tpiqgspaqvfeng2fovbximt4lm	249	6	acknowl-	acknowl-	VBP
work_tpiqgspaqvfeng2fovbximt4lm	249	7	edge	edge	VB
work_tpiqgspaqvfeng2fovbximt4lm	249	8	our	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	249	9	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	249	10	liaisons	liaison	NNS
work_tpiqgspaqvfeng2fovbximt4lm	249	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	249	12	field	field	NN
work_tpiqgspaqvfeng2fovbximt4lm	249	13	workers	worker	NNS
work_tpiqgspaqvfeng2fovbximt4lm	249	14	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	249	15	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	249	16	ex-	ex-	XX
work_tpiqgspaqvfeng2fovbximt4lm	249	17	traordinary	traordinary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	249	18	cooperation	cooperation	NN
work_tpiqgspaqvfeng2fovbximt4lm	249	19	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	249	20	support	support	NN
work_tpiqgspaqvfeng2fovbximt4lm	249	21	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	249	22	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	249	23	Amish	amish	JJ
work_tpiqgspaqvfeng2fovbximt4lm	249	24	com-	com-	NN
work_tpiqgspaqvfeng2fovbximt4lm	249	25	munity	munity	NN
work_tpiqgspaqvfeng2fovbximt4lm	249	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	249	27	without	without	IN
work_tpiqgspaqvfeng2fovbximt4lm	249	28	which	which	WDT
work_tpiqgspaqvfeng2fovbximt4lm	249	29	these	these	DT
work_tpiqgspaqvfeng2fovbximt4lm	249	30	studies	study	NNS
work_tpiqgspaqvfeng2fovbximt4lm	249	31	would	would	MD
work_tpiqgspaqvfeng2fovbximt4lm	249	32	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	249	33	have	have	VB
work_tpiqgspaqvfeng2fovbximt4lm	249	34	been	be	VBN
work_tpiqgspaqvfeng2fovbximt4lm	249	35	possible	possible	JJ
work_tpiqgspaqvfeng2fovbximt4lm	249	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	250	1	REFERENCES	reference	NNS
work_tpiqgspaqvfeng2fovbximt4lm	250	2	1	1	CD
work_tpiqgspaqvfeng2fovbximt4lm	250	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	251	1	Antman	Antman	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	2	EM	EM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	251	4	Hand	Hand	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	5	M	M	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	251	7	Armstrong	Armstrong	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	8	PW	PW	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	251	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	12	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	251	13	Ca-	Ca-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	14	nadian	nadian	NN
work_tpiqgspaqvfeng2fovbximt4lm	251	15	Cardiovascular	Cardiovascular	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	16	Society	Society	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	17	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	251	18	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	19	Academy	Academy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	251	21	Family	Family	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	22	Physicians	Physicians	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	251	23	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	251	24	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	25	College	College	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	26	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	251	27	Cardiology	Cardiology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	28	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	251	29	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	30	Heart	Heart	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	31	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	251	32	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	252	1	2007	2007	CD
work_tpiqgspaqvfeng2fovbximt4lm	252	2	focused	focus	VBD
work_tpiqgspaqvfeng2fovbximt4lm	252	3	update	update	NN
work_tpiqgspaqvfeng2fovbximt4lm	252	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	252	5	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	252	6	ACC	ACC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	7	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	252	8	AHA	AHA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	9	2004	2004	CD
work_tpiqgspaqvfeng2fovbximt4lm	252	10	guidelines	guideline	NNS
work_tpiqgspaqvfeng2fovbximt4lm	252	11	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	252	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	252	13	management	management	NN
work_tpiqgspaqvfeng2fovbximt4lm	252	14	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	252	15	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	252	16	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	252	17	ST	ST	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	18	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	252	19	elevation	elevation	NN
work_tpiqgspaqvfeng2fovbximt4lm	252	20	myocardial	myocardial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	252	21	infarction	infarction	NN
work_tpiqgspaqvfeng2fovbximt4lm	252	22	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	252	23	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	252	24	report	report	NN
work_tpiqgspaqvfeng2fovbximt4lm	252	25	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	252	26	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	252	27	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	28	College	College	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	29	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	252	30	Cardiology/	cardiology/	CD
work_tpiqgspaqvfeng2fovbximt4lm	252	31	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	32	Heart	Heart	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	33	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	34	Task	Task	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	35	Force	Force	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	36	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	252	37	Practice	Practice	NNP
work_tpiqgspaqvfeng2fovbximt4lm	252	38	Guidelines	Guidelines	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	252	39	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	253	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	253	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	253	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	253	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	253	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	254	1	2008;51(2):210-	2008;51(2):210-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	254	2	247	247	CD
work_tpiqgspaqvfeng2fovbximt4lm	254	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	255	1	2	2	LS
work_tpiqgspaqvfeng2fovbximt4lm	255	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	256	1	King	King	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	2	SB	SB	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	3	III	III	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	4	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	256	5	Smith	Smith	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	6	SC	SC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	7	Jr	Jr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	256	9	Hirshfeld	Hirshfeld	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	10	JW	JW	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	11	Jr	Jr	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	256	13	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	14	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	15	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	256	16	2005	2005	CD
work_tpiqgspaqvfeng2fovbximt4lm	256	17	WRITING	WRITING	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	18	COMMITTEE	COMMITTEE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	256	19	MEMBERS	member	NNS
work_tpiqgspaqvfeng2fovbximt4lm	256	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	257	1	2007	2007	CD
work_tpiqgspaqvfeng2fovbximt4lm	257	2	Focused	Focused	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	3	Up-	Up-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	4	date	date	NN
work_tpiqgspaqvfeng2fovbximt4lm	257	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	6	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	257	7	ACC	ACC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	8	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	257	9	AHA	AHA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	10	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	257	11	SCAI	SCAI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	12	2005	2005	CD
work_tpiqgspaqvfeng2fovbximt4lm	257	13	Guideline	Guideline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	14	Update	Update	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	15	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	16	Percutaneous	Percutaneous	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	17	Coronary	Coronary	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	18	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	19	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	257	20	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	257	21	report	report	NN
work_tpiqgspaqvfeng2fovbximt4lm	257	22	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	23	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	257	24	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	25	College	College	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	26	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	27	Cardiology	Cardiology	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	28	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	257	29	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	30	Heart	Heart	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	31	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	32	Task	Task	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	33	Force	Force	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	34	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	35	Practice	Practice	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	36	Guidelines	Guidelines	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	257	37	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	257	38	2007	2007	CD
work_tpiqgspaqvfeng2fovbximt4lm	257	39	Writing	Writing	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	40	Group	Group	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	41	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	257	42	Review	Review	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	43	New	New	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	44	Evidence	Evidence	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	45	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	257	46	Update	update	VB
work_tpiqgspaqvfeng2fovbximt4lm	257	47	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	257	48	ACC	ACC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	49	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	257	50	AHA	AHA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	51	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	257	52	SCAI	SCAI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	53	2005	2005	CD
work_tpiqgspaqvfeng2fovbximt4lm	257	54	Guideline	Guideline	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	55	Update	Update	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	56	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	57	Per-	Per-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	58	cutaneous	cutaneous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	257	59	Coronary	Coronary	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	60	Intervention	Intervention	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	61	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	257	62	Writing	write	VBG
work_tpiqgspaqvfeng2fovbximt4lm	257	63	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	64	Behalf	Behalf	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	65	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	257	66	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	257	67	2005	2005	CD
work_tpiqgspaqvfeng2fovbximt4lm	257	68	Writing	Writing	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	69	Committee	Committee	NNP
work_tpiqgspaqvfeng2fovbximt4lm	257	70	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	258	1	Circulation	circulation	NN
work_tpiqgspaqvfeng2fovbximt4lm	258	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	259	1	2008	2008	CD
work_tpiqgspaqvfeng2fovbximt4lm	259	2	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	259	3	117(2):261	117(2):261	NNS
work_tpiqgspaqvfeng2fovbximt4lm	259	4	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	259	5	295	295	CD
work_tpiqgspaqvfeng2fovbximt4lm	259	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	260	1	3	3	LS
work_tpiqgspaqvfeng2fovbximt4lm	260	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	261	1	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	261	2	PA	PA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	261	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	261	4	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	261	5	US	US	NNP
work_tpiqgspaqvfeng2fovbximt4lm	261	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	262	1	Clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	262	2	resistance	resistance	NN
work_tpiqgspaqvfeng2fovbximt4lm	262	3	?	?	.
work_tpiqgspaqvfeng2fovbximt4lm	263	1	Thromb	Thromb	NNP
work_tpiqgspaqvfeng2fovbximt4lm	263	2	Res	Res	NNP
work_tpiqgspaqvfeng2fovbximt4lm	263	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	264	1	2007;120(3):311	2007;120(3):311	NNP
work_tpiqgspaqvfeng2fovbximt4lm	264	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	264	3	321	321	CD
work_tpiqgspaqvfeng2fovbximt4lm	264	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	265	1	4	4	LS
work_tpiqgspaqvfeng2fovbximt4lm	265	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	266	1	Hollopeter	Hollopeter	NNP
work_tpiqgspaqvfeng2fovbximt4lm	266	2	G	g	NN
work_tpiqgspaqvfeng2fovbximt4lm	266	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	266	4	Jantzen	Jantzen	NNP
work_tpiqgspaqvfeng2fovbximt4lm	266	5	HM	HM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	266	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	266	7	Vincent	Vincent	NNP
work_tpiqgspaqvfeng2fovbximt4lm	266	8	D	D	NNP
work_tpiqgspaqvfeng2fovbximt4lm	266	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	266	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	266	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	266	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	267	1	Iden-	iden-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	267	2	tification	tification	NN
work_tpiqgspaqvfeng2fovbximt4lm	267	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	267	4	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	267	5	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	267	6	ADP	ADP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	267	7	receptor	receptor	NN
work_tpiqgspaqvfeng2fovbximt4lm	267	8	targeted	target	VBN
work_tpiqgspaqvfeng2fovbximt4lm	267	9	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	267	10	an-	an-	CC
work_tpiqgspaqvfeng2fovbximt4lm	267	11	tithrombotic	tithrombotic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	267	12	drugs	drug	NNS
work_tpiqgspaqvfeng2fovbximt4lm	267	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	268	1	Nature	nature	NN
work_tpiqgspaqvfeng2fovbximt4lm	268	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	269	1	2001;409(6817):202-	2001;409(6817):202-	CD
work_tpiqgspaqvfeng2fovbximt4lm	269	2	207	207	CD
work_tpiqgspaqvfeng2fovbximt4lm	269	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	270	1	5	5	CD
work_tpiqgspaqvfeng2fovbximt4lm	270	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	271	1	Savi	Savi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	271	2	P	p	NN
work_tpiqgspaqvfeng2fovbximt4lm	271	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	271	4	Pereillo	Pereillo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	271	5	JM	JM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	271	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	271	7	Uzabiaga	Uzabiaga	NNP
work_tpiqgspaqvfeng2fovbximt4lm	271	8	MF	MF	NNP
work_tpiqgspaqvfeng2fovbximt4lm	271	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	271	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	271	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	271	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	272	1	Identifica-	Identifica-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	272	2	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	272	3	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	272	4	biological	biological	JJ
work_tpiqgspaqvfeng2fovbximt4lm	272	5	activity	activity	NN
work_tpiqgspaqvfeng2fovbximt4lm	272	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	272	7	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	272	8	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	272	9	metabolite	metabolite	NN
work_tpiqgspaqvfeng2fovbximt4lm	272	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	272	11	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	272	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	273	1	Thromb	Thromb	NNP
work_tpiqgspaqvfeng2fovbximt4lm	273	2	Haemost	Haemost	NNP
work_tpiqgspaqvfeng2fovbximt4lm	273	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	274	1	2000;84(5):891-	2000;84(5):891-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	274	2	896	896	CD
work_tpiqgspaqvfeng2fovbximt4lm	274	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	275	1	6	6	CD
work_tpiqgspaqvfeng2fovbximt4lm	275	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	276	1	Angiolillo	Angiolillo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	2	DJ	DJ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	276	4	Fernandez	Fernandez	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	5	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	276	6	Ortiz	Ortiz	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	7	A	A	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	276	9	Bernardo	Bernardo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	10	E	E	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	276	12	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	13	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	276	14	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	277	1	Variability	variability	NN
work_tpiqgspaqvfeng2fovbximt4lm	277	2	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	277	3	individual	individual	JJ
work_tpiqgspaqvfeng2fovbximt4lm	277	4	responsiveness	responsiveness	NN
work_tpiqgspaqvfeng2fovbximt4lm	277	5	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	277	6	clopido-	clopido-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	277	7	grel	grel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	277	8	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	277	9	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	277	10	implications	implication	NNS
work_tpiqgspaqvfeng2fovbximt4lm	277	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	277	12	management	management	NN
work_tpiqgspaqvfeng2fovbximt4lm	277	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	277	14	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	277	15	future	future	JJ
work_tpiqgspaqvfeng2fovbximt4lm	277	16	perspectives	perspective	NNS
work_tpiqgspaqvfeng2fovbximt4lm	277	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	278	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	278	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	278	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	278	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	278	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	279	1	2007;49(14):1505-	2007;49(14):1505-	CD
work_tpiqgspaqvfeng2fovbximt4lm	279	2	1516	1516	CD
work_tpiqgspaqvfeng2fovbximt4lm	279	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	280	1	7	7	LS
work_tpiqgspaqvfeng2fovbximt4lm	280	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	281	1	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	2	PA	PA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	281	4	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	5	KP	KP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	281	7	Hiatt	Hiatt	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	8	BL	BL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	281	10	O’Connor	O’Connor	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	11	CM	CM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	281	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	282	1	Clo-	Clo-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	282	2	pidogrel	pidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	3	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	282	4	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	282	5	stenting	stenting	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	6	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	282	7	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	8	variability	variability	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	282	10	drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	11	resistance	resistance	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	282	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	282	14	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	282	15	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	16	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	282	17	pretreatment	pretreatment	JJ
work_tpiqgspaqvfeng2fovbximt4lm	282	18	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	19	reactivity	reactivity	NN
work_tpiqgspaqvfeng2fovbximt4lm	282	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	283	1	Circulation	circulation	NN
work_tpiqgspaqvfeng2fovbximt4lm	283	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	284	1	2003;107(23):2908	2003;107(23):2908	CD
work_tpiqgspaqvfeng2fovbximt4lm	284	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	284	3	2913	2913	CD
work_tpiqgspaqvfeng2fovbximt4lm	284	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	285	1	8	8	LS
work_tpiqgspaqvfeng2fovbximt4lm	285	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	286	1	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	286	2	PA	PA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	286	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	286	4	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	286	5	US	US	NNP
work_tpiqgspaqvfeng2fovbximt4lm	286	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	287	1	Drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	287	2	insight	insight	NN
work_tpiqgspaqvfeng2fovbximt4lm	287	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	287	4	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	287	5	nonresponsiveness	nonresponsiveness	NN
work_tpiqgspaqvfeng2fovbximt4lm	287	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	288	1	Nat	Nat	NNP
work_tpiqgspaqvfeng2fovbximt4lm	288	2	Clin	Clin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	288	3	Pract	Pract	NNP
work_tpiqgspaqvfeng2fovbximt4lm	288	4	Cardiovasc	Cardiovasc	NNP
work_tpiqgspaqvfeng2fovbximt4lm	288	5	Med	Med	NNP
work_tpiqgspaqvfeng2fovbximt4lm	288	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	289	1	2006;3(7):387	2006;3(7):387	CD
work_tpiqgspaqvfeng2fovbximt4lm	289	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	289	3	395	395	CD
work_tpiqgspaqvfeng2fovbximt4lm	289	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	290	1	9	9	CD
work_tpiqgspaqvfeng2fovbximt4lm	290	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	291	1	Angiolillo	Angiolillo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	291	2	DJ	DJ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	291	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	291	4	Alfonso	Alfonso	NNP
work_tpiqgspaqvfeng2fovbximt4lm	291	5	F.	F.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	291	6	Platelet	Platelet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	291	7	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	291	8	testing	testing	NN
work_tpiqgspaqvfeng2fovbximt4lm	291	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	291	10	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	291	11	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	291	12	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	291	13	steps	step	NNS
work_tpiqgspaqvfeng2fovbximt4lm	291	14	forward	forward	RB
work_tpiqgspaqvfeng2fovbximt4lm	291	15	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	291	16	iden-	iden-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	291	17	tifying	tifye	VBG
work_tpiqgspaqvfeng2fovbximt4lm	291	18	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	291	19	best	good	JJS
work_tpiqgspaqvfeng2fovbximt4lm	291	20	predictive	predictive	JJ
work_tpiqgspaqvfeng2fovbximt4lm	291	21	measure	measure	NN
work_tpiqgspaqvfeng2fovbximt4lm	291	22	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	292	1	Thromb	Thromb	NNP
work_tpiqgspaqvfeng2fovbximt4lm	292	2	Haemost	Haemost	NNP
work_tpiqgspaqvfeng2fovbximt4lm	292	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	293	1	2007;98(4):707	2007;98(4):707	CD
work_tpiqgspaqvfeng2fovbximt4lm	293	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	293	3	709	709	NNP
work_tpiqgspaqvfeng2fovbximt4lm	293	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	294	1	10	10	CD
work_tpiqgspaqvfeng2fovbximt4lm	294	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	295	1	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	2	KP	KP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	295	4	Dichiara	Dichiara	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	5	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	295	7	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	8	US	US	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	295	10	Bassi	Bassi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	11	AK	AK	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	295	13	Chaganti	Chaganti	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	14	SK	SK	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	295	16	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	17	PA	PA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	295	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	296	1	Increased	increase	VBN
work_tpiqgspaqvfeng2fovbximt4lm	296	2	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	3	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	296	4	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	296	5	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	296	6	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	296	7	plate-	plate-	NNS
work_tpiqgspaqvfeng2fovbximt4lm	296	8	let	let	VB
work_tpiqgspaqvfeng2fovbximt4lm	296	9	aggregation	aggregation	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	10	receiving	receive	VBG
work_tpiqgspaqvfeng2fovbximt4lm	296	11	chronic	chronic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	296	12	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	13	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	14	undergoing	undergo	VBG
work_tpiqgspaqvfeng2fovbximt4lm	296	15	percutaneous	percutaneous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	296	16	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	296	17	intervention	intervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	18	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	296	19	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	296	20	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	296	21	current	current	JJ
work_tpiqgspaqvfeng2fovbximt4lm	296	22	antiplatelet	antiplatelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	23	therapy	therapy	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	24	adequate	adequate	NN
work_tpiqgspaqvfeng2fovbximt4lm	296	25	?	?	.
work_tpiqgspaqvfeng2fovbximt4lm	297	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	297	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	297	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	297	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	297	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	298	1	2007;49(6):657	2007;49(6):657	CD
work_tpiqgspaqvfeng2fovbximt4lm	298	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	298	3	666	666	CD
work_tpiqgspaqvfeng2fovbximt4lm	298	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	299	1	11	11	CD
work_tpiqgspaqvfeng2fovbximt4lm	299	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	300	1	Buonamici	Buonamici	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	2	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	300	4	Marcucci	Marcucci	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	5	R	R	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	300	7	Migliorini	Migliorini	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	8	A	A	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	300	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	300	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	301	1	Im-	im-	IN
work_tpiqgspaqvfeng2fovbximt4lm	301	2	pact	pact	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	301	4	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	5	reactivity	reactivity	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	6	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	301	7	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	8	adminis-	adminis-	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	9	tration	tration	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	10	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	301	11	drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	301	13	eluting	elute	VBG
work_tpiqgspaqvfeng2fovbximt4lm	301	14	stent	stent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	301	15	thrombosis	thrombosis	NN
work_tpiqgspaqvfeng2fovbximt4lm	301	16	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	302	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	302	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	302	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	302	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	302	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	303	1	2007;49(24):2312	2007;49(24):2312	CD
work_tpiqgspaqvfeng2fovbximt4lm	303	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	303	3	2317	2317	CD
work_tpiqgspaqvfeng2fovbximt4lm	303	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	304	1	12	12	CD
work_tpiqgspaqvfeng2fovbximt4lm	304	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	305	1	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	2	PA	PA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	305	4	Bliden	Bliden	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	5	KP	KP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	305	7	Guyer	Guyer	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	8	K	K	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	305	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	305	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	306	1	Platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	306	2	re-	re-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	306	3	activity	activity	NN
work_tpiqgspaqvfeng2fovbximt4lm	306	4	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	306	5	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	306	6	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	306	7	recurrent	recurrent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	306	8	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	306	9	post-	post-	VBP
work_tpiqgspaqvfeng2fovbximt4lm	306	10	stenting	stente	VBG
work_tpiqgspaqvfeng2fovbximt4lm	306	11	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	306	12	results	result	NNS
work_tpiqgspaqvfeng2fovbximt4lm	306	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	306	14	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	306	15	PREPARE	PREPARE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	306	16	POST	POST	NNP
work_tpiqgspaqvfeng2fovbximt4lm	306	17	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	306	18	STENTING	STENTING	NNP
work_tpiqgspaqvfeng2fovbximt4lm	306	19	Study	Study	NNP
work_tpiqgspaqvfeng2fovbximt4lm	306	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	307	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	307	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	307	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	307	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	307	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	308	1	2005;46(10):1820-	2005;46(10):1820-	CD
work_tpiqgspaqvfeng2fovbximt4lm	308	2	1826	1826	CD
work_tpiqgspaqvfeng2fovbximt4lm	308	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	309	1	13	13	CD
work_tpiqgspaqvfeng2fovbximt4lm	309	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	310	1	Farid	Farid	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	2	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	310	4	Small	Small	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	5	DS	DS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	310	7	Payne	Payne	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	8	CD	CD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	310	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	310	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	311	1	Effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	311	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	311	3	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	311	4	torvastatin	torvastatin	NN
work_tpiqgspaqvfeng2fovbximt4lm	311	5	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	311	6	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	311	7	pharmacokinetics	pharmacokinetic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	311	8	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	311	9	pharmaco-	pharmaco-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	311	10	dynamics	dynamic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	311	11	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	311	12	prasugrel	prasugrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	311	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	311	14	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	311	15	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	311	16	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	311	17	subjects	subject	NNS
work_tpiqgspaqvfeng2fovbximt4lm	311	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	312	1	Pharmacotherapy	Pharmacotherapy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	312	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	313	1	2008;28(12):1483-	2008;28(12):1483-	CD
work_tpiqgspaqvfeng2fovbximt4lm	313	2	1494	1494	CD
work_tpiqgspaqvfeng2fovbximt4lm	313	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	314	1	14	14	CD
work_tpiqgspaqvfeng2fovbximt4lm	314	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	315	1	Gilard	Gilard	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	2	M	M	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	315	4	Arnaud	Arnaud	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	5	B	B	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	315	7	Le	Le	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	8	Gal	Gal	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	9	G	G	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	315	11	Abgrall	Abgrall	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	12	JF	JF	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	13	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	315	14	Boschat	Boschat	NNP
work_tpiqgspaqvfeng2fovbximt4lm	315	15	J.	J.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	316	1	Influence	influence	NN
work_tpiqgspaqvfeng2fovbximt4lm	316	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	316	3	omeprazol	omeprazol	NN
work_tpiqgspaqvfeng2fovbximt4lm	316	4	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	316	5	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	316	6	antiplatelet	antiplatelet	JJ
work_tpiqgspaqvfeng2fovbximt4lm	316	7	action	action	NN
work_tpiqgspaqvfeng2fovbximt4lm	316	8	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	316	9	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	316	10	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	316	11	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	316	12	aspirin	aspirin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	316	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	317	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	317	2	Thromb	Thromb	NNP
work_tpiqgspaqvfeng2fovbximt4lm	317	3	Haemost	Haemost	NNP
work_tpiqgspaqvfeng2fovbximt4lm	317	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	318	1	2006;4(11):2508	2006;4(11):2508	CD
work_tpiqgspaqvfeng2fovbximt4lm	318	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	318	3	2509	2509	CD
work_tpiqgspaqvfeng2fovbximt4lm	318	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	319	1	15	15	CD
work_tpiqgspaqvfeng2fovbximt4lm	319	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	320	1	Lau	Lau	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	2	WC	WC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	320	4	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	5	PA	PA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	320	7	Watkins	Watkins	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	8	PB	PB	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	320	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	320	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	321	1	Contri-	Contri-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	321	2	bution	bution	NN
work_tpiqgspaqvfeng2fovbximt4lm	321	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	321	4	hepatic	hepatic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	321	5	cytochrome	cytochrome	VBN
work_tpiqgspaqvfeng2fovbximt4lm	321	6	P450	p450	NN
work_tpiqgspaqvfeng2fovbximt4lm	321	7	3A4	3a4	CD
work_tpiqgspaqvfeng2fovbximt4lm	321	8	metabolic	metabolic	NN
work_tpiqgspaqvfeng2fovbximt4lm	321	9	ac-	ac-	DT
work_tpiqgspaqvfeng2fovbximt4lm	321	10	tivity	tivity	NN
work_tpiqgspaqvfeng2fovbximt4lm	321	11	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	321	12	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	321	13	phenomenon	phenomenon	NN
work_tpiqgspaqvfeng2fovbximt4lm	321	14	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	321	15	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	321	16	resistance	resistance	NN
work_tpiqgspaqvfeng2fovbximt4lm	321	17	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	322	1	Circulation	circulation	NN
work_tpiqgspaqvfeng2fovbximt4lm	322	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	323	1	2004;109(2):166	2004;109(2):166	NNP
work_tpiqgspaqvfeng2fovbximt4lm	323	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	323	3	171	171	CD
work_tpiqgspaqvfeng2fovbximt4lm	323	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	324	1	16	16	CD
work_tpiqgspaqvfeng2fovbximt4lm	324	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	325	1	Siller	Siller	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	325	3	Matula	Matula	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	4	JM	JM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	325	6	Lang	Lang	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	7	I	I	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	325	9	Christ	Christ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	10	G	G	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	325	12	Jilma	Jilma	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	13	B.	B.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	14	Calcium-	Calcium-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	325	15	channel	channel	NN
work_tpiqgspaqvfeng2fovbximt4lm	325	16	blockers	blocker	NNS
work_tpiqgspaqvfeng2fovbximt4lm	325	17	reduce	reduce	VBP
work_tpiqgspaqvfeng2fovbximt4lm	325	18	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	325	19	antiplatelet	antiplatelet	JJ
work_tpiqgspaqvfeng2fovbximt4lm	325	20	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	325	21	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	325	22	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	325	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	326	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	326	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	326	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	326	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	326	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	327	1	2008;52(19):1557-	2008;52(19):1557-	CD
work_tpiqgspaqvfeng2fovbximt4lm	327	2	1563	1563	CD
work_tpiqgspaqvfeng2fovbximt4lm	327	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	328	1	17	17	CD
work_tpiqgspaqvfeng2fovbximt4lm	328	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	329	1	Kim	Kim	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	2	KA	KA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	329	4	Park	Park	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	5	PW	PW	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	329	7	Hong	Hong	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	8	SJ	SJ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	329	10	Park	Park	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	11	JY	JY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	329	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	330	1	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	330	2	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	330	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	330	4	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	330	5	polymorphism	polymorphism	NN
work_tpiqgspaqvfeng2fovbximt4lm	330	6	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	330	7	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	330	8	pharmacokinetics	pharmacokinetic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	330	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	330	10	pharmacodynamics	pharmacodynamic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	330	11	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	330	12	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	330	13	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	330	14	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	330	15	possible	possible	JJ
work_tpiqgspaqvfeng2fovbximt4lm	330	16	mechanism	mechanism	NN
work_tpiqgspaqvfeng2fovbximt4lm	330	17	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	330	18	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	330	19	resistance	resistance	NN
work_tpiqgspaqvfeng2fovbximt4lm	330	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	331	1	Clin	Clin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	331	2	Pharma-	Pharma-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	331	3	col	col	NN
work_tpiqgspaqvfeng2fovbximt4lm	331	4	Ther	Ther	NNP
work_tpiqgspaqvfeng2fovbximt4lm	331	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	332	1	2008;84(2):236	2008;84(2):236	CD
work_tpiqgspaqvfeng2fovbximt4lm	332	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	332	3	242	242	CD
work_tpiqgspaqvfeng2fovbximt4lm	332	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	333	1	18	18	CD
work_tpiqgspaqvfeng2fovbximt4lm	333	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	334	1	Mega	Mega	NNP
work_tpiqgspaqvfeng2fovbximt4lm	334	2	JL	JL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	334	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	334	4	Close	close	JJ
work_tpiqgspaqvfeng2fovbximt4lm	334	5	SL	SL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	334	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	334	7	Wiviott	Wiviott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	334	8	SD	SD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	334	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	334	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	334	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	334	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	335	1	Cyto-	Cyto-	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	335	2	chrome	chrome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	335	3	P-450	P-450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	335	4	polymorphisms	polymorphism	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	335	5	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	335	6	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	335	7	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	335	8	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	335	9	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	336	1	N	N	NNP
work_tpiqgspaqvfeng2fovbximt4lm	336	2	Engl	Engl	NNP
work_tpiqgspaqvfeng2fovbximt4lm	336	3	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	336	4	Med	Med	NNP
work_tpiqgspaqvfeng2fovbximt4lm	336	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	337	1	2009;360(4):354	2009;360(4):354	NNP
work_tpiqgspaqvfeng2fovbximt4lm	337	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	337	3	362	362	CD
work_tpiqgspaqvfeng2fovbximt4lm	337	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	338	1	19	19	CD
work_tpiqgspaqvfeng2fovbximt4lm	338	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	339	1	Brandt	Brandt	NNP
work_tpiqgspaqvfeng2fovbximt4lm	339	2	JT	JT	NNP
work_tpiqgspaqvfeng2fovbximt4lm	339	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	339	4	Close	close	JJ
work_tpiqgspaqvfeng2fovbximt4lm	339	5	SL	SL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	339	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	339	7	Iturria	Iturria	NNP
work_tpiqgspaqvfeng2fovbximt4lm	339	8	SJ	SJ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	339	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	339	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	339	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	339	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	340	1	Common	common	JJ
work_tpiqgspaqvfeng2fovbximt4lm	340	2	poly-	poly-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	340	3	morphisms	morphism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	340	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	340	5	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	340	6	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	340	7	CYP2C9	CYP2C9	:
work_tpiqgspaqvfeng2fovbximt4lm	340	8	affect	affect	VB
work_tpiqgspaqvfeng2fovbximt4lm	340	9	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	340	10	phar-	phar-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	340	11	macokinetic	macokinetic	NN
work_tpiqgspaqvfeng2fovbximt4lm	340	12	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	340	13	pharmacodynamic	pharmacodynamic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	340	14	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	340	15	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	340	16	clo-	clo-	NN
work_tpiqgspaqvfeng2fovbximt4lm	340	17	pidogrel	pidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	340	18	but	but	CC
work_tpiqgspaqvfeng2fovbximt4lm	340	19	not	not	RB
work_tpiqgspaqvfeng2fovbximt4lm	340	20	prasugrel	prasugrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	340	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	341	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	341	2	Thromb	Thromb	NNP
work_tpiqgspaqvfeng2fovbximt4lm	341	3	Haemost	Haemost	NNP
work_tpiqgspaqvfeng2fovbximt4lm	341	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	342	1	2007	2007	CD
work_tpiqgspaqvfeng2fovbximt4lm	342	2	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	342	3	5(12):2429	5(12):2429	CD
work_tpiqgspaqvfeng2fovbximt4lm	342	4	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	342	5	2436	2436	CD
work_tpiqgspaqvfeng2fovbximt4lm	342	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	343	1	20	20	CD
work_tpiqgspaqvfeng2fovbximt4lm	343	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	344	1	Fontana	Fontana	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	2	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	344	4	Hulot	Hulot	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	5	JS	JS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	344	7	De	De	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	8	Moerloose	Moerloose	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	9	P	P	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	10	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	344	11	Gaussem	Gaussem	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	12	CYTOCHROME	CYTOCHROME	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	13	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	14	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	344	15	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	344	16	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	344	17	CLOPIDOGREL	CLOPIDOGREL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	18	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	19	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	20	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	344	21	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	22	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	23	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	344	24	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	345	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	345	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	345	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	345	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	346	1	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	346	2	Reprinted	reprinted	JJ
work_tpiqgspaqvfeng2fovbximt4lm	346	3	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	346	4	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	346	5	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	346	6	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	346	7	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	346	8	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	346	9	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	346	10	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	346	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	346	12	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	346	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	347	1	8	8	CD
work_tpiqgspaqvfeng2fovbximt4lm	347	2	857	857	CD
work_tpiqgspaqvfeng2fovbximt4lm	347	3	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	347	4	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	347	5	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	347	6	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	347	7	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	347	8	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	347	9	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	347	10	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	347	11	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	347	12	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	347	13	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	347	14	04/05/2021	04/05/2021	CD
work_tpiqgspaqvfeng2fovbximt4lm	347	15	P.	P.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	347	16	Influence	Influence	NNP
work_tpiqgspaqvfeng2fovbximt4lm	347	17	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	347	18	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	347	19	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	347	20	CYP3A4	cyp3a4	JJ
work_tpiqgspaqvfeng2fovbximt4lm	347	21	gene	gene	NN
work_tpiqgspaqvfeng2fovbximt4lm	347	22	polymor-	polymor-	NN
work_tpiqgspaqvfeng2fovbximt4lm	347	23	phisms	phism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	347	24	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	347	25	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	347	26	responsiveness	responsiveness	NN
work_tpiqgspaqvfeng2fovbximt4lm	347	27	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	347	28	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	347	29	subjects	subject	NNS
work_tpiqgspaqvfeng2fovbximt4lm	347	30	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	348	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	348	2	Thromb	Thromb	NNP
work_tpiqgspaqvfeng2fovbximt4lm	348	3	Haemost	Haemost	NNP
work_tpiqgspaqvfeng2fovbximt4lm	348	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	349	1	2007;5(10):2153-	2007;5(10):2153-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	349	2	2155	2155	CD
work_tpiqgspaqvfeng2fovbximt4lm	349	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	350	1	21	21	CD
work_tpiqgspaqvfeng2fovbximt4lm	350	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	351	1	Frere	Frere	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	2	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	351	4	Cuisset	Cuisset	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	5	T	T	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	351	7	Morange	Morange	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	8	PE	PE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	351	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	351	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	352	1	Effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	352	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	352	3	cytochrome	cytochrome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	352	4	p450	p450	JJR
work_tpiqgspaqvfeng2fovbximt4lm	352	5	polymorphisms	polymorphism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	352	6	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	352	7	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	352	8	re-	re-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	352	9	activity	activity	NN
work_tpiqgspaqvfeng2fovbximt4lm	352	10	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	352	11	treatment	treatment	NN
work_tpiqgspaqvfeng2fovbximt4lm	352	12	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	352	13	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	352	14	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	352	15	acute	acute	NN
work_tpiqgspaqvfeng2fovbximt4lm	352	16	coro-	coro-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	352	17	nary	nary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	352	18	syndrome	syndrome	NN
work_tpiqgspaqvfeng2fovbximt4lm	352	19	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	353	1	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	353	2	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	353	3	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	353	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	354	1	2008;101(8):1088-	2008;101(8):1088-	CD
work_tpiqgspaqvfeng2fovbximt4lm	354	2	1093	1093	CD
work_tpiqgspaqvfeng2fovbximt4lm	354	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	355	1	22	22	CD
work_tpiqgspaqvfeng2fovbximt4lm	355	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	356	1	Hulot	Hulot	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	2	JS	JS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	356	4	Bura	Bura	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	5	A	A	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	356	7	Villard	Villard	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	8	E	E	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	356	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	356	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	357	1	Cytochrome	Cytochrome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	357	2	P450	p450	CD
work_tpiqgspaqvfeng2fovbximt4lm	357	3	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	357	4	loss	loss	NN
work_tpiqgspaqvfeng2fovbximt4lm	357	5	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	357	6	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	357	7	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	357	8	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	357	9	polymorphism	polymorphism	NN
work_tpiqgspaqvfeng2fovbximt4lm	357	10	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	357	11	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	357	12	major	major	JJ
work_tpiqgspaqvfeng2fovbximt4lm	357	13	de-	de-	NN
work_tpiqgspaqvfeng2fovbximt4lm	357	14	terminant	terminant	NN
work_tpiqgspaqvfeng2fovbximt4lm	357	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	357	16	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	357	17	responsiveness	responsiveness	NN
work_tpiqgspaqvfeng2fovbximt4lm	357	18	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	357	19	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	357	20	subjects	subject	NNS
work_tpiqgspaqvfeng2fovbximt4lm	357	21	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	358	1	Blood	blood	NN
work_tpiqgspaqvfeng2fovbximt4lm	358	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	359	1	2006;108(7):2244	2006;108(7):2244	CD
work_tpiqgspaqvfeng2fovbximt4lm	359	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	359	3	2247	2247	CD
work_tpiqgspaqvfeng2fovbximt4lm	359	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	360	1	23	23	CD
work_tpiqgspaqvfeng2fovbximt4lm	360	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	361	1	Malek	Malek	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	2	LA	LA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	361	4	Kisiel	Kisiel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	5	B	B	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	361	7	Spiewak	Spiewak	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	8	M	M	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	361	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	361	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	362	1	Coexisting	coexist	VBG
work_tpiqgspaqvfeng2fovbximt4lm	362	2	polymorphisms	polymorphism	NNS
work_tpiqgspaqvfeng2fovbximt4lm	362	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	362	4	P2Y12	P2Y12	NNS
work_tpiqgspaqvfeng2fovbximt4lm	362	5	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	362	6	CYP2C19	cyp2c19	VBP
work_tpiqgspaqvfeng2fovbximt4lm	362	7	genes	gene	NNS
work_tpiqgspaqvfeng2fovbximt4lm	362	8	as	as	IN
work_tpiqgspaqvfeng2fovbximt4lm	362	9	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	362	10	risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	362	11	factor	factor	NN
work_tpiqgspaqvfeng2fovbximt4lm	362	12	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	362	13	persistent	persistent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	362	14	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	362	15	activation	activation	NN
work_tpiqgspaqvfeng2fovbximt4lm	362	16	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	362	17	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	362	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	363	1	Circ	Circ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	363	2	J.	J.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	364	1	2008;72(7):1165	2008;72(7):1165	CD
work_tpiqgspaqvfeng2fovbximt4lm	364	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	364	3	1169	1169	CD
work_tpiqgspaqvfeng2fovbximt4lm	364	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	365	1	24	24	CD
work_tpiqgspaqvfeng2fovbximt4lm	365	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	366	1	Collet	Collet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	2	JP	JP	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	366	4	Hulot	Hulot	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	5	JS	JS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	366	7	Pena	Pena	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	8	A	A	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	366	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	366	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	367	1	Cytochrome	Cytochrome	NNP
work_tpiqgspaqvfeng2fovbximt4lm	367	2	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	367	3	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	367	4	polymorphism	polymorphism	NN
work_tpiqgspaqvfeng2fovbximt4lm	367	5	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	367	6	young	young	JJ
work_tpiqgspaqvfeng2fovbximt4lm	367	7	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	367	8	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	367	9	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	367	10	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	367	11	after	after	IN
work_tpiqgspaqvfeng2fovbximt4lm	367	12	myocardial	myocardial	JJ
work_tpiqgspaqvfeng2fovbximt4lm	367	13	infarction	infarction	NN
work_tpiqgspaqvfeng2fovbximt4lm	367	14	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	367	15	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	367	16	cohort	cohort	NN
work_tpiqgspaqvfeng2fovbximt4lm	367	17	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	367	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	368	1	Lancet	Lancet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	368	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	369	1	2009;373(9660):309	2009;373(9660):309	CD
work_tpiqgspaqvfeng2fovbximt4lm	369	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	369	3	317	317	CD
work_tpiqgspaqvfeng2fovbximt4lm	369	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	370	1	25	25	CD
work_tpiqgspaqvfeng2fovbximt4lm	370	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	371	1	Simon	Simon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	2	T	T	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	371	4	Verstuyft	Verstuyft	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	5	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	371	7	Mary	Mary	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	8	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	371	9	Krause	Krause	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	10	M	M	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	11	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	371	12	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	13	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	14	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	371	15	French	French	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	16	Registry	Registry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	17	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	371	18	Acute	Acute	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	19	ST	ST	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	20	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	371	21	Elevation	Elevation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	22	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	371	23	Non	Non	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	24	-	-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	371	25	ST-	st-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	371	26	Elevation	Elevation	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	27	Myocardial	Myocardial	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	28	Infarction	Infarction	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	29	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	371	30	FAST	FAST	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	31	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	371	32	MI	MI	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	33	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	371	34	Invest-	Invest-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	371	35	igators	igator	NNS
work_tpiqgspaqvfeng2fovbximt4lm	371	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	372	1	Genetic	genetic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	372	2	determinants	determinant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	372	3	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	372	4	response	response	NN
work_tpiqgspaqvfeng2fovbximt4lm	372	5	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	372	6	clopido-	clopido-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	372	7	grel	grel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	372	8	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	372	9	cardiovascular	cardiovascular	JJ
work_tpiqgspaqvfeng2fovbximt4lm	372	10	events	event	NNS
work_tpiqgspaqvfeng2fovbximt4lm	372	11	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	373	1	N	N	NNP
work_tpiqgspaqvfeng2fovbximt4lm	373	2	Engl	Engl	NNP
work_tpiqgspaqvfeng2fovbximt4lm	373	3	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	373	4	Med	Med	NNP
work_tpiqgspaqvfeng2fovbximt4lm	373	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	374	1	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	374	2	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	374	3	360(4):363	360(4):363	NNP
work_tpiqgspaqvfeng2fovbximt4lm	374	4	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	374	5	375	375	CD
work_tpiqgspaqvfeng2fovbximt4lm	374	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	375	1	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	375	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	376	1	Trenk	trenk	FW
work_tpiqgspaqvfeng2fovbximt4lm	376	2	D	d	NN
work_tpiqgspaqvfeng2fovbximt4lm	376	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	376	4	Hochholzer	Hochholzer	NNP
work_tpiqgspaqvfeng2fovbximt4lm	376	5	W	W	NNP
work_tpiqgspaqvfeng2fovbximt4lm	376	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	376	7	Fromm	Fromm	NNP
work_tpiqgspaqvfeng2fovbximt4lm	376	8	MF	MF	NNP
work_tpiqgspaqvfeng2fovbximt4lm	376	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	376	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	376	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	376	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	377	1	Cy-	cy-	WDT
work_tpiqgspaqvfeng2fovbximt4lm	377	2	tochrome	tochrome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	377	3	P450	p450	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	4	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	377	5	681G	681g	CD
work_tpiqgspaqvfeng2fovbximt4lm	377	6	�	�	NNS
work_tpiqgspaqvfeng2fovbximt4lm	377	7	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	377	8	polymorphism	polymorphism	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	9	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	377	10	high	high	JJ
work_tpiqgspaqvfeng2fovbximt4lm	377	11	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	377	12	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	377	13	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	14	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	15	reactivity	reactivity	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	16	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	377	17	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	377	18	adverse	adverse	JJ
work_tpiqgspaqvfeng2fovbximt4lm	377	19	1-year	1-year	CD
work_tpiqgspaqvfeng2fovbximt4lm	377	20	clinical	clinical	JJ
work_tpiqgspaqvfeng2fovbximt4lm	377	21	outcome	outcome	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	22	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	377	23	elective	elective	JJ
work_tpiqgspaqvfeng2fovbximt4lm	377	24	percuta-	percuta-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	377	25	neous	neous	JJ
work_tpiqgspaqvfeng2fovbximt4lm	377	26	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	377	27	intervention	intervention	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	28	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	377	29	drug	drug	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	30	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	377	31	eluting	elute	VBG
work_tpiqgspaqvfeng2fovbximt4lm	377	32	or	or	CC
work_tpiqgspaqvfeng2fovbximt4lm	377	33	bare-	bare-	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	34	metal	metal	NN
work_tpiqgspaqvfeng2fovbximt4lm	377	35	stents	stent	NNS
work_tpiqgspaqvfeng2fovbximt4lm	377	36	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	378	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	378	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	378	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	378	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	378	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	379	1	2008;51(20):1925-	2008;51(20):1925-	CD
work_tpiqgspaqvfeng2fovbximt4lm	379	2	1934	1934	CD
work_tpiqgspaqvfeng2fovbximt4lm	379	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	380	1	27	27	CD
work_tpiqgspaqvfeng2fovbximt4lm	380	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	381	1	ESPRIT	esprit	UH
work_tpiqgspaqvfeng2fovbximt4lm	381	2	Investigators	investigator	NNS
work_tpiqgspaqvfeng2fovbximt4lm	381	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	382	1	Novel	novel	JJ
work_tpiqgspaqvfeng2fovbximt4lm	382	2	dosing	dose	VBG
work_tpiqgspaqvfeng2fovbximt4lm	382	3	regimen	regimen	NN
work_tpiqgspaqvfeng2fovbximt4lm	382	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	382	5	ep-	ep-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	382	6	tifibatide	tifibatide	NN
work_tpiqgspaqvfeng2fovbximt4lm	382	7	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	382	8	planned	plan	VBN
work_tpiqgspaqvfeng2fovbximt4lm	382	9	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	382	10	stent	stent	JJ
work_tpiqgspaqvfeng2fovbximt4lm	382	11	implantation	implantation	NN
work_tpiqgspaqvfeng2fovbximt4lm	382	12	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	382	13	ESPRIT	esprit	NN
work_tpiqgspaqvfeng2fovbximt4lm	382	14	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	382	15	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	382	16	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	382	17	randomised	randomised	JJ
work_tpiqgspaqvfeng2fovbximt4lm	382	18	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	382	19	placebo	placebo	NN
work_tpiqgspaqvfeng2fovbximt4lm	382	20	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	382	21	controlled	control	VBN
work_tpiqgspaqvfeng2fovbximt4lm	382	22	trial	trial	NN
work_tpiqgspaqvfeng2fovbximt4lm	382	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	383	1	Lancet	Lancet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	383	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	384	1	2000;356(9247):2037	2000;356(9247):2037	CD
work_tpiqgspaqvfeng2fovbximt4lm	384	2	-	-	:
work_tpiqgspaqvfeng2fovbximt4lm	384	3	2044	2044	CD
work_tpiqgspaqvfeng2fovbximt4lm	384	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	385	1	28	28	CD
work_tpiqgspaqvfeng2fovbximt4lm	385	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	386	1	Lincoff	lincoff	NN
work_tpiqgspaqvfeng2fovbximt4lm	386	2	AM	am	NN
work_tpiqgspaqvfeng2fovbximt4lm	386	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	386	4	Bittl	Bittl	NNP
work_tpiqgspaqvfeng2fovbximt4lm	386	5	JA	JA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	386	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	386	7	Harrington	Harrington	NNP
work_tpiqgspaqvfeng2fovbximt4lm	386	8	RA	RA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	386	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	386	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	386	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	386	12	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	386	13	REPLACE-2	REPLACE-2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	386	14	Investigators	Investigators	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	386	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	387	1	Bivalirudin	Bivalirudin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	2	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	387	3	provisional	provisional	JJ
work_tpiqgspaqvfeng2fovbximt4lm	387	4	glycoprotein	glycoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	5	IIb	IIb	NNS
work_tpiqgspaqvfeng2fovbximt4lm	387	6	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	387	7	IIIa	IIIa	NNS
work_tpiqgspaqvfeng2fovbximt4lm	387	8	blockade	blockade	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	9	compared	compare	VBN
work_tpiqgspaqvfeng2fovbximt4lm	387	10	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	387	11	hepa-	hepa-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	12	rin	rin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	387	14	planned	plan	VBN
work_tpiqgspaqvfeng2fovbximt4lm	387	15	glycoprotein	glycoprotein	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	16	IIb	IIb	NNS
work_tpiqgspaqvfeng2fovbximt4lm	387	17	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	387	18	IIIa	IIIa	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	387	19	blockade	blockade	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	20	d	d	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	21	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	22	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	23	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	24	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	387	25	g	g	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	26	p	p	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	27	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	28	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	29	c	c	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	30	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	31	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	32	a	a	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	33	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	34	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	35	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	36	u	u	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	37	s	s	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	38	c	c	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	39	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	40	r	r	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	41	o	o	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	42	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	43	a	a	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	44	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	45	y	y	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	46	i	i	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	47	n	n	CC
work_tpiqgspaqvfeng2fovbximt4lm	387	48	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	49	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	50	r	r	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	51	v	v	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	52	e	e	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	53	n	n	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	54	t	t	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	55	i	i	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	56	o	o	XX
work_tpiqgspaqvfeng2fovbximt4lm	387	57	n	n	XX
work_tpiqgspaqvfeng2fovbximt4lm	387	58	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	387	59	REPLACE-2	REPLACE-2	NNP
work_tpiqgspaqvfeng2fovbximt4lm	387	60	randomized	randomized	JJ
work_tpiqgspaqvfeng2fovbximt4lm	387	61	trial	trial	NN
work_tpiqgspaqvfeng2fovbximt4lm	387	62	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	388	1	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	388	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	389	1	2003;289	2003;289	LS
work_tpiqgspaqvfeng2fovbximt4lm	389	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	389	3	7):853	7):853	NNS
work_tpiqgspaqvfeng2fovbximt4lm	389	4	-	-	:
work_tpiqgspaqvfeng2fovbximt4lm	389	5	863	863	CD
work_tpiqgspaqvfeng2fovbximt4lm	389	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	390	1	29	29	CD
work_tpiqgspaqvfeng2fovbximt4lm	390	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	391	1	Applegate	applegate	VB
work_tpiqgspaqvfeng2fovbximt4lm	391	2	RJ	RJ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	391	4	Sacrinty	Sacrinty	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	5	MT	MT	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	391	7	Little	little	JJ
work_tpiqgspaqvfeng2fovbximt4lm	391	8	WC	WC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	391	10	Santos	Santos	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	11	RM	RM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	391	13	Gandhi	Gandhi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	14	SK	SK	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	15	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	391	16	Kutcher	Kutcher	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	17	MA	MA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	391	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	392	1	Incidence	incidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	392	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	392	3	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	392	4	stent	stent	NN
work_tpiqgspaqvfeng2fovbximt4lm	392	5	thrombosis	thrombosis	NN
work_tpiqgspaqvfeng2fovbximt4lm	392	6	based	base	VBN
work_tpiqgspaqvfeng2fovbximt4lm	392	7	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	392	8	academic	academic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	392	9	research	research	NN
work_tpiqgspaqvfeng2fovbximt4lm	392	10	consortium	consortium	NN
work_tpiqgspaqvfeng2fovbximt4lm	392	11	definitions	definition	NNS
work_tpiqgspaqvfeng2fovbximt4lm	392	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	393	1	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	393	2	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	393	3	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	393	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	394	1	2008;102(6):683	2008;102(6):683	NNP
work_tpiqgspaqvfeng2fovbximt4lm	394	2	-	-	:
work_tpiqgspaqvfeng2fovbximt4lm	394	3	688	688	CD
work_tpiqgspaqvfeng2fovbximt4lm	394	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	395	1	30	30	CD
work_tpiqgspaqvfeng2fovbximt4lm	395	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	396	1	Almasy	Almasy	NNP
work_tpiqgspaqvfeng2fovbximt4lm	396	2	L	L	NNP
work_tpiqgspaqvfeng2fovbximt4lm	396	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	396	4	Blangero	Blangero	NNP
work_tpiqgspaqvfeng2fovbximt4lm	396	5	J.	J.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	396	6	Multipoint	Multipoint	NNP
work_tpiqgspaqvfeng2fovbximt4lm	396	7	quantitative-	quantitative-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	396	8	trait	trait	NNP
work_tpiqgspaqvfeng2fovbximt4lm	396	9	linkage	linkage	NN
work_tpiqgspaqvfeng2fovbximt4lm	396	10	analysis	analysis	NN
work_tpiqgspaqvfeng2fovbximt4lm	396	11	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	396	12	general	general	JJ
work_tpiqgspaqvfeng2fovbximt4lm	396	13	pedigrees	pedigree	NNS
work_tpiqgspaqvfeng2fovbximt4lm	396	14	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	397	1	Am	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	397	2	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	397	3	Hum	Hum	NNP
work_tpiqgspaqvfeng2fovbximt4lm	397	4	Genet	Genet	NNP
work_tpiqgspaqvfeng2fovbximt4lm	397	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	398	1	1998;62(5):1198	1998;62(5):1198	CD
work_tpiqgspaqvfeng2fovbximt4lm	398	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	398	3	1211	1211	CD
work_tpiqgspaqvfeng2fovbximt4lm	398	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	399	1	31	31	CD
work_tpiqgspaqvfeng2fovbximt4lm	399	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	400	1	Agarwala	Agarwala	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	2	R	R	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	400	4	Biesecker	Biesecker	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	5	LG	LG	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	400	7	Hopkins	Hopkins	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	8	KA	KA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	400	10	Francomano	Francomano	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	11	CA	CA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	400	13	Schäffer	Schäffer	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	14	AA	AA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	400	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	401	1	Software	software	NN
work_tpiqgspaqvfeng2fovbximt4lm	401	2	for	for	IN
work_tpiqgspaqvfeng2fovbximt4lm	401	3	constructing	construct	VBG
work_tpiqgspaqvfeng2fovbximt4lm	401	4	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	401	5	verify-	verify-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	401	6	ing	ing	NN
work_tpiqgspaqvfeng2fovbximt4lm	401	7	pedigrees	pedigree	NNS
work_tpiqgspaqvfeng2fovbximt4lm	401	8	within	within	IN
work_tpiqgspaqvfeng2fovbximt4lm	401	9	large	large	JJ
work_tpiqgspaqvfeng2fovbximt4lm	401	10	genealogies	genealogy	NNS
work_tpiqgspaqvfeng2fovbximt4lm	401	11	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	401	12	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	401	13	applica-	applica-	VBN
work_tpiqgspaqvfeng2fovbximt4lm	401	14	tion	tion	NN
work_tpiqgspaqvfeng2fovbximt4lm	401	15	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	401	16	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	401	17	Old	Old	NNP
work_tpiqgspaqvfeng2fovbximt4lm	401	18	Order	Order	NNP
work_tpiqgspaqvfeng2fovbximt4lm	401	19	Amish	Amish	NNP
work_tpiqgspaqvfeng2fovbximt4lm	401	20	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	401	21	Lancaster	Lancaster	NNP
work_tpiqgspaqvfeng2fovbximt4lm	401	22	County	County	NNP
work_tpiqgspaqvfeng2fovbximt4lm	401	23	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	402	1	Ge-	ge-	CC
work_tpiqgspaqvfeng2fovbximt4lm	402	2	nome	nome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	402	3	Res	Res	NNP
work_tpiqgspaqvfeng2fovbximt4lm	402	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	403	1	1998;8(3):211	1998;8(3):211	CD
work_tpiqgspaqvfeng2fovbximt4lm	403	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	403	3	221	221	CD
work_tpiqgspaqvfeng2fovbximt4lm	403	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	404	1	32	32	CD
work_tpiqgspaqvfeng2fovbximt4lm	404	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	405	1	Brandt	Brandt	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	2	JT	JT	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	405	4	Payne	Payne	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	5	CD	CD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	405	7	Wiviott	Wiviott	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	8	SD	SD	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	405	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	405	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	406	1	A	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	406	2	com-	com-	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	3	parison	parison	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	406	5	prasugrel	prasugrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	6	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	406	7	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	8	loading	loading	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	9	doses	dose	NNS
work_tpiqgspaqvfeng2fovbximt4lm	406	10	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	406	11	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	12	function	function	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	13	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	406	14	magnitude	magnitude	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	15	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	406	16	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	17	inhibition	inhibition	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	18	is	be	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	406	19	related	relate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	406	20	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	406	21	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	406	22	metabolite	metabolite	JJ
work_tpiqgspaqvfeng2fovbximt4lm	406	23	formation	formation	NN
work_tpiqgspaqvfeng2fovbximt4lm	406	24	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	407	1	Am	be	VBP
work_tpiqgspaqvfeng2fovbximt4lm	407	2	Heart	Heart	NNP
work_tpiqgspaqvfeng2fovbximt4lm	407	3	J.	J.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	408	1	2007;153(1):66.e9	2007;153(1):66.e9	LS
work_tpiqgspaqvfeng2fovbximt4lm	408	2	-	-	:
work_tpiqgspaqvfeng2fovbximt4lm	408	3	66.e16	66.e16	CD
work_tpiqgspaqvfeng2fovbximt4lm	408	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	409	1	33	33	CD
work_tpiqgspaqvfeng2fovbximt4lm	409	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	410	1	Takahashi	Takahashi	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	2	M	M	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	410	4	Pang	Pang	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	5	H	H	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	410	7	Kawabata	Kawabata	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	8	K	K	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	410	10	Farid	Farid	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	11	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	12	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	410	13	Kurihara	Kurihara	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	14	A.	a.	NN
work_tpiqgspaqvfeng2fovbximt4lm	410	15	Quantitative	quantitative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	410	16	determination	determination	NN
work_tpiqgspaqvfeng2fovbximt4lm	410	17	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	410	18	clop-	clop-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	19	idogrel	idogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	20	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	410	21	metabolite	metabolite	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	22	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	410	23	human	human	JJ
work_tpiqgspaqvfeng2fovbximt4lm	410	24	plasma	plasma	NN
work_tpiqgspaqvfeng2fovbximt4lm	410	25	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	410	26	LC	LC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	27	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	410	28	MS	MS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	29	/	/	SYM
work_tpiqgspaqvfeng2fovbximt4lm	410	30	MS	MS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	410	31	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	411	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	411	2	Pharm	Pharm	NNP
work_tpiqgspaqvfeng2fovbximt4lm	411	3	Biomed	Biomed	NNP
work_tpiqgspaqvfeng2fovbximt4lm	411	4	Anal	Anal	NNP
work_tpiqgspaqvfeng2fovbximt4lm	411	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	412	1	2008;48(4	2008;48(4	LS
work_tpiqgspaqvfeng2fovbximt4lm	412	2	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	412	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	412	4	1219	1219	CD
work_tpiqgspaqvfeng2fovbximt4lm	412	5	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	412	6	1224	1224	CD
work_tpiqgspaqvfeng2fovbximt4lm	412	7	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	413	1	34	34	CD
work_tpiqgspaqvfeng2fovbximt4lm	413	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	414	1	Umemura	Umemura	NNP
work_tpiqgspaqvfeng2fovbximt4lm	414	2	K	K	NNP
work_tpiqgspaqvfeng2fovbximt4lm	414	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	414	4	Furuta	Furuta	NNP
work_tpiqgspaqvfeng2fovbximt4lm	414	5	T	T	NNP
work_tpiqgspaqvfeng2fovbximt4lm	414	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	414	7	Kondo	Kondo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	414	8	K.	K.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	414	9	The	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	414	10	common	common	JJ
work_tpiqgspaqvfeng2fovbximt4lm	414	11	gene	gene	NN
work_tpiqgspaqvfeng2fovbximt4lm	414	12	variants	variant	NNS
work_tpiqgspaqvfeng2fovbximt4lm	414	13	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	414	14	CYP2C19	cyp2c19	VBP
work_tpiqgspaqvfeng2fovbximt4lm	414	15	affect	affect	VBP
work_tpiqgspaqvfeng2fovbximt4lm	414	16	pharmacokinetics	pharmacokinetic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	414	17	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	414	18	phar-	phar-	NN
work_tpiqgspaqvfeng2fovbximt4lm	414	19	macodynamics	macodynamic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	414	20	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	414	21	an	an	DT
work_tpiqgspaqvfeng2fovbximt4lm	414	22	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	414	23	metabolite	metabolite	NN
work_tpiqgspaqvfeng2fovbximt4lm	414	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	414	25	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	414	26	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	414	27	healthy	healthy	JJ
work_tpiqgspaqvfeng2fovbximt4lm	414	28	subjects	subject	NNS
work_tpiqgspaqvfeng2fovbximt4lm	414	29	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	415	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	415	2	Thromb	Thromb	NNP
work_tpiqgspaqvfeng2fovbximt4lm	415	3	Haemost	Haemost	NNP
work_tpiqgspaqvfeng2fovbximt4lm	415	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	416	1	2008;6	2008;6	LS
work_tpiqgspaqvfeng2fovbximt4lm	416	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	416	3	8):1439	8):1439	CD
work_tpiqgspaqvfeng2fovbximt4lm	416	4	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	416	5	1441	1441	CD
work_tpiqgspaqvfeng2fovbximt4lm	416	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	417	1	35	35	CD
work_tpiqgspaqvfeng2fovbximt4lm	417	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	418	1	Wallentin	Wallentin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	2	L	L	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	418	4	Varenhorst	Varenhorst	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	5	C	C	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	418	7	James	James	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	8	S	S	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	418	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	418	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	419	1	Prasu-	Prasu-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	419	2	grel	grel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	419	3	achieves	achieve	VBZ
work_tpiqgspaqvfeng2fovbximt4lm	419	4	greater	great	JJR
work_tpiqgspaqvfeng2fovbximt4lm	419	5	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	419	6	faster	fast	JJR
work_tpiqgspaqvfeng2fovbximt4lm	419	7	P2Y12	P2Y12	NNP
work_tpiqgspaqvfeng2fovbximt4lm	419	8	receptor-	receptor-	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	9	mediated	mediate	VBD
work_tpiqgspaqvfeng2fovbximt4lm	419	10	platelet	platelet	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	11	inhibition	inhibition	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	12	than	than	IN
work_tpiqgspaqvfeng2fovbximt4lm	419	13	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	14	due	due	IN
work_tpiqgspaqvfeng2fovbximt4lm	419	15	to	to	IN
work_tpiqgspaqvfeng2fovbximt4lm	419	16	more	more	RBR
work_tpiqgspaqvfeng2fovbximt4lm	419	17	efficient	efficient	JJ
work_tpiqgspaqvfeng2fovbximt4lm	419	18	generation	generation	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	19	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	419	20	its	-PRON-	PRP$
work_tpiqgspaqvfeng2fovbximt4lm	419	21	active	active	JJ
work_tpiqgspaqvfeng2fovbximt4lm	419	22	metabolite	metabolite	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	23	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	419	24	aspirin	aspirin	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	25	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	419	26	treated	treat	VBN
work_tpiqgspaqvfeng2fovbximt4lm	419	27	patients	patient	NNS
work_tpiqgspaqvfeng2fovbximt4lm	419	28	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	419	29	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	419	30	artery	artery	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	31	disease	disease	NN
work_tpiqgspaqvfeng2fovbximt4lm	419	32	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	420	1	Eur	Eur	NNP
work_tpiqgspaqvfeng2fovbximt4lm	420	2	Heart	Heart	NNP
work_tpiqgspaqvfeng2fovbximt4lm	420	3	J.	j.	NN
work_tpiqgspaqvfeng2fovbximt4lm	421	1	2008;29(1):21	2008;29(1):21	CD
work_tpiqgspaqvfeng2fovbximt4lm	421	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	421	3	30	30	CD
work_tpiqgspaqvfeng2fovbximt4lm	421	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	422	1	36	36	CD
work_tpiqgspaqvfeng2fovbximt4lm	422	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	423	1	Luo	Luo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	2	HR	HR	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	423	4	Poland	Poland	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	5	RE	RE	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	423	7	Lin	Lin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	8	KM	KM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	423	10	Wan	Wan	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	11	YJ	YJ	NNP
work_tpiqgspaqvfeng2fovbximt4lm	423	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	424	1	Genetic	genetic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	424	2	poly-	poly-	NN
work_tpiqgspaqvfeng2fovbximt4lm	424	3	morphism	morphism	NN
work_tpiqgspaqvfeng2fovbximt4lm	424	4	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	424	5	cytochrome	cytochrome	JJ
work_tpiqgspaqvfeng2fovbximt4lm	424	6	P450	p450	NN
work_tpiqgspaqvfeng2fovbximt4lm	424	7	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	424	8	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	424	9	Mexican	Mexican	NNP
work_tpiqgspaqvfeng2fovbximt4lm	424	10	Americans	Americans	NNPS
work_tpiqgspaqvfeng2fovbximt4lm	424	11	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	424	12	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	424	13	cross	cross	JJ
work_tpiqgspaqvfeng2fovbximt4lm	424	14	-	-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	424	15	ethnic	ethnic	JJ
work_tpiqgspaqvfeng2fovbximt4lm	424	16	comparative	comparative	JJ
work_tpiqgspaqvfeng2fovbximt4lm	424	17	study	study	NN
work_tpiqgspaqvfeng2fovbximt4lm	424	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	425	1	Clin	Clin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	425	2	Phar-	Phar-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	425	3	macol	macol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	425	4	Ther	Ther	NNP
work_tpiqgspaqvfeng2fovbximt4lm	425	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	426	1	2006;80(1):33	2006;80(1):33	CD
work_tpiqgspaqvfeng2fovbximt4lm	426	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	426	3	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	426	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	427	1	37	37	CD
work_tpiqgspaqvfeng2fovbximt4lm	427	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	428	1	Xiao	Xiao	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	2	ZS	ZS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	428	4	Goldstein	Goldstein	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	5	JA	JA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	428	7	Xie	Xie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	8	HG	HG	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	428	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	428	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	429	1	Differences	difference	NNS
work_tpiqgspaqvfeng2fovbximt4lm	429	2	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	429	3	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	429	4	incidence	incidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	429	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	429	6	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	429	7	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	429	8	polymorphism	polymorphism	NN
work_tpiqgspaqvfeng2fovbximt4lm	429	9	af-	af-	IN
work_tpiqgspaqvfeng2fovbximt4lm	429	10	fecting	fecte	VBG
work_tpiqgspaqvfeng2fovbximt4lm	429	11	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	429	12	S	S	NNP
work_tpiqgspaqvfeng2fovbximt4lm	429	13	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	429	14	mephenytoin	mephenytoin	NN
work_tpiqgspaqvfeng2fovbximt4lm	429	15	phenotype	phenotype	NN
work_tpiqgspaqvfeng2fovbximt4lm	429	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	429	17	Chinese	Chinese	NNP
work_tpiqgspaqvfeng2fovbximt4lm	429	18	Han	Han	NNP
work_tpiqgspaqvfeng2fovbximt4lm	429	19	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	429	20	Bai	Bai	NNP
work_tpiqgspaqvfeng2fovbximt4lm	429	21	populations	population	NNS
work_tpiqgspaqvfeng2fovbximt4lm	429	22	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	429	23	identification	identification	NN
work_tpiqgspaqvfeng2fovbximt4lm	429	24	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	429	25	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	429	26	new	new	JJ
work_tpiqgspaqvfeng2fovbximt4lm	429	27	rare	rare	JJ
work_tpiqgspaqvfeng2fovbximt4lm	429	28	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	429	29	mutant	mutant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	429	30	allele	allele	NNP
work_tpiqgspaqvfeng2fovbximt4lm	429	31	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	430	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	430	2	Pharmacol	Pharmacol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	430	3	Exp	Exp	NNP
work_tpiqgspaqvfeng2fovbximt4lm	430	4	Ther	Ther	NNP
work_tpiqgspaqvfeng2fovbximt4lm	430	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	431	1	1997	1997	CD
work_tpiqgspaqvfeng2fovbximt4lm	431	2	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	431	3	281(1):604	281(1):604	NNP
work_tpiqgspaqvfeng2fovbximt4lm	431	4	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	431	5	609	609	CD
work_tpiqgspaqvfeng2fovbximt4lm	431	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	432	1	38	38	CD
work_tpiqgspaqvfeng2fovbximt4lm	432	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	433	1	Takakubo	Takakubo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	433	2	F	F	NNP
work_tpiqgspaqvfeng2fovbximt4lm	433	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	433	4	Kuwano	Kuwano	NNP
work_tpiqgspaqvfeng2fovbximt4lm	433	5	A	A	NNP
work_tpiqgspaqvfeng2fovbximt4lm	433	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	433	7	Kondo	Kondo	NNP
work_tpiqgspaqvfeng2fovbximt4lm	433	8	I.	I.	NNP
work_tpiqgspaqvfeng2fovbximt4lm	434	1	Evidence	evidence	NN
work_tpiqgspaqvfeng2fovbximt4lm	434	2	that	that	IN
work_tpiqgspaqvfeng2fovbximt4lm	434	3	poor	poor	JJ
work_tpiqgspaqvfeng2fovbximt4lm	434	4	metabolizers	metabolizer	NNS
work_tpiqgspaqvfeng2fovbximt4lm	434	5	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	434	6	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	434	7	S)-mephenytoin	S)-mephenytoin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	434	8	could	could	MD
work_tpiqgspaqvfeng2fovbximt4lm	434	9	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	434	10	iden-	iden-	RB
work_tpiqgspaqvfeng2fovbximt4lm	434	11	tified	tifie	VBN
work_tpiqgspaqvfeng2fovbximt4lm	434	12	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	434	13	haplotypes	haplotype	NNS
work_tpiqgspaqvfeng2fovbximt4lm	434	14	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	434	15	CYP2C19	CYP2C19	NNP
work_tpiqgspaqvfeng2fovbximt4lm	434	16	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	434	17	Japanese	Japanese	NNP
work_tpiqgspaqvfeng2fovbximt4lm	434	18	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	435	1	Pharmacogenetics	pharmacogenetic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	435	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	436	1	1996;6(3):265	1996;6(3):265	CD
work_tpiqgspaqvfeng2fovbximt4lm	436	2	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	436	3	267	267	CD
work_tpiqgspaqvfeng2fovbximt4lm	436	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	437	1	39	39	CD
work_tpiqgspaqvfeng2fovbximt4lm	437	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	438	1	Gurbel	Gurbel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	438	2	PA	PA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	438	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	438	4	Lau	Lau	NNP
work_tpiqgspaqvfeng2fovbximt4lm	438	5	WC	WC	NNP
work_tpiqgspaqvfeng2fovbximt4lm	438	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	438	7	Tantry	Tantry	NNP
work_tpiqgspaqvfeng2fovbximt4lm	438	8	US	US	NNP
work_tpiqgspaqvfeng2fovbximt4lm	438	9	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	439	1	Omeprazole	omeprazole	NN
work_tpiqgspaqvfeng2fovbximt4lm	439	2	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	439	3	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	439	4	possible	possible	JJ
work_tpiqgspaqvfeng2fovbximt4lm	439	5	new	new	JJ
work_tpiqgspaqvfeng2fovbximt4lm	439	6	candidate	candidate	NN
work_tpiqgspaqvfeng2fovbximt4lm	439	7	influencing	influence	VBG
work_tpiqgspaqvfeng2fovbximt4lm	439	8	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	439	9	antiplatelet	antiplatelet	JJ
work_tpiqgspaqvfeng2fovbximt4lm	439	10	effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	439	11	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	439	12	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	439	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	440	1	J	J	NNP
work_tpiqgspaqvfeng2fovbximt4lm	440	2	Am	Am	NNP
work_tpiqgspaqvfeng2fovbximt4lm	440	3	Coll	Coll	NNP
work_tpiqgspaqvfeng2fovbximt4lm	440	4	Cardiol	Cardiol	NNP
work_tpiqgspaqvfeng2fovbximt4lm	440	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	441	1	2008	2008	CD
work_tpiqgspaqvfeng2fovbximt4lm	441	2	;	;	:
work_tpiqgspaqvfeng2fovbximt4lm	441	3	51(3):261	51(3):261	CD
work_tpiqgspaqvfeng2fovbximt4lm	441	4	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	441	5	263	263	CD
work_tpiqgspaqvfeng2fovbximt4lm	441	6	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	442	1	40	40	CD
work_tpiqgspaqvfeng2fovbximt4lm	442	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	443	1	Ho	Ho	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	2	PM	PM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	443	4	Maddox	Maddox	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	5	TM	TM	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	443	7	Wang	Wang	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	8	L	L	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	443	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	443	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	444	1	Risk	risk	NN
work_tpiqgspaqvfeng2fovbximt4lm	444	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	444	3	ad-	ad-	CC
work_tpiqgspaqvfeng2fovbximt4lm	444	4	verse	verse	NN
work_tpiqgspaqvfeng2fovbximt4lm	444	5	outcomes	outcome	NNS
work_tpiqgspaqvfeng2fovbximt4lm	444	6	associated	associate	VBN
work_tpiqgspaqvfeng2fovbximt4lm	444	7	with	with	IN
work_tpiqgspaqvfeng2fovbximt4lm	444	8	concomitant	concomitant	JJ
work_tpiqgspaqvfeng2fovbximt4lm	444	9	use	use	NN
work_tpiqgspaqvfeng2fovbximt4lm	444	10	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	444	11	clopidogrel	clopidogrel	NNP
work_tpiqgspaqvfeng2fovbximt4lm	444	12	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	444	13	proton	proton	NNP
work_tpiqgspaqvfeng2fovbximt4lm	444	14	pump	pump	NN
work_tpiqgspaqvfeng2fovbximt4lm	444	15	inhibitors	inhibitor	NNS
work_tpiqgspaqvfeng2fovbximt4lm	444	16	following	follow	VBG
work_tpiqgspaqvfeng2fovbximt4lm	444	17	acute	acute	JJ
work_tpiqgspaqvfeng2fovbximt4lm	444	18	coronary	coronary	JJ
work_tpiqgspaqvfeng2fovbximt4lm	444	19	syndrome	syndrome	NN
work_tpiqgspaqvfeng2fovbximt4lm	444	20	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	445	1	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	445	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	446	1	2009;301(9):937-	2009;301(9):937-	NNP
work_tpiqgspaqvfeng2fovbximt4lm	446	2	944	944	CD
work_tpiqgspaqvfeng2fovbximt4lm	446	3	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	447	1	41	41	CD
work_tpiqgspaqvfeng2fovbximt4lm	447	2	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	448	1	Small	Small	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	2	DS	DS	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	3	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	448	4	Farid	Farid	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	5	NA	NA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	6	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	448	7	Li	Li	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	8	YG	YG	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	9	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	448	10	et	et	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	11	al	al	NNP
work_tpiqgspaqvfeng2fovbximt4lm	448	12	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	449	1	Effect	effect	NN
work_tpiqgspaqvfeng2fovbximt4lm	449	2	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	449	3	raniti-	raniti-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	449	4	dine	dine	NN
work_tpiqgspaqvfeng2fovbximt4lm	449	5	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	449	6	the	the	DT
work_tpiqgspaqvfeng2fovbximt4lm	449	7	pharmacokinetics	pharmacokinetic	NNS
work_tpiqgspaqvfeng2fovbximt4lm	449	8	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	449	9	pharmacodynam-	pharmacodynam-	JJ
work_tpiqgspaqvfeng2fovbximt4lm	449	10	ics	ics	NN
work_tpiqgspaqvfeng2fovbximt4lm	449	11	of	of	IN
work_tpiqgspaqvfeng2fovbximt4lm	449	12	prasugrel	prasugrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	449	13	and	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	449	14	clopidogrel	clopidogrel	NN
work_tpiqgspaqvfeng2fovbximt4lm	449	15	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	450	1	Curr	curr	UH
work_tpiqgspaqvfeng2fovbximt4lm	450	2	Med	Med	NNP
work_tpiqgspaqvfeng2fovbximt4lm	450	3	Res	Res	NNP
work_tpiqgspaqvfeng2fovbximt4lm	450	4	Opin	Opin	NNP
work_tpiqgspaqvfeng2fovbximt4lm	450	5	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	451	1	2008;24(8):2251	2008;24(8):2251	CD
work_tpiqgspaqvfeng2fovbximt4lm	451	2	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	451	3	2257	2257	CD
work_tpiqgspaqvfeng2fovbximt4lm	451	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	452	1	In	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	452	2	order	order	NN
work_tpiqgspaqvfeng2fovbximt4lm	452	3	to	to	TO
work_tpiqgspaqvfeng2fovbximt4lm	452	4	be	be	VB
work_tpiqgspaqvfeng2fovbximt4lm	452	5	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	452	6	realist	realist	NN
work_tpiqgspaqvfeng2fovbximt4lm	452	7	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	452	8	you	-PRON-	PRP
work_tpiqgspaqvfeng2fovbximt4lm	452	9	must	must	MD
work_tpiqgspaqvfeng2fovbximt4lm	452	10	believe	believe	VB
work_tpiqgspaqvfeng2fovbximt4lm	452	11	in	in	IN
work_tpiqgspaqvfeng2fovbximt4lm	452	12	miracles	miracle	NNS
work_tpiqgspaqvfeng2fovbximt4lm	452	13	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	453	1	—	—	:
work_tpiqgspaqvfeng2fovbximt4lm	453	2	David	David	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	3	Ben	Ben	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	4	-	-	HYPH
work_tpiqgspaqvfeng2fovbximt4lm	453	5	Gurion	Gurion	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	6	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	453	7	1886	1886	CD
work_tpiqgspaqvfeng2fovbximt4lm	453	8	-	-	SYM
work_tpiqgspaqvfeng2fovbximt4lm	453	9	1973	1973	CD
work_tpiqgspaqvfeng2fovbximt4lm	453	10	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	453	11	CYTOCHROME	CYTOCHROME	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	12	P450	P450	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	13	2C19	2c19	CD
work_tpiqgspaqvfeng2fovbximt4lm	453	14	GENOTYPE	GENOTYPE	NNS
work_tpiqgspaqvfeng2fovbximt4lm	453	15	AND	and	CC
work_tpiqgspaqvfeng2fovbximt4lm	453	16	CLOPIDOGREL	CLOPIDOGREL	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	17	THERAPY	THERAPY	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	18	858	858	CD
work_tpiqgspaqvfeng2fovbximt4lm	453	19	JAMA	JAMA	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	20	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	453	21	August	August	NNP
work_tpiqgspaqvfeng2fovbximt4lm	453	22	26	26	CD
work_tpiqgspaqvfeng2fovbximt4lm	453	23	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	453	24	2009—Vol	2009—vol	CD
work_tpiqgspaqvfeng2fovbximt4lm	453	25	302	302	CD
work_tpiqgspaqvfeng2fovbximt4lm	453	26	,	,	,
work_tpiqgspaqvfeng2fovbximt4lm	453	27	No	no	UH
work_tpiqgspaqvfeng2fovbximt4lm	453	28	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	454	1	8	8	LS
work_tpiqgspaqvfeng2fovbximt4lm	454	2	(	(	-LRB-
work_tpiqgspaqvfeng2fovbximt4lm	454	3	Reprinted	Reprinted	NNP
work_tpiqgspaqvfeng2fovbximt4lm	454	4	)	)	-RRB-
work_tpiqgspaqvfeng2fovbximt4lm	454	5	©	©	NNP
work_tpiqgspaqvfeng2fovbximt4lm	454	6	2009	2009	CD
work_tpiqgspaqvfeng2fovbximt4lm	454	7	American	American	NNP
work_tpiqgspaqvfeng2fovbximt4lm	454	8	Medical	Medical	NNP
work_tpiqgspaqvfeng2fovbximt4lm	454	9	Association	Association	NNP
work_tpiqgspaqvfeng2fovbximt4lm	454	10	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	455	1	All	all	DT
work_tpiqgspaqvfeng2fovbximt4lm	455	2	rights	right	NNS
work_tpiqgspaqvfeng2fovbximt4lm	455	3	reserved	reserve	VBD
work_tpiqgspaqvfeng2fovbximt4lm	455	4	.	.	.
work_tpiqgspaqvfeng2fovbximt4lm	456	1	Downloaded	download	VBN
work_tpiqgspaqvfeng2fovbximt4lm	456	2	From	from	IN
work_tpiqgspaqvfeng2fovbximt4lm	456	3	:	:	:
work_tpiqgspaqvfeng2fovbximt4lm	456	4	https://jamanetwork.com/	https://jamanetwork.com/	CD
work_tpiqgspaqvfeng2fovbximt4lm	456	5	by	by	IN
work_tpiqgspaqvfeng2fovbximt4lm	456	6	a	a	DT
work_tpiqgspaqvfeng2fovbximt4lm	456	7	Carnegie	Carnegie	NNP
work_tpiqgspaqvfeng2fovbximt4lm	456	8	Mellon	Mellon	NNP
work_tpiqgspaqvfeng2fovbximt4lm	456	9	University	University	NNP
work_tpiqgspaqvfeng2fovbximt4lm	456	10	User	User	NNP
work_tpiqgspaqvfeng2fovbximt4lm	456	11	on	on	IN
work_tpiqgspaqvfeng2fovbximt4lm	456	12	04/05/2021	04/05/2021	CD